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“My brain is only a receiver, in the Universe there is a core from 
which we obtain knowledge, strength and inspiration. I have not 
penetrated into the secrets of this core, but I know that it exists.” 
Nikola Tesla  
 
Nikola Tesla (1856-1943). Austro-Hungarian electrical and 
mechanical engineer, Tesla was one of the greatest and most 
enigmatic scientists of the 20th century. Tesla obtained over 
700 patents in fields including electricity, robotics, radar and 
wireless transmission of energy. Tesla's discoveries laid the 
groundwork for many of the technological advances of the 20th 
century. 
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Summary 
Nutritional immunotherapy is based on promoting health through the dietary intake of natural 
bioactive compounds found in food, such as the procyanidins and docosahexaenoic n-3 
polyunsaturated fatty acid (DHA), optimising the functionality of the host’s own immune 
system and improving its role in the preservation of the body against destabilisers of 
homeostasis. The research that this thesis encompasses is focused on the role of the 
nutritional profile in the regulation of immunometabolism.  
To accomplish this purpose, in the first part of the work presented in this thesis, we 
determined whether macrophages, the effector cells of innate immunity, could differentially 
sense dietary composition. We demonstrated that bioactive food compounds modulate, at 
the molecular level, the functionality of macrophages by hindering macrophage activation. 
Furthermore, this immunomodulatory effect is compound-dependent, relying on the intrinsic 
factors of each compound, such as chemical and nutritional properties, to determine its 
bioactivity. 
The second part was aimed at determining the role of the dietary pattern within the complex 
crosstalk of immunity and metabolism using an in vivo model of diet-induced obesity. We 
determined that immunometabolic regulation depends on the nutritional profile. While a diet 
based on foods with a high energy content can weaken immunometabolism, the presence of 
bioactive foods such as procyanidins or DHA can strengthen the relationship. 
Within the third part, we evaluated the role of gene-diet interactions in the phenotypic 
expression of obesity-related complex traits. Using a diet-induced obesity model, two distinct 
genetic backgrounds (phenotypically different inbred rat strains) were immunometabolically 
challenged. Our results revealed that interactions between genetic and dietary factors are 
fundamental for the susceptibility of a genotype to diet-induced obesity. 
We established that the nutritional profile is a powerful tool to target the functionality of the 
immunometabolic axis. We further concluded that bioactive compounds present in food 
improve the efficiency of this axis, thereby promoting a healthy state. 
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1. Introduction 
The dietary intake pattern, and specifically the nutritional profile, are essential for the 
regulation of metabolism and also fundamental for correct functioning of the immune system 
and its capacity to sense harmful stimuli. Thus, depending on the nutritional profile the 
immune response could be improved or compromised.  
A deeper understanding of how our dietary patterns and nutritional status affect the 
composition and the dynamic interactions between metabolism and the immune system 
could be considered an opportunity and a powerful tool for developing nutrition-based 
immune therapies to target metabolic diseases, as well as to modulate the ability of the 
metabolic system to regulate immune function. 
Immunotherapy refers to the treatment of pathologies through the improvement of the 
functionality of the host immune system, based on the activation, enhancement or 
suppression of the immune response. Therefore, nutritional immunotherapy is focused on 
the nutritional profile, and specifically in natural bioactive food compounds, as tools to target 
the immune system and, through the promotion of its proper function, promote and/or restore 
homeostasis. 
1.1.  Immunometabolism 
Immunometabolism refers to the interface between the immune and metabolic systems, two 
closely integrated disciplines, as the proper functioning of one is dependent upon the other 
[1]. A greater interest in immunometabolism has recently emerged as a consequence of the 
obesity epidemic and because obesity affects not only metabolism but also the functionality 
of the immune system [2].  
Two central mechanisms are essential for the survival of multicellular organisms: the ability 
to store energy to prevent starvation and the ability to fight infection. Both immune and 
metabolic pathways are highly conserved and a delicate balance has evolved. The activation 
of the immune response is highly energy-demanding and shifts energy away from 
nonessential functions [3]. Conversely, infection often results in metabolic disruptions such 
as insulin resistance [4].  
The immune system monitors and responds to the metabolic state of tissues and organisms 
[2]. Therefore, although obesity is not classically considered an immunopathology, it results 
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in the mobilisation of the innate and adaptive immune systems and is characterised by a 
state of low-grade inflammation. On the other hand, the metabolic state is able to control the 
function of immune cells, and deregulation of the immune system is also an etiopathological 
event in obesity. Thus, the proper functioning of the immunometabolic axis is central for the 
promotion and maintenance of body homeostasis and therefore health. 
1.2.  Immune system 
The immune system is an interactive network of lymphoid organs, immune cells, humoral 
factors and a wide array of molecules, with the main goal of defending the host against 
endogenous or exogenous noxious stimuli.  
Immunity results from the interaction between two branches: innate and adaptive immune 
responses (Figure 1). Innate immunity is the first line of host defence and is mediated mainly 
by leukocytes, including mast cells, granulocytes, monocytes, macrophages and natural 
killer cells. These immune cells are involved in the phagocytosis of pathogens, free radical 
production (the oxidative burst), cytokine production and antigen presentation to 
lymphocytes.  
 
Figure 1. Simplified overview of the innate and adaptive immune systems. Adapted from [7]. 
In contrast, the adaptive immune response is involved in the elimination of pathogens in the 
late phase as well as in the generation of immunological memory. Adaptive immunity 
depends on the production of antibodies (immunoglobulins (Igs)) by B-lymphocytes directed 
against specific antigens present on pathogens (also termed the humoral immune 
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response). The adaptive immune response also depends on the attack of infected body cells 
by cytotoxic (CD8+) and helper (CD4+) T-lymphocytes (also termed the cell-mediated 
immune response). In addition, due to the presence of memory cells, the adaptive immune 
response is characterised by enhanced and fast responses after repetitive contact with the 
same antigen. 
Thus, after leukocytes of the innate system sense a harmful stimuli they become activated, 
inducing the production and secretion of cytokines as well as presenting antigens to T- and 
B-lymphocytes, which in turn activates the adaptive immune system [5,6]. 
However, the innate immune response is not completely nonspecific, as was originally 
thought, but rather is able to discriminate between harmful and non-harmful stimuli. The 
innate immune system recognises microorganisms via a limited number of germline-
encoded receptors, in contrast to the large repertoire of receptors generated via genetic 
recombination through the adaptive immune system.  
1.2.1. Signalling in innate immunity and inflammation 
Inflammation is defined as the body’s immediate response, and it is triggered by innate 
immune cells after sensing molecular patterns from noxious stimuli to combat them and 
restore the system back to the homeostasis [8]. Thus, to neutralise the causative agent, the 
innate immune system orchestrates a coordinated action involving innate immune cells and 
inflammatory mediators, whose roles will depend on the nature of the triggering stimuli. The 
inflammatory response underlies a wide variety of physiological and pathological processes 
[9]. 
Innate immune cells recognise pathogen invasion or cell stress through highly conserved 
germline-encoded pattern recognition receptors (PRRs). These receptors bind to common 
pathogen-associated molecular patterns (PAMPs) such as microbial nucleic acids, 
lipoproteins and carbohydrates, or damage-associated molecular patterns (DAMPs) 
released from injured cells. Once activated, PRRs oligomerise and assemble large multi-
subunit complexes that initiate cell-signalling cascades to trigger the release of factors that 
promote the recruitment of leukocytes to the region [8,10]. 
There are several families of PRRs, including the Toll-like receptors (TLRs) that sense 
conserved molecules from bacteria, viruses and parasites, and the NOD-like receptors 
(NLRs) that sense bacterial products and endogenous stress-induced molecules [8]. 
PAMPs and DAMPs are also involved in the activation of adaptive immunity, as T cells can 
be activated either indirectly, through the production of pro-inflammatory cytokines by innate 
immune cells, or directly by binding of PRRs on T cells [11]. 
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Figure 2. PAMP- and DAMP-mediated activation of innate immune response. Adapted from [11]. 
Inflammation can also be classified depending on the duration of the response. Acute 
inflammation is a short-term response, mainly initiated by tissue-resident macrophages and 
mast cells that recruit leukocytes, acute-phase proteins and adhesion molecules to the 
damaged region. This acute response leads to the activation of several transcription factors 
such as mitogen-activated protein kinase (MAPK), janus kinase/signal transducer and 
activator of transcription (JAK/STAT) and nuclear factor kappa B (NF-κB). Chronic 
inflammation, by contrast, is a non-resolved, dysregulated and maladaptive inflammatory 
response that involves not only the activation of the innate but also the adaptive immune 
response. Additionally, distinct from the classically described inflammatory response is 
metabolic inflammation, also termed metaflammation (Figure 3).  
Metaflammation is defined as a low-grade chronic inflammation and is orchestrated by 
metabolic cells in response to an excess of nutrients and energy. Furthermore, 
metaflammation is distinctive and is outside the paradigm of classical inflammation defined 
by the cardinal signs of redness, swelling, heat and pain. Additionally, metaflammation is not 
accompanied by increased basal energy expenditure. 
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Figure 3. Signalling pathways involved in classical inflammation and in metabolic inflammation. 
Adapted from [12]. 
1.2.1.1. Toll-like receptors and NF-κB 
Toll-like receptors are type I membrane glycoproteins that contain an extracellular leucine-
rich repeat (LRR) domain, a transmembrane domain and a cytoplasmic Toll/IL-1 receptor 
(TIR) domain required for downstream signal transduction. Based on their primary 
sequences, 9 different TLRs have been identified in humans and 13 in mice; they are further 
divided into several subfamilies, each of which recognises specific PAMPs. 
The expression of TLRs is not static but rather is modulated rapidly in response to 
pathogens, a variety of cytokines and environmental stress. TLRs may be expressed extra- 
or intra-cellularly. Thus, whereas certain TLRs (TLR1, 2, 4, 5 and 6) are expressed on the 
surface, others (TLR3, 7, 8 and 9) are found almost exclusively within endocytic 
compartments in the cytoplasm, and their ligands, mainly nucleic acids, require 
internalisation to the endosome before signalling [13] can occur. TLRs are expressed on 
immune cells, including macrophages, dendritic cells and B cells, but also in non-immune 
cells such as epithelial cells, endothelial cells or adipocytes. Although TLRs are essential for 
protective immunity against infection, TLR signalling must be tightly regulated to avoid 
inappropriate TLR responses, which result in acute and chronic inflammation as well as 
autoimmune diseases. 
The TLR4 signalling pathway has a pivotal role in the initiation and amplification of innate 
immune response through the activation of the inducible transcription factor NF-κB. TLR4 
recognises a very divergent collection of ligands, of which the gram-negative bacteria 
lipopolysaccharide (LPS) is the best characterised. The LPS-TLR4 interaction is mediated by 
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the lipid moiety constituent of LPS, Lipid A. This is of great relevance, because the key for 
LPS toxicity is the shape and conformation of this lipid, particularly the number and length of 
the fatty acid chains, which determine the toxicity of a given pathogen [14]. The recognition 
and subsequent interaction between the PAMP and TLR4 result in the triggering of 
downstream signalling cascades that lead to the activation of the inducible transcription 
factor NF-κB. 
The NF-κB family is comprised of dimeric transcription factors that contain Rel- N-terminal 
Rel homology domains (RHD) that are responsible for binding to discrete DNA sequences, 
known as κB sites, present in promoter and enhancer regions of target genes. In 
mammalian cells, there are five members of the NF-κB family: p65 (RelA), c-Rel, RelB, p105 
(the precursor of p50) and p100 (the precursor of p52). Although the NF-κB proteins form 
several homo- and hetero-dimers, the most frequently activated form of NF-κB is a 
heterodimer composed of the p50 and p65 subunits. The IκB family is characterised by 
ankyrin repeats and consists of several members: IκBα, IκBβ, IκBγ, IκBε, Bcl-3 and IκBζ. 
IκBα, IκBβ, IκBγ and IκBε, can mask the nuclear localisation signal of NF-κB in the 
cytoplasm through direct interactions to prevent translocation of NF-κB [15]. There are two 
described NF-κB signalling pathways: the canonical pathway and the alternative route. The 
main difference between the pathways is the specific members from IκB kinase (IKK) that 
are involved [16]. 
 
Figure 4. The canonical NF-κB signalling pathway. Adapted from [18]. 
INTRODUCTION 
 9 
Activation of NF-κB signalling is initiated by extracellular stimuli (Figure 4). These stimuli are 
recognised by receptors and transmitted into the cell, where adaptor-signalling proteins 
initiate a signalling cascade that culminates in the activation of IκB kinase (IKK). IKK is a 
multi-protein complex composed of two catalytic components, IKKα and IKKβ, and a 
regulatory component, NEMO. IKK phosphorylates the inhibitory subunit of the NF-κB-IκB 
complex, which is sequestered in the cytoplasm as an inactive form during non-stimulatory 
conditions. This phosphorylation marks IκB for proteasomal degradation and releases NF-
κB from the inhibitory complex. The freed NF-κB proteins are then transported into the 
nucleus where, by binding to specific DNA sequences, they promote the transcription of 
target genes. These genes are involved in innate and adaptive immunity, inflammation, anti-
apoptosis, proliferation, the stress response and cancer progression [17].  
1.2.1.2. Nod-like receptors and the Inflammasome 
The inflammasome is considered an immune sensor and part of a signalling pathway that 
integrates metabolism and inflammation, exerting pro-inflammatory functions not only locally 
but also on systemic metabolic parameters. Inflammasome activation has been implicated in 
a wide variety of metabolic processes (Figure 5), including hepatocyte function, the 
development of atherosclerotic lesions, inflammation and β-cell death in the pancreas, and 
adipose tissue homeostasis [19]. 
The inflammasome is a cytosol-localised protein complex of the host innate immune system 
that is composed of Nod-like receptor protein 3 (NLRP3), apoptosis associated speck-like 
protein (ASC) and caspase-1, which mediate the maturation process and secretion of the 
cytokines interleukin (IL)-1β and IL18 [20]. The inflammasome can sense a wide variety of 
danger signals, including pathogen-derived molecular patterns, noxious foreign substances 
and host-derived endogenous signals (Figure 6). 
 
Figure 5. The role of inflammasomes in metabolic syndrome. Adapted from [19]. 
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IL-1β is a multifunctional and pivotal inflammatory cytokine that is known as an endogenous 
pyrogen. It is mainly synthesised by monocytes and macrophages and is capable of 
affecting almost all cell types, including acting as a lymphocyte-activating factor through 
stimulation of T-cell proliferation [21]. IL-1β has local effects (leukocyte infiltration and 
lymphocyte activation) and distant effects (fever and acute phase protein induction) by 
binding to IL-1 receptors (IL1Rs) and IL1R AcP (accessory protein) on immune cells. Upon 
IL1R activation, MAPK and NF-κB pathways can amplify the inflammatory response by 
promoting the secretion of cytokines and chemokines that may activate the adaptive immune 
response [22]. 
 
Figure 6. Inflammasome activity regulates homeostatic processes and inflammation. Adapted from 
[23]. 
The inflammasome-mediated maturation and secretion of IL-1β is the result of a two-step 
process (Figure 7). A first signal, known as the priming signal, is responsible for priming the 
cell, via TLR4 downstream signal transduction, to induce the activation of NF-κB. This 
mediates the transcription of the NLRP3 and the immature form of IL-1β, pro-IL-1β, which 
are both indispensable factors for inflammasome activation. Then, a second stimulus, or the 
activating signal, promotes NLRP3 inflammasome assembly into a platform that results in 
the processing of pro-caspase-1 into active caspase-1. Caspase-1 mediates the cleavage of 
pro-IL-1β into the secreted cytokines IL-1β and IL-18.  
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Figure 7. NLRP3 inflammasome-mediated maturation and secretion of IL-1β. Adapted from [24]. 
1.2.1.3. Prostaglandin synthesis and metabolism: role of 
cyclooxygenases 
Lipids can be metabolised through a variety of lipid biosynthetic pathways, such as the 
eicosanoid-signalling pathway, that connect inflammation and lipid metabolism. Eicosanoids 
can be divided into four subclasses including the prostaglandins, thromboxanes, 
leukotrienes and other oxidised products. 
Prostaglandins are generated from n-6 arachidonic acid, the most abundant fatty acid 
present in cell membranes, through the sequential actions of phospholipase A2 (PLA2) and 
cyclooxygenase enzymes (COX) (Figure 8). Both enzymes are controlled directly by 
signalling pathways that respond to PAMPs and inflammatory cytokines, enabling rapid and 
robust increases in prostaglandin generation. The resulting prostaglandin metabolites have 
been involved in different biological roles, including the amplification of inflammatory 
responses [25]. Three COX isoforms have been described, COX1 (or prostaglandin 
endoperoxidase 1), COX2 (or prostaglandin endoperoxidase 2) and COX3 (or prostaglandin 
endoperoxidase 3). COX1 is constitutively expressed in most cells, as it is a housekeeping 
enzyme involved in the mediation of different physiological roles, including the protection of 
the gastric epithelium and platelet aggregation. COX2 is undetectable in basal conditions, 
although it can be rapidly activated by several pro-inflammatory stimuli, leading to the 
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synthesis of prostaglandin E2 (PGE2). COX3 is a splice variant of COX1, however, its 
biological role is poorly understood [26,27]. Remarkably, the COX1 and COX2 isoforms are 
the major targets of NSAIDs (non-steroidal anti-inflammatory drugs). 
 
Figure 8. Cyclooxygenase (COX) mediated biosynthesis of prostaglandins (PGs), including PGE2, 
PGD2, PGF2α, PGI2 and thromboxane A2 (TxA2). Adapted from [28]. 
Additionally, two different series of eicosanoids can be generated, E2 and E3, depending on 
the chemical nature of the fatty acid converted. Whereas utilisation of n-6 results in the E2 
series of eicosanoids, eicosanoid generation from n-3 fatty acids leads to the E3 series of 
eicosanoids [29]. 
1.2.2. Immune cells 
For appropriate functioning of the immune system, cell-mediated immunity must be highly 
regulated and sequentially and temporally orchestrated. Both innate and adaptive immune 
responses are orchestrated by the complex interactions and activities of a diverse group of 
cell types, where leukocytes or white blood cells are the most important.  
Leukocytes mature in primary lymphoid organs and circulate in the blood within the pool of 
immune cells, known as peripheral blood mononuclear cells (PBMCs), and interact with 
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other cells, pathogens and pathogen-derived products. The presentation of host and foreign 
antigens in secondary lymphoid organs and other tissues is a pivotal event in the induction 
of adaptive immune responses and the development of immunological memory. The bone 
marrow and thymus are primary lymphoid organs, whereas spleen and lymph nodes are 
secondary lymphoid organs. Most leukocytes are generated from committed hematopoietic 
stem cells located in the bone marrow that give rise myeloid cells, platelets, erythrocytes and 
lymphoid stem cells. Myeloid cells are derived from a granulocyte-monocyte common 
precursor, a process mediated by the expression of diverse cytokines, including the 
granulocyte colony-stimulating factors (GCSF) and macrophage colony-stimulating factors 
(MCSF). Lymphoid stem cells are the precursors of T and B lymphocytes. However, 
whereas T cell precursors undergo selection and mature into the repertoire of T cells within 
the thymus, B cells mature in the bone marrow and in the spleen [30]. In addition, whereas 
phagocytic cells are involved in innate immunity, the adaptive immune response includes 
antigen-specific defence mechanisms mediated mainly by lymphocytes. 
PBMCs, as cells that circulate in the bloodstream, are continuously exposed to both 
exogenous and endogenous stimuli from tissues throughout the body, including nutrients 
and metabolism-derived hormones. In this sense, PBMCs are of high interest because 
modulation of gene expression in PBMCs has been suggested to reflect the changes of 
gene expression in many of the solid tissues, including liver, adipose tissue and muscle 
[31,32].  
1.2.2.1. The mononuclear phagocytic system: monocytes and 
macrophages 
The mononuclear phagocytic system represents a subgroup of leukocytes defined as 
myeloid cells derived from the bone marrow. Macrophage precursors are released into the 
bloodstream as monocytes, and within a few days they populate tissues during both the 
steady state and inflammation.  
Monocytes are considered sentinel immune effector cells that can detect and respond to 
invading pathogens and dietary components. Upon chemokine secretion, tissue injury, or 
pathogen signalling, monocytes are recruited to the affected area and diapedese across the 
blood vessel wall into the inflamed tissue. Once within the tissue, monocytes differentiate 
into macrophages or dendritic cells (DCs) under the instruction of a wide variety of proteins, 
including cytokines, matrix proteins, and growth factors [30,33,34]. Thus, the primary role of 
monocytes is to replenish the pool of tissue-resident macrophages and DCs in both healthy 
conditions and in response to inflammation. Monocytes, DCs and macrophages, along with 
neutrophils and mast cells, are the ‘professional’ phagocytic cells due to the expression of a 
multitude of receptors on their surfaces that detect exogenous or endogenous signals which 
are not normally found in healthy tissues [35]. Within the mononuclear phagocytic pool, 
macrophages are often distinguished form DCs by the differential expression of surface 
markers, such as the macrophage marker F4/80 [36]. 
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Tissue macrophages are involved in important functions for homeostasis. As resident 
phagocytic cells in lymphoid and non-lymphoid tissue, they monitor constantly the immediate 
milieu for early signs of infection or tissue damage. In this role, macrophages are 
responsible for sensing, integrating and appropriately responding to a sizeable array of 
stimuli from the local environment [35,37]. Macrophages express a broad range of pathogen-
recognition receptors, including TLRs, NLRs and the interleukin-1 receptor (IL-1R), that 
make them efficient at phagocytosis and the production of inflammatory cytokines.  
Macrophages have remarkable plasticity that allows them to efficiently respond to 
environmental signals and change their phenotype, and their physiology allows them to 
encompass both innate and adaptive immune responses [38]. Macrophages can be divided 
into different subpopulations based on their anatomical location and functional phenotype 
(Figure 9) [39]. Included within the specialised tissue-resident macrophages are osteoclasts 
(bone), alveolar macrophages (lung), histiocytes (interstitial connective tissue) and Kuppfer 
cells (liver). Secondary lymphoid organs also have distinct populations of macrophages that 
perform unique functions, including marginal zone macrophages in the spleen, which are 
involved in the suppression of innate and adaptive immunity against apoptotic cells [40]. 
 
Figure 9. Macrophages are located throughout the body and perform important surveillance 
activities such as phagocytosis, antigen presentation and immune suppression. Extracted from [35]. 
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Different macrophages subsets with distinct functions have been described; classically 
activated macrophages (M1 macrophages) mediate defence of the host against a variety of 
bacteria, protozoa and viruses and also have roles in antitumor immunity. Alternatively 
activated macrophages (M2 macrophages) have an anti-inflammatory function and regulate 
wound healing. Numerous studies have documented flexibility in macrophage programming, 
where macrophages switch from one functional phenotype to another in response to the 
variable microenvironmental signals of the local milieu [41,42]. 
1.2.2.2. Cell-mediated adaptive immunity: lymphocytes 
Lymphocytes are key cellular components of the adaptive immune system. The bone 
marrow-generated lymphocytes mature in lymphoid organs and circulate through 
cardiovascular and lymphatic circulatory systems to peripheral tissues of specialised 
secondary lymphoid organs, such as the lymph nodes and the spleen (Figure 10). Antigen-
mediated triggering of T and B cells, the main lymphocyte subsets, initiates specific cell-
mediated and humoral adaptive immune responses. 
The adaptive immune system relies on the specificity of antigen recognition. Lymphocytes 
have a wide range of antigen receptors, known as the TCR and BRC (T and B cells 
receptors, respectively), which are generated by somatic recombination. 
T cells are categorised into two principal subsets, the CD4+ T cells and the CD8+ T cells. 
Naïve CD4+ and CD8+ T cells result from thymus maturation and must come in contact with 
antigen-presenting cells (APCs) to become activated. In this way, the interaction between a 
TCR and its peptide-major histocompatibility complex (MHC) ligand plays a critical role in 
determining the activity and specificity of the T cell. MHC class I present peptides to the TCR 
on CD8+ T cells, whereas MHC II engages with the TCR on CD4+ T cells [43]. 
  
Figure 10. Generation, differentiation and peripheral circulation of T (blue) and B (red) lymphocytes. 
Adapted from [44].  
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CD4+ T cells play a central role in immune protection by their capacity to help B cells to 
produce antibodies; to induce macrophages to develop enhanced microbial activity; to recruit 
neutrophils eosinophils and basophils to sites of inflammation; and through their production 
of cytokines and chemokines that orchestrate the spectrum of immune responses. Moreover, 
CD4+ T cells act as T helper (TH) cells and, after being activated, can differentiate into 
distinct effector fates, including TH1, TH2, TH17 and regulatory T (Treg) cells, which differ 
from each other in their pattern of cytokine production and related functions, their distinctive 
expression of cell surface receptors and their characteristic transcription factors [45]. TH1 
produce pro-inflammatory cytokines such as IFN-γ to support cell-mediated immunity, 
whereas TH2 cells produce anti-inflammatory cytokines, including IL-4 to support humoral 
immunity. Furthermore, TH17 cells are characterised by expression of IL-17 and play a 
critical function in protection against microbial challenges, particularly extracellular bacteria 
and fungi. Treg are characterised by the expression of the forkhead-winged-helix 
transcription factor 3 (Foxp3), can secrete anti-inflammatory signals, inhibit macrophage 
migration and induce M2-like macrophage differentiation [46].  
Upon engagement with antigen, naïve CD8+ T cells rapidly expand and differentiate into 
effector CD8+ T cells, also referred as cytotoxic T cells (Tc), which produce cytokines, 
including IFN-γ, and effector molecules that mediate a local inflammatory response and 
effect target cell apoptosis [47]. 
On the other hand, B cells are central to humoral immunity and for the maintenance of 
immune homeostasis. B cells can modulate immunity by releasing immunomodulatory 
cytokines that influence a variety of T cell, dendritic cell and antigen presenting cell 
functions, and regulate lymphoid tissue organisation and neogenesis. B cells can also 
function as polarised cytokine-producing effector cells that influence T-cell differentiation 
[48]. 
1.2.3. Lymphoid organs 
1.2.3.1. Thymus 
The thymus has a central role for the immune system. As a primary lymphoid organ, the 
thymus is crucially required for T cell differentiation and repertoire selection. Bone marrow-
generated progenitor T lymphocytes circulate within the thymus where they will undergo 
maturation by progression through several phenotypic stages (the T cell maturation process 
is described in Figure 11). T cell development involves an obligatory interaction of the TCR 
of immature thymocytes with MHC-peptide complexes. Immature thymocytes become first 
double negative (DN) cells and then double positive (DP). Finally, mature lymphocytes are 
single positive (SP) and are selected based on two main phenotypic categories: CD4+ and 
CD8+ T cells [44,49]. 
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Figure 11. Major events in T cell differentiation in the thymus. Haematopoietic stem cells (HSCs) 
from the bone marrow give rise to early thymic progenitors (ETPs). First, ETP cells become double 
negative (DN) cells, which undergo crucial rearrangements of TCR genes. TCRβ gene selection 
leads to the generation of double positive (CD4+CD8+ or DP) cells. This is followed by the 
rearrangement of the TCR α-chain locus and expression of the αβ TCR. Then, by positive selection 
(PS), cells that have TCRs that bind to MHC class I molecules retain expression of CD8, whereas the 
cells that bind to MHC class II molecules retain CD4. A small percentage of the CD4+ cells up-
regulate the transcription factor FOXP3 and exert regulatory T (TReg) cell functions. γδ T cells 
originate from DN cells that have not yet undergone β-selection. Extracted from [44]. 
1.2.3.2. Spleen 
The spleen, the largest secondary lymphoid organ in the body, besides filtering the blood to 
remove and destroy the non-functional erythrocytes and other blood cells, plays a pivotal 
role for the host immune system. The spleen is a key location for phagocytosis, the storage 
reservoir for immature monocytes, as well as a key place for T cell and B cell mediated 
immunity. The spleen also integrates the immune system, metabolism and the endocrine 
network [50].  
1.3.  Metabolism  
Metabolism is involved in the regulation of food intake, nutrient uptake, catabolic and 
anabolic pathways, the distribution of nutrients, and the accumulation and mobilisation of 
stored energy within the body.  
Obesity can be defined as a consequence of the maladaptation to the current dietary 
pattern, which is rich in energy density mainly due to the high content of fats and sugars 
[51]. As a result of this lifestyle, circulating free fatty acids (FFAs) are elevated, hindering 
glucose oxidation and interfering with the response to insulin. The incidence of obesity and 
its related metabolic disorders have increased dramatically throughout the last quarter 
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century, representing the greatest public health challenge of our time. The rise of worldwide 
obesity has resulted in the explosion of obesity-related health problems, including type 2 
diabetes, coronary arterial disease, fatty liver disease and some cancers and degenerative 
diseases. 
1.3.1. The adipose tissue as an immunological organ  
Adipose tissue is a metabolically dynamic organ that, besides being the primary site of 
storage for an excess of energy, acts as an endocrine organ capable of synthesising a 
number of biologically active compounds, including a wide variety of hormones, cytokines, 
chemokines and growth factors, that regulate metabolic homeostasis [52–54]. The adipose 
tissue is composed not only of adipocytes but also of other cell types called the stromal-
vascular fraction, comprised of blood cells, endothelial cells, macrophages and lymphocytes. 
1.3.1.1. The role of immune cells in adipose tissue 
Cell-mediated immunity plays a pivotal role in the orchestration of the metabolic response to 
obesity. Indeed, obesity is associated with an increased number of leukocytes within 
adipose tissue and adipocytes within the lymphoid microenvironment, both of which are 
considered part of the adaptive response to the impairment of energy balance. Therefore, an 
impaired immune-metabolic cell crosstalk underlies the development of obesity-related 
pathologies. 
Adipose tissue accumulates the excess of energy intake as triglycerides, but the continuous 
overflow of adipocyte-storage capacities endangers its functionality causing hypertrophy, 
hypoxia and acidosis. As obesity develops, qualitative changes in the expanding adipose 
tissue can promote the transition from normal metabolic function to a metabolically 
dysfunctional phenotype. Thereby, compromised adipocytes trigger an adipocytokine-driven 
response characterised by the secretion of pro-inflammatory chemokines resulting in an 
obesity-induced local inflammatory response. These factors favour the apoptosis of 
adipocytes and cause the recruitment and infiltration of immune cells within the adipose 
tissue, which underlies the amplification of the inflammatory response up to systemic levels 
and disturbs the immunometabolic homeostasis [55]. 
Adipose tissue-associated macrophages switch from an M2-like phenotype to a classically 
activated M1-like phenotype with potent pro-inflammatory activity, with the NLRP3 
inflammasome serving as the molecular switch by sensing obesity-associated danger 
signals [56]. Therefore, metabolically dysfunctional adipose tissue can be associated with 
high levels of necrotic adipocytes, and the M1 macrophages arrange around these dead 
cells forming crown-like structures to phagocytose the released lipids (Figure 12). Indeed, 
the recruitment of M1 activated macrophages into the adipose tissue coincides in time with 
the appearance of necrotic adipocytes and the onset of insulin resistance. 
INTRODUCTION 
 19 
 
Figure 12. Obesity-induced structural and functional changes of adipose tissue. Adapted from [57]. 
Lean adipose tissue in mainly enriched by Tregs and M2 activated macrophages, which 
secrete IL-10 to enhance insulin action and glucose disposal in adipocytes. The M2 
macrophage phenotype is regulated by peroxisome-activated receptor-γ (PPAR-γ) signalling 
and has been found to regulate important metabolic functions, including the maintenance of 
adipocyte function, insulin sensitivity and glucose tolerance, preventing the development of 
diet-induced obesity and type 2 diabetes [37,58].  
Nevertheless, during obesity energy storage increases proportionally to the increase of 
nutrient intake, reaching adipocyte maximal storage capacity and undergoing necrotic cell 
death, which promotes macrophages recruitment. With the persistence of increased nutrient 
intake, more adipocytes undergo cell death, thereby providing the antigenic stimulus for 
macrophages to activate the adaptive immune system. Adipose tissue M1 macrophages are 
potentially capable of presenting antigens to B and T cells to promote the adaptive immune 
response. This is postulated to promote clonal expansion of CD4+ T helper 1 (TH1) cells and 
an increased infiltration by CD8+ T cells. In a feed-forward loop, interferon-γ (IFNγ) 
production by CD4+ TH1 and the secretion of pro-inflammatory cytokines and chemotactic 
factors by CD8+ T cells results in increased recruitment and classical activation of 
macrophages. Concomitant with this, the obesity-induced decrease of immunosuppressive 
Tregs cell numbers in adipose tissue further contributes to adipose tissue inflammation and 
insulin resistance. B cells, which infiltrate obese adipose tissue, can present antigens on 
MHC class I and II molecules to naïve T cells. IgG2 autoantibodies produced by mature B 
cells further amplify adipose tissue inflammation and insulin resistance (Figure 13) [58]. 
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Figure 13. Crosstalk between innate and adaptive immune cells in adipose tissue. Extracted from 
[58].  
1.3.2. Immunometabolism and obesity: the non-
resolved inflammation 
Changes in dietary patterns as well in lifestyle underlie the exposure of the immunometabolic 
axis to a constant excess of nutrients and energy, threatening the delicate balance between 
immunity and metabolism, even underlying some pathologies. 
Normally, in response to a fixed insult, classical inflammation mediates its removal or 
neutralisation and the inflammation is finally resolved. However, the inflammatory response 
found in the obese state is of a different nature and is characterised by an array of hallmarks 
(Figure 14) that differentiate it from the classical inflammatory response [59]. 
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Figure 14. Hallmarks of metaflammation [60]. 
I. Obesity-induced inflammation is triggered by nutrients and orchestrated by 
metabolic cells. 
The inflammatory trigger in obesity is metabolic, and inflammation is mainly induced as 
consequence of an energy imbalance promoted by an excess of nutrient consumption. 
Thereby, not only is metabolism the nature of the inducing stimuli but also metabolic 
cells, such as adipocytes, are the cells that sustain the insult and whose response 
begins the inflammatory cascade, thus mediating the interface between the metabolic 
input and the inflammatory output. Therefore, metabolic signals emerging from 
metabolic cells trigger the inflammatory response and impair metabolic homeostasis. 
II. The inflammatory response is moderate, there is a low-grade and local 
expression of inflammatory mediators induced by stress sensors. 
The first evidence regarding the implication of inflammatory pathways in metabolic 
diseases was based on the expression of a pro-inflammatory cytokine, TNF-α, in the 
adipose tissue, and in adipocytes themselves, of obese rodents and humans [61]. It is 
now considered that not only TNF-α but also a wide array of inflammatory cytokines are 
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increased in obese tissue, including IL-6, IL-1β and monocyte chemotactic protein-1 
(MCP-1) [9,62]. In addition, while adipose tissue is a predominant site for cytokine 
expression in obesity, other metabolic tissues such as the liver [63], muscle [64], 
pancreas [65], and brain [66], have been also postulated as targets of the obesity-
induced inflammatory response [60]. Furthermore, obesity-induced inflammation 
increases the systemic levels of cytokines, acute-phase reactants and adhesion 
molecules [67]. 
III. The milieu is modified, altering the composition of immune cells to favour a pro-
inflammatory tissue environment. 
Obesity-induced metabolic tissue inflammation is associated with an increased number 
of infiltrated immune cells that contribute to increased tissue cytokine expression. The 
state of activation of the adipose tissue resident macrophage population, pro-
inflammatory (M1) or anti-inflammatory (M2), is determined by metabolic factors. 
Although multiple types of immune cells are involved in the response to the metabolic 
overload of obesity, particularly in the adipose tissue, the role of immune cells in 
metaflammation are unclear. 
IV. Metabolic inflammation induced by obesity is chronic. 
The pulsatile nature of the trigger stimulus is one of the most important aspects to 
understanding the intricacies of obesity-induced inflammation (Figure 15). In obesity, as 
a consequence of the fasting-feeding cycle a pulsatile inflammatory response is 
chronically induced in metabolic cells. Under homeostatic conditions, low-level 
inflammatory peaks resulting from feeding are resolved once the nutrients are 
metabolised. However, in overfeeding or obesity conditions, a constant stimulus from 
nutrient intake results in a more consistently active inflammatory response. Over time, 
these low-level signals accumulate and amplify with each nutrient exposure, begin to 
impair normal metabolic pathways and cause the activation of immune cells. 
 
Figure 15. Pulsatile nature of diet-induced inflammatory responses. Extracted from [60]. 
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The occurrences of inflammatory cytokine expression and immune cell infiltration 
associated with the onset of the metabolic inflammation appear to happen gradually but 
are unresolved over time. This deficiency of resolution could be associated with the 
new emergence of obesity as pathology and the lack of evolutionary selection to 
develop such a response to metabolic signals. 
1.3.3. Leptin links the crossroad between immunity and 
metabolism 
Leptin, the product of the obese (ob or Lep) gene, is an adipocyte-derived cytokine that 
belongs to the family of long-chain helical cytokines and is structurally similar to IL-6. The 
leptin signalling pathway is one of the most important networks that senses and manages 
nutrients, playing a key role in linking the nutritional status with neuroendocrine immune 
functions, influencing directly the physiological and pathological metabolic states in the body 
[68]. Once leptin is secreted into the bloodstream it has central and peripheral effects. In the 
hypothalamus, leptin regulates appetite, basal metabolism, autonomic nervous system 
outflow and bone mass [69]. In the periphery, leptin increases basal metabolism, influences 
reproductive function, regulates pancreatic β-cell function and insulin secretion, is pro-
angiogenic for epithelial cells, regulates bone marrow haematopoiesis, and affects thymic 
generation of T cells and the differentiation of TH1 cells in lymph nodes (Figure 16). 
 
Figure 16. Central and peripheral effects of leptin. Extracted from [68]. 
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In addition, leptin modulates both the innate and adaptive immune systems. In innate 
immunity, leptin promotes the activation of monocytes and macrophages [70,71]. In PBMCs, 
leptin increases the production of growth hormone, a cytokine-like hormone that influences 
the immune response by controlling the survival and proliferation of immune cells [72]. The 
adaptive immune response is also modulated by leptin, which modulates the proliferation 
and cytokine production of CD4+ T cells. Leptin induces the production of adhesion 
molecules, such as intercellular adhesion molecule 1 (ICAM1) and very late antigen 2 
(VLA2), which are responsible for the induction of clustering, activation and migration of 
immune cells to sites of inflammation. Interestingly, thymic homeostasis is also affected by 
leptin, including the generation, maturation and survival of thymic T cells. In memory T cells, 
leptin promotes switching towards TH1-cell immune responses by increasing IFN-γ and TNF-
α secretion, production of IgG2a by B cells and delayed-type hypertensive (DTH) responses. 
Furthermore, leptin has anti-apoptotic effects on mature T cells and on haematopoietic 
precursors (Figure 17). 
 
Figure 17. Effects of leptin on innate and adaptive immune responses. Extracted from [68]. 
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1.3.3.1. Leptin receptor signalling 
The leptin receptor, which plays a pivotal role in the transduction of leptin signalling, is a 
member of the class I cytokine receptor (gp130) superfamily and has at least six splice 
forms as a result of alternative splicing, with cytoplasmic domains of different lengths 
(LepRa-LepRf). The short forms of the leptin receptors are expressed by several non-
immune tissues and are involved in the transport and degradation of leptin. The long form of 
the leptin receptor, leptin receptor B (LepRb), is the only variant with full signalling capability 
and is expressed by the hypothalamus as well as by immune cells, including lymphocytes, 
monocytes and macrophages, and is fundamental for the transduction of the intracellular 
leptin signalling pathway [73]. 
Therefore, upon leptin binding to its extracellular domain, LepRb undergoes a 
conformational change that activates Janus-family tyrosine kinase 2 (JAK2) (Figure 18). 
JAK2 becomes activated by cross-phosphorylation, and tyrosine phosphorylates the 
cytoplasmic domain of the receptor. Four of the phosphorylated tyrosine residues (Tyr974, 
Tyr985, Tyr1077 and Tyr1138) function as docking sites for cytoplasmic adaptors.  
 
Figure 18. Signalling pathways activated by the leptin receptor. Extracted from [68]. 
The phosphorylation of the distal membrane Tyr1138 serves as a docking site for the signal 
transducer and activator of transcription 3 (STAT3), which is a substrate of JAK2. STAT3 is 
a latent transcription factor that, after subsequent recruitment, is phosphorylated by JAK2 
and dimerises, leading to nuclear translocation and inducing the expression of suppressor of 
cytokine signalling 3 (SOCS3) and other genes. SOCS3 takes part in a feedback loop that 
inhibits leptin signalling by binding to phosphorylated tyrosine (Tyr1077) [74–76]. Similarly, 
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Tyr1077 recruits and mediates the phosphorylation of a related transcription factor, STAT5 
[77]. Tyr985 and Tyr974 in turn recruit the SRC homology 2 (SH2) domain-containing 
phosphatase 2 (SHP2) and activate extracellular signal-regulated kinase (ERK) and p38 
mitogen-activated protein kinase (MAPK) pathways through the adaptor protein growth 
factor receptor-bound protein 2 (GRB2), ultimately inducing the expression of FOS and JUN 
[78]. In addition, after leptin binding, JAK2 can induce phosphorylation of the insulin receptor 
substrate (IRS) proteins, which are responsible for the activation of phosphatidylinositol 3-
kinase (PI3K) [79]. In contrast, the phosphotyrosine phosphatase 1B (PTP1B) is involved in 
negative regulation of LepRb signalling through the dephosphorylation of JAK2. 
However, the transduction of leptin signalling can be attenuated in consequence of 
homeostatic alterations such as those that happen in obesity. This event is known as leptin 
resistance and underlies the pathogenesis of several immunometabolic disorders. 
1.3.3.2. Leptin resistance and obesity 
Obesity leads to the development of leptin resistance through the attenuation of 
hypothalamic LepRb signal transduction. Two potential mechanisms have been 
hypothesised to explain the failure of circulating leptin to reach its targets in the brain and 
inhibit intracellular LepRb signalling [80]. These mechanisms include an impaired leptin 
transport across the blood-brain barrier as well as the inability of leptin to activate 
hypothalamic-signalling, a consequence of the presence of intracellular inhibitors such as 
SOCS3, PTP1B and SHP-2 [81–84]. 
Leptin can access the brain by different mechanisms, including a specific transport across 
the blood-brain barrier, diffusion from the circumventricular organs or direct access from the 
blood to neuroendocrine neurons that project to the circulation [76]. These leptin transport 
mechanisms can be saturated. In fact, it has been described that in diet-induced obesity 
leptin transport to the brain is decreased [85]. In addition, a physical interaction between 
leptin and CRP, an acute-phase protein overexpressed in obesity, may also impede the 
transmission of leptin across the blood-brain barrier [86,87]. 
Moreover, specific molecular inhibitors can also down-regulate hypothalamic leptin 
signalling. In a physiological state, when circulating leptin concentrations are low, STAT3 
activation and the expression of SOCS3 are modest. In this basal condition, an increase of 
leptin secretion is almost fully translated into increased central LepRb signal transduction. 
However, in obesity, where leptin is continuously overexpressed, the activation of STAT3 is 
promoted, which results in an increase in SOCS3 expression. Thus, chronic high levels of 
LepRb activation induce its own feedback inhibition, limiting the downstream leptin signalling 
pathway [76,88]. 
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1.4.  Nutritional profile 
Foods are more than just a combination of nutrients intended to cover the energetic and 
metabolic requirements, but foods are also a complex network of molecular signals able to 
modulate the functionality of the body. Thus, the effects of nutrition on health and disease 
cannot be understood without the knowledge of how nutrients act at the molecular level [89]. 
There is strong evidence supporting the fact that the nutritional profile affects both 
metabolism and the immune system [3,90,91]. The interactions between food composition 
and the immune-metabolic interface can occur at many levels, ranging from endocrine 
signalling to the direct sensing of food components by immune cells [90,92].  
Thus, a greater understanding of the critical parts of immunometabolism that are susceptible 
to targeting through the nutrition profile may provide opportunities to break the close 
connection existing between the defects in metabolism and immunity with the onset and 
propagation of diseases.   
1.4.1. Immunometabolism and nutrient sensing 
On one hand, the ability to use macronutrients is essential for the generation and 
maintenance of a protective effector immune response [90]. On the other, the capacity of the 
immune system to sense metabolic stress is a pivotal event linked to the progression of 
obesity and its related pathologies. Therefore, the proper functioning of the pathways that 
are involved in the sensing and management of nutrients is pivotal for the correct functioning 
of immunometabolism and the maintenance of homeostasis. 
The immune system is able to respond against peripheral signals, including pathogenic and 
food-derived molecular signals. Indeed, abnormalities of lipid metabolism impair 
immunometabolic homeostasis. Immune and lipid abnormalities are not completely separate 
processes, and these two systems are closely intertwined and can feed back to each other. 
Circulating free fatty acids (FFAs) are typically elevated in diet-induced obesity, and the 
dietary fat intake has an important influence on the composition of these FFAs [93]. In 
addition to circulating FFAs, immune cell types in adipose tissue are exposed to high local 
concentrations of FFAs released from adipocytes by lipolysis. Therefore, these cells exist 
within a lipid-rich environment that could amplify the effects of fatty acids within adipose 
tissue [94]. 
1.4.2. Targeting immunometabolism through nutrition: 
from a weak to boosted immune system 
There is evidence that an inflammatory response may be acutely evoked by nutrients. For 
example, the administration of an acute dose of lipids was associated with the activation of 
inflammation in skeletal muscle and liver tissues from mice [95], or after the ingestion of a 
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high-fat, high-carbohydrate meal in humans, resulted in the secretion of reactive oxygen 
species (ROS) and NF-κB activation in circulating blood mononuclear leukocytes [96].  
In this way, classical innate immune recognition pathways have evolved to survey the 
nutrient environment. TLR4 can sense the presence of free fatty acids [97], whereas ATP is 
an important activator of the NLRP3 inflammasome [98]. Several other immune cell-
associated sensors couple information about the local nutrient or metabolite environment to 
the coordination of local immune responses. 
Taking then into account the extensive evidence that connects metabolic and immune 
pathways, added to the fact that metabolism controls function in immune cells, leads to the 
conclusion that it is possible to modulate immunometabolism through nutrition. Indeed, 
nutrition has to be considered a two-sided coin: on the one hand, diets based on energy-
dense foods or containing high levels of fat or carbohydrates promote an imbalance in 
energy metabolism as well as induce obesity and its related pathologies. On the other hand, 
immunometabolism could also be improved through nutrition, based on nutritional 
immunotherapy; the immunometabolism can be targeted with nutrition for treating immune 
disorders and related pathologies.  
Thereby, immunometabolic homeostasis could be improved through the promotion of 
healthy eating habits, including the diminution of energy-dense foods and the increase of 
foods containing immunologically active compounds such as grape seed procyanidin extract 
(GSPE) or docosahexaenoic acid (DHA). 
1.4.2.1. The Western dietary pattern as model of obesity-induced 
immune impairment: the cafeteria diet 
The pandemic increase of obesity is in accordance with the change of the dietary pattern in 
Western societies, where the prevalence of highly palatable, energy dense foods has 
exponentially increased. In this sense, the cafeteria diet (CAF) refers to a robust model for 
human metabolic syndrome induced by mimicking the western dietary pattern [99]. Using 
this model, animals are allowed free access to standard chow while being concurrently 
offered highly palatable, energy-dense, unhealthy human foods. Through feeding the 
cafeteria diet, voluntary hyperphagia is promoted, which results in rapid weight gain as well 
as in the increase of adiposity. 
1.4.2.2. In immunometabolism the type of fat matters: dietary fat 
and fatty acids 
The typical Western-type diet contains around 23% of the total energy intake as fat 
[100,101]. Fat is present naturally in foods such as red meat, fish, dairy, eggs and oils, and 
aside from its principal role as energy source, dietary fat also influences many physiological 
processes. In this way, the fatty acid composition of cell membranes modulates its structure, 
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fluidity and function [102], as well as the production of eicosanoids and other secondary 
messengers, the function of receptors and the activity of several enzymes.  
In chemical terms, fats are acylglycerols, which are defined as compounds with a fatty acid 
molecule (acyl group) linked to a glycerol by an ester bond. The broad majority of dietary 
and storage fats are triglycerides, compounds in which 3 fatty acid molecules are bound to a 
single glycerol molecule [101]. Fatty acids differ in respect to the length of their chain and in 
the number and position of double bonds in the chain. Therefore, fatty acids are classified as 
saturated fatty acids (SFAs), monounsaturated fatty acids (MUFAs) and polyunsaturated 
fatty acids (PUFAs). SFAs are straight chain fatty acids with no double bonds within the 
carbon chain of variable length, MUFAs are fatty acids with one double bond along its chain 
and PUFAs contain more than one double bond within the fatty acid chain. Additionally, 
PUFAs are divided into two biologically important families, the n-6 PUFAs, which have their 
first double bond located on the sixth carbon atom from the methyl end, and the n-3 PUFAs, 
which have their first double bond on the third carbon atom [103]. 
In the 1950’s, it was first recognised that dietary fat could contribute to cardiovascular 
disease in Western cultures. However, the Greenland Eskimos ate large amounts of fat but 
had a very low incidence of cardiovascular diseases, along with low levels of cholesterol and 
lipoproteins. Therefore, the analysis of the nutritional profile of the Eskimo diet revealed that 
they intake high amounts of marine PUFAs, suggesting that the quality of dietary fat rather 
than quantity is fundamental for the development of cardiovascular diseases. In this way, the 
long-chain n-3 PUFAs are thought to promote beneficial effects on metabolic functions as a 
consequence of their anti-inflammatory properties. Immune cells normally contain large 
quantities of the n-6 PUFA arachidonic acid that, as has been explained previously (see; 
1.2.1.3. Prostaglandin synthesis and metabolism: role of cyclooxygenases), can be 
converted to eicosanoids by cyclooxygenase. Increased dietary intake of long-chain n-3 
PUFAs leads to its incorporation into the phospholipids of cells membranes, replacing 
arachidonic acid and repressing the production of eicosanoids from arachidonic acid. 
Furthermore, n-3 PUFAs from fish, such as docosahexaenoic acid (DHA), can modulate 
inflammation by interfering with the activation and transcriptional activity of transcription 
factors such as the peroxisome proliferator-activated receptors (PPARs) or NF-κB. 
1.4.2.3. Procyanidins as bioactive food compounds: improving 
health through the diet 
Foods such as fruits and vegetables contain a largely array of bioactive compounds not 
among the essential nutrients. Included in these bioactive food compounds are the 
polyphenols, which are secondary metabolites of plants characterised by at least one 
aromatic ring and one hydroxyl group. Polyphenols are classified according to their chemical 
structure. In this way, procyanidins, or flavan-3-ols, belong to the flavan group, which is part 
of the flavonoid compounds within the polyphenols.  
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The consideration of polyphenols as bioactive molecules derives from the xenohormesis 
theory. Xenohormesis (Figure 19) is a hypothesis that some stress-signalling molecules 
synthesised by plants, such as the polyphenols, might also provide their functional activity to 
their consumer, also known as interspecies communication.  
In this sense, the most basic purpose of the growth of the grape and its seed in the vine, as 
in the vast majority of plants, is the propagation of its species. Therefore, the grape seed 
contains the most essential components required for the formation of a new plant, among 
which are the polyphenols. Polyphenols in plants play important physiological functions, 
including their function as chemical messengers within the plant and their protective activity. 
Polyphenols defend the plant against microbes, fungi, insects and UV radiation, chelate 
potentially harmful metals and act as antioxidants to the free radicals derived from 
photosynthesis [104]. Furthermore, it has been described that grapes, under nutritionally 
stressful conditions, produce and accumulate greater amounts of polyphenols.  
 
Figure 19. The xenohormesis hypothesis. Adapted from [105]. 
A compendium about the effects of procyanidins in inflammation, regarding their molecular 
targets and health implications, is enclosed at the end of this introduction. 
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1.5.  The obese phenotype, a complex interplay 
between the genotype and the environment 
So far, we have noted that the onset and development of obesity is linked to a sedentary 
lifestyle and high intake of energy-dense and micronutrient-poor foods, such as diets rich in 
fat or sugar. However, in addition to these environmental factors, genetics also plays a key 
role in the resulting obese phenotype. The obesity phenotype is, therefore, the result of 
complex interactions between genetic and environmental factors [106]. 
Nutrigenomics, a study of the genome-wide influences of nutrition, considers nutrients as 
dietary signals that, once they are detected by the cellular sensor systems of 
immunometabolism, influence gene and protein expression and, subsequently, metabolite 
production. So, the modulation of gene, protein or metabolite expression patterns in 
response to particular food compounds or different nutritional profiles are considered dietary 
signatures [89]. 
The genetic component has a large impact on susceptibility to obesity; therefore, the 
phenotypic response to diet is partly determined by genetic factors [107]. For instance, 
studies of monozygotic twins have shown that differences in obesity-related traits, such as 
adiposity, are strongly influenced by genetic background, although the genes that are 
responsible for the individual differences in the sensitivity to diet remain to be fully identified 
[108].  
Thus, in obesity the interaction between the genotype and the environment, that is, the 
response or the adaptation to an environmental factor, such as the nutritional profile, is 
dependent upon the genotype of the individual [109]. However, this interaction can be at two 
different levels. First, as nutrients can act at the molecular level, the nutritional profile of the 
diet or the presence of bioactive compounds might differentially modulate the expression of 
key genes involved in the regulation of immunometabolism. Second, individual genetic 
predisposition also plays a pivotal role in the molecular management of these food-derived 
signals [106]. 
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Abstract.
The inflammatory response has been implicated in the
pathogenesis of many chronic diseases. Thus, the
modulation of the inflammatory response by the
consumption of bioactive food compounds, such as
procyanidins, is a powerful tool to promote health.
Procyanidin-mediated anti-inflammatory molecular
mechanisms include, among others, the modulation of the
arachidonic acid pathway, the inhibition of the gene
transcription, protein expression and enzymatic activity of
eicosanoid generating enzymes, the production and
secretion of inflammatory mediators (such as cytokines and
nitric oxide), the inhibition of mitogen-activated protein
kinase (MAPK) pathway activation, and the modulation of
the nuclear factor-jB (NF-jB) pathway. The NF-jB pathway
can be regulated by procyanidins at several levels. During
early events in NF-jB signaling, procyanidins modulate Ijj
activity, and the cytoplasmic retention of p65:p50 NF-jB by
the inhibition of IjB phosphorylation and proteasomal
degradation, while at late stages, they affect the nuclear
translocation of pro/anti-inflammatory NF-jB homo/hetero
dimers and their subsequent binding to the promoter
regions of target genes. To identify and understand the
value of procyanidins in the modulation of the inflammatory
response, the molecular mechanisms underlying the anti-
inflammatory activities and prohomeostatic effects of
procyanidins need to be investigated further.
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1. Introduction
The human diet consists largely of plant-derived products,
such as vegetables, fruits, and cereals. Polyphenols repre-
sent a large and diverse group of secondary plant metabo-
lites that are commonly found in fruits, vegetables, legumes,
dark chocolate, tea, and red wine [1–3].
The main classes of polyphenols can be classified as
phenolic acids, flavonoids, and the less common stilbenes
and lignans [4]. In turn, flavonoids can be divided into flava-
nols, flavones, anthocyanidins, isoflavonoids, and neoflavo-
noids. Flavanols (or flavan-3-ols) can exist as monomers,
such as catechin, epicatechin, and its gallated forms, or as
monomeric and oligomeric forms, which are referred to as
proanthocyanidins [5]. The proanthocyanidins that consist
exclusively of (epi)catechin units linked together are called
procyanidins, and these are the most abundant type of
proanthocyanidins in plants. Procyanidins are structurally
diverse, and this diversity is based on the number of mono-
mer units involved (Fig. 1). Procyanidins usually occur to-
gether with monomeric (þ)-catechin and (#)-epicatechin;
thus, it is difficult to attribute the observed effects to the
procyanidins, the monomeric forms or both [6].
In recent years, the role of dietary procyanidins as
health protective agents has become an important area of
human nutrition research [7–10]. Epidemiological studies
have indicated that populations that consume procyanidin-
rich foods have lower incidences of inflammatory disease
and diseases of multifactorial pathogenesis, including meta-
bolic syndrome, atherosclerosis, and cancer [11,12].
Inflammation is a defense mechanism that can be trig-
gered by a trauma or by an array of proinflammatory media-
tors. These mediators may be external pathogens, such as
bacterial lipopolysaccharides, or intrinsic mediators, such as
Abbreviations: THP-1, human monocytic cell line; B1 and B2, procyanidin dimers; C1,
procyanidin trimer; LPS, lipopolysaccharide; COX1, cyclooxygenase-1; COX2, cyclooxy-
genase-2; PGE2, prostaglandin E2; TPA, 12-O-tetradecanoylphorbol-13-acetate.
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some cytokines, eicosanoids, and fatty acids [13,14]. The
inflammatory response represents a complex network of
cellular and molecular interactions that are common to a va-
riety of proinflammatory triggers and pathways; these
shared inflammatory mediators include specific patterns of
eicosanoid and cytokine production [15]. Therefore, the mod-
ulation of the inflammatory response by the dietary intake
of bioactive food compounds, such as procyanidins, is a
powerful tool for promoting health and homeostasis and for
preventing disease [16,17]. In this review, we summarize
these findings regarding the prohomeostatic effects of pro-
cyanidins in the modulation of the inflammatory response.
2. Metabolism, absorption, and
bioavailability of procyanidins
Flavanols (and, in turn, procyanidins) are the most ubiqui-
tous class of molecules in plants that are consumed by
humans. Procyanidins are present as bioactive compounds in
a wide range of foods, such as fruits, legume seeds, and ce-
real grains, and in beverages such as red wine, tea, or co-
coa; cocoa has the highest known procyanidin content
among all foods (Table 1).
The prohomeostatic biological properties of procyani-
dins depend on both the amount consumed and their bioa-
vailability. The average polyphenol intake in a healthy human
diet has been estimated to be % 1 g per day [18], and pro-
cyanidins represent over 50% of the total daily intake. The
bioavailability of various procyanidins differs according to
their chemical structure. The degree of polymerization and
the presence of galloyl moieties are critical for bioavailabil-
ity, as are the nature of the metabolites circulating in plasma
and their subsequent biological effects [5]. For these rea-
sons, the most common procyanidins in the human diet are
not necessarily the most biologically active.
The metabolism and absorption of polyphenols and
procyanidins have been studied intensively [18–22]. The pro-
cyanidins found in foods vary significantly in their degree of
polymerization. The bioavailability of procyanidins depends
on their absorption and on their metabolism at the gastroin-
testinal tract, tissue, and cellular levels after absorption [23].
Although Spencer et al. [24] used in vitro experiments to
demonstrate that procyanidins with high levels of polymer-
ization are degraded to mixtures of epicatechin monomers
and dimers under conditions similar to those in gastric
juices, Rios et al. [25] demonstrated that procyanidins are
stable during gastric transit in humans in vivo. Tsang et al.
[26] found that the small and large intestines of grapeseed-
fed rats contained (#)-epicatechin dimers, trimers, tet-
ramers, and higher molecular weight procyanidins. More
recent studies have demonstrated that monomers, dimers,
and trimers are absorbed intact in the gastrointestinal tract
[21,27]. Once absorbed, procyanidins are conjugated to glu-
curonide, sulfate, and methyl groups, mainly in the gut mu-
cosa and liver. In the plasma, monomers are present exten-
sively as conjugated metabolites and to a lesser extent as
nonconjugated molecules [23]. The polyphenols that reach
the colon can be metabolized by the microflora into a wide
array of phenolic acids [28].
3. Procyanidin modulation of the
inflammatory response
Although the inflammatory response can be beneficial, man-
aging the host defense against infectious agents and
trauma, inflammation also contributes to the pathophysiol-
ogy of many chronic diseases. The interactions between cells
in the innate and acquired immune response systems and
inflammatory mediators orchestrate the acute and chronic
inflammation underlying many diseases [13].
The inflammatory response involves both local and sys-
temic events. Although the inflammatory response may vary
depending on the triggering stimuli, there is a common
spectrum of mediators involved. If the normal, healthy state
is not restored (i.e., homeostasis is disturbed), the inflam-
mation persists and becomes chronic.
Procyanidins, as bioactive food compounds, exert phys-
iological and cellular activities that promote homeostasis.
There is a large body of scientific evidence describing the
broad effects of procyanidins on inflammation [5,23]. The
molecular mechanisms targeted by procyanidins include, but
are not limited to, the modulation of various mediators of
Fig. 1. Structures of oligomeric procyanidins.
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inflammation (eicosanoids, cytokines, and nitric oxide (NO)
production) as well as the NF-jB and MAPK pathways.
This review will focus mainly on the effects of procya-
nidins on cell signaling and other molecular mechanisms
related to inflammation.
3.1. Procyanidins and inflammatory mediators
3.1.1. Procyanidin modulation of arachidonic acid
pathway. In 1972, Flower and Vane [29] found that aspirin, a
nonsteroidal anti-inflammatory drug, is an inhibitor of cyclo-
oxygenase (COX) activity. Aspirin inhibits the transformation
of arachidonic acid (AA) molecules into prostaglandins (PGs),
a class of compounds that mediate physiological and patho-
physiological inflammation. These findings have made the
AA pathway the subject of intense research.
The potential of flavonoids as inhibitors of AA-metabo-
lizing enzymes was initially reported in 1980 [30]. Since
then, the modulation of the AA pathway has been consid-
ered one of the most important anti-inflammatory mecha-
nisms of dietary flavonoids, including procyanidins. This
modulation involves the inhibition of eicosanoid-generating
enzymes, including phospholipase A2, cyclooxygenases, and
lipoxygenases (LOXs), thereby reducing the secretion of
prostanoids and leukotrienes (LTs) [30–34].
COX2 is considered a pivotal enzyme in inflammation;
therefore, the modulation of COX2 plays a key role in the
regulation of the inflammatory response. COX2 is regulated
at the transcriptional level by proinflammatory stimuli, such
as LPS, proinflammatory cytokines, and growth factors,
which activate the MAPK and NF-jB pathways that ultimately
promote the transcription of the COX2 gene [35]. Procyani-
dins have been found to inhibit COX2 in several ways, includ-
ing through COX2 gene transcription, COX2 protein expres-
sion, and COX2 enzyme activity. Four transcription factors,
NF-jB, CCAAT/enhancer-binding protein (C/EBP), activator
protein 1 (AP-1), and CRE-binding protein (CREB), can modu-
late the transcription of COX2 by binding to the cis-acting
elements in the COX2 promoter region [36]. The pretreatment
of mouse or human macrophages with procyanidin-rich
extracts or with pure procyanidin compounds inhibits the
transcription of COX2 mRNA [36,37]. Procyanidins inhibit
COX2 transcription by downregulating the pathways
upstream of COX2 transcription factors [36]. COX2 protein
expression can also be downregulated by procyanidins in
different cell types. In LPS-activated human THP-1-derived
Table 1
Procyanidin concentrations in commonly consumed foods
Food Total procyanidins Oligomeric forms Food Total procyanidins Oligomeric forms
Four groups of foods have been classified according to their procyanidin contents, expressed as mg/100 g of edible
portion. The data are expressed as total monomeric and oligomeric procyanidin content and as oligomeric content
only. Group 1 ( ) contains foods with low procyanidin contents (< 50 mg/100 g of edible portion). Group 2 ( )
contains foods with moderate procyanidin contents (50–100 mg/100 g of edible portion). Group 3 ( ) contains foods
with high procyanidin contents (100–1000 mg/100 g of edible portion). Group 4( ) contains foods with very high
procyanidin contents (> 1000 mg/100 g of edible portion). Data source: USDA Database for the Proanthocyanidin
Content of Selected Foods.
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macrophages and mouse RAW264.7 macrophages, a
decrease in COX2 protein expression was observed on pre-
treatment with procyanidin-rich extract or B2 procyanidin
dimer [36,37]. Procyanidin-rich extracts and the B2 procyani-
din dimer are also dose-dependent inhibitors of the COX2
protein expression in other cell inflammation models in both
mice and humans [38–40]. Using a cell-free assay, Martinez-
Micaelo et al. [17] found that pure procyanidin dimers (B1
and B2) and trimers (C1) selectively altered COX1 and COX2
activity. Specifically, they found that B1 is a selective and
competitive inhibitor of COX1 activity, with an IC50 value of
8.0 lM, and that B2 and C1 are selective and competitive
inhibitors of COX2, with IC50 values of 9.7 and 3.3 lM,
respectively. Procyanidins apparently compete with AA for
binding to the active site of COX proteins, decreasing the
catalytic efficiency of PG biosynthesis. The potential of
procyanidins as strong inhibitors of COX activity, gene, and
protein expression is consistent with the decrease of PG
secretion observed in primary human macrophages [17,41].
On the other hand, LOXs are involved in the metabo-
lism of AA into several inflammatory mediators, including
LTs, and 5-, 12-, and 15-LOX are critical enzymes in the syn-
thesis of proinflammatory eicosanoids [42] (Fig. 2). The
effects of procyanidins on LT patterns were demonstrated by
Schramm et al. [43], who found that the intake of procyani-
din-rich chocolate in humans led to significant decreases in
the plasma concentrations of cysteinyl LTs, which are metab-
olites of the degradation of AA by the 5-lipoxygenase path-
way, as well as an increase of (#)-epicatechin metabolites in
the plasma. Moreover, Sies et al. [44] found that oligomeric
procyanidins can inhibit both the dioxygenase and LTA4 syn-
thase activities of human recombinant 5-lipoxygenase in a
dose-dependent manner. In this way, these molecules modu-
late the first two steps in the conversion of AA to various
proinflammatory LTs [42]. Although dietary procyanidins have
been identified as modulators of LOX activity, the interac-
tions between procyanidins and LOXs have not been fully
elucidated.
Even though several pure procyanidin compounds have
been described to be strong COX and LOX inhibitors, some
studies of the structure–activity relationship of procyanidins
suggest that the presence of galloyl moieties may be impor-
tant for this inhibitory activity [36,38,45].
In conclusion, the COX and LOX enzymes play key roles
in the modulation of the AA pathway and thus the inflamma-
tory response. Therefore, the prohomeostatic modulation of
the AA pathway by procyanidins is a potential mechanism by
which they may modulate the inflammatory response.
3.1.2. Modulation of cytokine production by
procyanidins. Cytokines are intercellular mediators that
modulate a broad range of cellular and physiological
responses, including the activation of several proinflamma-
tory pathways and transcription factors [46]. Therefore, an
imbalance of proinflammatory/anti-inflammatory cytokine
secretion is considered a hallmark of the activation/repres-
sion of an inflammatory response. Cytokines are often used
as biomarkers of inflammation, and their transcription and
secretion have been directly associated with several human
diseases [47].
Several in vitro and in vivo studies have shown that
procyanidins (extracts as well as monomers, dimers, or
trimers) can downregulate the transcription and secretion of
proinflammatory cytokines, including the interleukins (ILs)
IL-1b, IL-2, Il-6, and IL-8, tumor necrosis factor-a (TNF-a) and
interferon-c (INF-c), and can upregulate the secretion of
anti-inflammatory cytokines such as IL-10, IL-4, or transform-
ing growth factor-b (TGF-b) in peripheral blood mononuclear
cells, macrophages, or lymphoid cell lines. This behavior of
procyanidins has also been observed using in vivo models
of inflammation [48–52]. Miyake et al. [53] reported that the
oral administration of highly oligomeric procyanidins purified
from a South American herb jatoba dramatically reduced the
secretion of IFN-c and arthritis symptoms in mice.
3.1.3. No-mediated effects of procyanidins. NO, a gaseous
free radical, is synthesized from L-arginine by nitric oxide
synthases (NOS), including endothelial NOS (eNOS), neuro-
nal NOS (nNOS), and inducible NOS (iNOS) isoforms. NO is
considered to be a pivotal signaling molecule in endothelial
macrophages [54]. At physiological concentrations, NO exerts
several anti-inflammatory, antioxidant, antiatherosclerotic,
and vasodilatory activities; however, when produced in ex-
cessive amounts under oxidative and inflammatory condi-
tions, NO can be a precursor of potent pro-oxidant and
nitrating compounds, such as peroxynitrite and nitrogen
dioxide [44]. Procyanidins have been found to be strong
in vitro inhibitors of NO synthesis, downregulating iNOS
mRNA and protein expression, and therefore reducing NO
production and secretion in murine macrophages [41,46,54].
3.2. Procyanidins and signaling pathways
3.2.1. The nuclear factor-jb pathway and procyanidins. The
transcription factor NF-jB is responsible for the transcrip-
tional regulation of numerous genes underlying immune
response control [55,56]. NF-jB plays an essential role in
normal physiology, and its constitutive activation is associ-
ated with several diseases [57]. The NF-jB signaling path-
ways can be differentiated as classical/canonical pathways
or alternative pathways based on the specific IkappaB ki-
nase (Ijj) family members that are involved in their activa-
tion [58]. In mammals, the NF-jB family comprises five pro-
teins, including p65 (RelA), RelB, c-Rel, p105/p50 (NF-jB1),
and p100/p52 (NF-jB2), which associate with each other to
form transcriptionally distinct homo- and heterodimeric com-
plexes; the p65:p50 heterodimer is the most abundant and
the most relevant in inflammation compared with the other
Rel dimers [57]. In resting cells, the p65:p50 NF-jB hetero-
dimer is sequestered in the cytoplasm by the binding of its
inhibitory protein, IkappaB (IjB), a member of the IjB family
of proteins. In response to an inflammatory stimulus, such
as LPS from a bacterial cell wall, the classical pathway of
NF-jB activation leads to the activation of the IjB kinase
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(IjjB), a member of the Ijj complex, triggering IjB-a phos-
phorylation (pIjB-a). Then, pIjB-a is recognized by the ubiq-
uitin ligase machinery, causing its polyubiquitination and
subsequent proteasomal degradation. After pIjB-a degrada-
tion, the p65:p50 heterodimers are able to translocate to
the nucleus, where they bind to the jB motif found in the
promoter or enhancer regions of numerous proinflammatory
genes and induce their expression [56]. The alternative acti-
vation pathway of nuclear factor NF-jB is not activated by
LPS, and it is independent of IjjB and the Ijjc kinase [59].
NF-jB plays a critical role in the transcriptional regula-
tion of a wide range of genes that are involved in the regula-
tion of inflammation and also underlying inflammatory dis-
eases [60]. NF-jB transcriptional regulation include genes
encoding for cytokines (IL-1-a and b, IL-2, IL-6, IL-8, IL-9, IL-
11, IL-12, IL-13, IL-15, TNF-a, lymphotoxin a and b, and
Fig. 2. AA pathways. AA can be converted to either PGs or LTs by COXs or LOXs. AA, an eicosanoid precursor, is
released from cell membrane phospholipids through phospholipase A2 (PLA2) cleavage. AA can then be metabolized
by the COX pathway into PGs and thromboxane A2 (TXA2) or by the LOXs pathway to hydroperoxyeicosatetraenoic
acids (HpETEs), hydroxyeicosatetraenoic acids (HETEs) and LTs. COX1 is a housekeeping enzyme that is constitutively
expressed in most cells and is involved in the modulation of many physiological responses, whereas COX2 is an
inducible enzyme that produces large amounts of PGs. COX2 is highly expressed in inflammatory-related cell types,
including macrophages and mast cells, and its expression is triggered by proinflammatory stimuli such as
lipopolysaccharides (LPS) or cytokines. LOXs metabolize the AA-generating hydroxyl acid and LTs. Three different LOX
isoenzymes (5-, 12-, and 15-LOX) have been found in different cells and tissues. 5-LOX produces proinflammatory 5-
HETE and LTs, 12-LOX synthesises 12-HETE and is involved in the induction of the inflammatory response, and 15-LOX
produces anti-inflammatory 15-HETE.
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granulocyte-macrophage colony-stimulating factor (GM-CSF)),
adhesion molecules (e.g., intercellular adhesion molecule
(ICAM-1), vascular cell adhesion molecule (VCAM-1), and en-
dothelial leukocyte adhesion molecule (ELAM-1)), acute
phase proteins (serum amyloid A (SAA) and acute-phase
protein (CRP)), inducible enzymes (iNOS and COX2) and
cytokine receptors (interleukin-2 receptor (IL-2R), chemokine
receptor transporter 5, IL-1 receptor antagonist (IL-1RA), and
TNF receptor member 6 (TNFSR6)). All of these genes con-
tain verified NF-jB binding sites in their sequences, provid-
ing strong experimental evidence of their direct control by
NF-jB [61].
Procyanidins have been described as strong and selec-
tive inhibitors of NF-jB activation in both in vitro and animal
models [17,52,62–65]. One finding supporting this assump-
tion is that procyanidins (extracts, dimers, or trimers) down-
regulate IjjB activity, thus decreasing the phosphorylation
of pIjB-a and its subsequent ubiquitination and proteasomal
degradation [52,62]. Thus, procyanidins can inhibit NF-jB
activation by promoting the retention of the p65:p50 hetero-
dimer in the cytoplasm as an inactive complex bound to IjB
(Fig. 3).
A previous investigation [62] reported that in Jurkat T
cells, treatment with procyanidin dimers might regulate NF-
jB activation through the accumulation of B2 in the nucleus
and its direct interaction with the p65 and p50 NF-jB subu-
nits. The B2 procyanidin, due to its molecular structure, can
establish hydrogen bonds with the arginine residues in the
DNA binding regions of p50 and p65, thus mimicking the
guanine pairs present in the jB DNA sequence [23].
Recently, a novel p65:p50 cytosolic sequestering mech-
anism has been described [17]. p105 is a NF-jB family mem-
ber with dual functions in the NF-jB signaling system. First,
due to the ankyrin repeats in its structure, p105 can act as
an IjB family member and thus inhibit the nuclear transloca-
tion of p65. Second, p105 is a precursor of the p50 subunit,
so the cytoplasmic over-expression of p105 is associated
with a decrease in NF-jB and MAPK pathway activation. Pro-
cyanidins, especially B2, can also promote the formation of
p50:p50 homodimers and their nuclear translocation, which
is associated with a repression of NF-jB transcriptional
activity. In addition, procyanidins downregulate the binding
of NF-jB p65 to the corresponding jB-consensus sequences
in the promoter and enhancer regions of several proinflam-
matory genes [36,17,64].
3.2.2. MAPK pathways. MAPKs are Ser/Thr kinases that are
involved in the regulation of several cellular processes [46].
MAPKs are part of the three-tiered signaling pathways,
Fig. 3. The proposed anti-inflammatory mechanisms of procyanidins. The mechanisms underlying the anti-
inflammatory effects of procyanidins involve, among others, the modulation of AA pathway, the production and
secretion of inflammatory mediators and the modulation of the MAPK and NF-jB pathways. [Color figure can be
viewed in the online issue, which is available at wileyonlinelibrary.com.]
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including the extracellular signal related kinase (ERK), p38
MAPK and Jun N-terminal kinase (JNK) pathways, that regu-
late NF-jB and activator protein-1 (AP-1) DNA binding [33]
(Fig. 3). Mitogens, growth factors, stress, and inflammatory
stimuli are activators of the ERK, JNK, and p38 cascades.
MAPK signaling pathway activation can be regulated by pro-
tein phosphorylation, and procyanidin extracts and pure pro-
cyanidin compounds such as B1 dimer and C1 trimer mark-
edly suppressed the phosphorylation of ERK, JNK, and p38
in immune cells [36,46,52]. The inhibition of MAPK activation
elicits a decrease in AP-1 activity and thus suppresses the
production of several proinflammatory cytokines [46].
4. Conclusions
Procyanidins, which are plant polyphenols formed by the po-
lymerization of flavan-3-ols, comprise a vast array of biologi-
cally active compounds that are common in human diets all
over the world. Procyanidins possess anti-inflammatory
activities both in vitro and in vivo.
The mechanisms underlying the anti-inflammatory
effects of procyanidins involve, among others, the modula-
tion of several pivotal pathways in the regulation of cellular
homeostasis, such as the AA pathway (through the modula-
tion of eicosanoid-generating enzymes), the production and
secretion of inflammatory mediators (e.g., cytokines or nitric
oxide), and the modulation of MAPKs and NF-jB pathways.
The modulation of the inflammatory response by the
dietary intake of bioactive food compounds may be a power-
ful tool for promoting health and homeostasis and for pre-
venting disease development. However, there is a lack of
human intervention studies on the effects of individual pro-
cyanidins or combinations of procyanidins on inflammation.
The beneficial effects promoted by bioactive foods are
not exclusive to polyphenols or procyanidins but are also
exerted by other bioactive food compounds present in food;
for example, several fatty acids have been described as bio-
active prohomeostatic compounds. In this context, there is a
growing area of functional food science devoted to studying
and understanding the possible additive or synergistic inter-
actions between different bioactive compounds and their
potential benefits [10,17,66,67].
Acknowledgements
This work was supported by a grant from the Universitat
Rovira i Virgili for PhD students and by two grants from the
Ministerio de Educaci!on y Ciencia (MEYC) AGL2008-00387
and AGL2008-01310 of the Spanish Government.
References
[1] Erdman, J. W., Balentine, D., Arab, L., Beecher, G., Dwyer, J. T., Folts, J.,
Harnly, J., Hollman, P., Keen, C. L., Mazza, G., Messina, M., Scalbert, A.,
Vita, J., Williamson, G., and Burrowes, J. (2007) Flavonoids and heart
health: Proceedings of the ILSI North America Flavonoids Workshop,
May 31–June 1, 2005, Washington, DC. J. Nutr. 137, 718S–737S.
[2] Landberg, R., Sun, Q., Rimm, E. B., Cassidy, A., Scalbert, A., Mantzoros,
C. S., Hu, F. B., and Van Dam, R. M. (2011) Selected dietary flavonoids
are associated with markers off inflammation and endothelial dysfunc-
tion in U.S. Women. J. Nutr. 141, 618–625.
[3] Perez-Jimenez, J., Fezeu, L., Touvier, M., Arnault, N., Manach, C., Herc-
berg, S., Galan, P., and Scalbert, A. (2011) Dietary intake of 337 poly-
phenols in French adults. Am. J. Clin. Nutr. 93, 1220–1228.
[4] Scalbert, A., Manach, C., Morand, C., Remesy, C., and Jimenez, L.
(2005) Dietary polyphenols and the prevention of diseases. Crit. Rev.
Food Sci. Nutr. 45, 287–306.
[5] De La Iglesia, R., Milagro, F. I., Campion, J., Boque, N., and Martinez, J.
A. (2010) Healthy properties of proanthocyanidins. Biofactors 36,
159–168.
[6] Williamson, G. and Manach, C. (2005) Bioavailability and bioefficacy of
polyphenols in humans. II. Review of 93 intervention studies. Am. J.
Clin. Nutr. 81, 243S–255S.
[7] Auger, C., Al-Awwadi, N., Bornet, A., Rouanet, J. M., Gasc, F., Cros, G.,
and Teissedre, P. L. (2004) Catechins and procyanidins in Mediterra-
nean diets. Food Res. Int. 37, 233–245.
[8] Yilmaz, Y. and Toledo, R. T. (2004) Health aspects of functional grape
seed constituents. Trends Food Sci. Technol. 15, 422–433.
[9] Kenny, T. P., Keen, C. L., Schmitz, H. H., and Gershwin, M. E. (2007)
Immune effects of cocoa procyanidin oligomers on peripheral blood
mononuclear cells. Exp. Biol. Med. 232, 293–300.
[10] Martinez-Micaelo, N., Gonzalez-Abuin, N., Pinent, M., Ardevol, A., Blay,
M. (2011) Anti-inflammatory effects of procyanidins and docosahexanoic
acid in human macrophages THP-1. Inflamm. Res. 60, 258–259.
[11] Engler, M. B. and Engler, M. M. (2006) The emerging role of flavonoid-
rich cocoa and chocolate in cardiovascular health and disease. Nutr.
Rev. 64, 109–118.
[12] Khan, N., Monagas, M., Llorach, R., Urpi-Sarda, M., Rabassa, M.,
Estruch, R., and Andres-Lacueva, C. (2010) Targeted and metabolomic
study of biomarkers of cocoa powder consumption effects on inflamma-
tory biomarkers in patients at high risk of cardiovascular disease. Agro
Food Industry Hi-Tech 21, 51–54.
[13] Libby, P. (2007) Inflammatory mechanisms: the molecular basis of
inflammation and disease. Nutr. Rev. 65, S140–S146.
[14] Olefsky, J. M. and Glass, C. K. (2010) Macrophages, inflammation, and
insulin resistance. Annu. Rev. Physiol. 72, 219–246.
[15] Selmi, C., Mao, T. K., Keen, C. L., Schmitz, H. H., and Gershwin, M. E.
(2006) The anti-inflammatory properties of cocoa flavanols. J. Cardio-
vasc. Pharmacol. 47, S163–S171.
[16] Gonzalez, R., Ballester, I., Lopez-Posadas, R., Suarez, M. D., Zarzuelo,
A., Martinez-Augustin, O., and Sanchez De Medina, F. (2011) Effects of
flavonoids and other polyphenols on inflammation. Crit. Rev. Food Sci.
Nutr. 51, 331–362.
[17] Martinez-Micaelo, N., Gonzalez-Abuin, N., Terra, X., Richart, C., Ardevol,
A., Pinent, M., and Blay, M. (2012) Omega-3 docosahexaenoic acid and
procyanidins inhibit cyclo-oxygenase activity and attenuate NF-kappaB
activation through a p105/p50 regulatory mechanism in macrophage
inflammation. Biochem. J. 441, 653–663.
[18] Scalbert, A. and Williamson, G. (2000) Dietary intake and bioavailability
of polyphenols. J. Nutr. 130, 2073S–2085S.
[19] Baba, S., Osakabe, N., Natsume, M., and Terao, J. (2002) Absorption
and urinary excretion of procyanidin B2 epicatechin-(4 beta-8)-epicate-
chin in rats. Free Radic. Biol. Med. 33, 142–148.
[20] Holt, R. R., Lazarus, S. A., Sullards, M. C., Zhu, Q. Y., Schramm, D. D.,
Hammerstone, J. F., Fraga, C. G., Schmitz, H. H., and Keen, C. L. (2002)
Procyanidin dimer B2 epicatechin-(4 beta-8)-epicatechin in human
plasma after the consumption of a flavanol-rich cocoa. Am. J. Clin. Nutr.
76, 798–804.
[21] Gonthier, M. P., Donovan, J. L., Texier, O., Felgines, C., Remesy, C., and
Scalbert, A. (2003) Metabolism of dietary procyanidins in rats. Free
Radic. Biol. Med. 35, 837–844.
[22] Stoupi, S., Williamson, G., Viton, F., Barron, D., King, L. J., Brown, J. E.,
and Clifford, M. N. (2010) In vivo bioavailability, absorption, excretion,
and pharmacokinetics of (14)C procyanidin B2 in male rats. Drug
Metab. Dispos. 38, 287–291.
Procyanidins and inflammation 263
[23] Fraga, C. G. and Oteiza, P. I. (2011) Dietary flavonoids: role of (-)-epica-
techin and related procyanidins in cell signaling. Free Radic. Biol. Med.
51, 813–823.
[24] Spencer, J. P., Chaudry, F., Pannala, A. S., Srai, S. K., Debnam, E., and
Rice-Evans, C. (2000) Decomposition of cocoa procyanidins in the gas-
tric milieu. Biochem. Biophys. Res. Commun. 272, 236–241.
[25] Rios, L. Y., Bennett, R. N., Lazarus, S. A., Remesy, C., Scalbert, A., and
Williamson, G. (2002) Cocoa procyanidins are stable during gastric
transit in humans. Am. J. Clin. Nutr. 76, 1106–1110.
[26] Tsang, C., Auger, C., Mullen, W., Bornet, A., Rouanet, J. M., Crozier, A.,
and Teissedre, P. L. (2005) The absorption, metabolism and excretion
of flavan-3-ols and procyanidins following the ingestion of a grape
seed extract by rats. Br. J. Nutr. 94, 170–181.
[27] Deprez, S., Mila, I., Huneau, J. F., Tome, D., and Scalbert, A. (2001)
Transport of proanthocyanidin dimer, trimer, and polymer across mono-
layers of human intestinal epithelial Caco-2 cells. Antioxid. Redox. Sig-
nal. 3, 957–967.
[28] Han, X. Z., Shen, T., and Lou, H. X. (2007) Dietary polyphenols and
their biological significance. Int. J. Mol. Sci. 8, 950–988.
[29] Flower, R. J. and Vane, J. R. (1972) Inhibition of prostaglandin synthe-
tase in brain explains the anti-pyretic activity of paracetamol (4-acet-
amidophenol). Nature 240, 410–411.
[30] Baumann, J., Von Bruchhausen, F., and Wurm, G. (1980) Flavonoids and
related compounds as inhibition of arachidonic acid peroxidation. Pros-
taglandins 20, 627–639.
[31] Welton, A. F., Tobias, L. D., Fiedler-Nagy, C., Anderson, W., Hope, W.,
Meyers, K., and Coffey, J. W. (1986) Effect of flavonoids on arachidonic
acid metabolism. Prog. Clin. Biol. Res. 213, 231–242.
[32] Hong, J., Bose, M., Ju, J., Ryu, J. H., Chen, X., Sang, S., Lee, M. J., and
Yang, C. S. (2004) Modulation of arachidonic acid metabolism by curcu-
min and related beta-diketone derivatives: effects on cytosolic phos-
pholipase A(2), cyclooxygenases and 5-lipoxygenase. Carcinogenesis
25, 1671–1679.
[33] Kim, H. P., Son, K. H., Chang, H. W., and Kang, S. S. (2004) Anti-inflam-
matory plant flavonoids and cellular action mechanisms. J. Pharmacol.
Sci. 96, 229–245.
[34] Hamalainen, M., Nieminen, R., Asmawi, M. Z., Vuorela, P., Vapaatalo,
H., and Moilanen, E. (2011) Effects of flavonoids on prostaglandin E(2)
production and on COX-2 and mPGES-1 expressions in activated macro-
phages. Planta Med. 77, 1504–1511.
[35] Kang, Y. J., Wingerd, B. A., Arakawa, T., and Smith, W. L. (2006) Cyclo-
oxygenase-2 gene transcription in a macrophage model of inflamma-
tion. J. Immunol. 177, 8111–8122.
[36] Hou, D. X., Masuzaki, S., Hashimoto, F., Uto, T., Tanigawa, S., Fujii, M.,
and Sakata, Y. (2007) Green tea proanthocyanidins inhibit cyclooxygen-
ase-2 expression in LPS-activated mouse macrophages: molecular
mechanisms and structure-activity relationship. Arch. Biochem. Biophys.
460, 67–74.
[37] Zhang, W. Y., Liu, H. Q., Xie, K. Q., Yin, L. L., Li, Y., Kwik-Uribe, C. L.,
and Zhu, X. Z. (2006) Procyanidin dimer B2 epicatechin-(4 beta-8)-epi-
catechin suppresses the expression of cyclooxygenase-2 in endotoxin-
treated monocytic cells. Biochem. Biophys. Res. Commun. 345,
508–515.
[38] Kundu, J. K., Na, H. K., Chun, K. S., Kim, Y. K., Lee, S. J., Lee, S. S.,
Lee, O. S., Sim, Y. C., and Surh, Y. J. (2003) Inhibition of phorbol ester-
induced COX-2 expression by epigallocatechin gallate in mouse skin
and cultured human mammary epithelial cells. J. Nutr. 133,
3805S–3810S.
[39] Kang, N. J., Lee, K. W., Lee, D. E., Rogozin, E. A., Bode, A. M., Lee, H.
J., and Dong, Z. (2008) Cocoa procyanidins suppress transformation by
inhibiting mitogen-activated protein kinase kinase. J. Biol. Chem. 283,
20664–20673.
[40] Meeran, S. M., Vaid, M., Punathil, T., and Katiyar, S. K. (2009) Dietary
grape seed proanthocyanidins inhibit 12-O-tetradecanoyl phorbol-13-ac-
etate-caused skin tumor promotion in 7,12-dimethylbenz[a]anthracene-
initiated mouse skin, which is associated with the inhibition of inflam-
matory responses. Carcinogenesis 30, 520–528.
[41] Terra, X., Valls, J., Vitrac, X., Merrillon, J. M., Arola, L., Ardevol, A.,
Blade, C., Fernandez-Larrea, J., Pujadas, G., Salvado, J., and Blay, M.
(2007) Grape-seed procyanidins act as antiinflammatory agents in en-
dotoxin-stimulated RAW 264.7 macrophages by inhibiting NFkB signal-
ing pathway. J. Agric. Food Chem. 55, 4357–4365.
[42] Samuelsson, B., Rouzer, C. A., and Matsumoto, T. (1987) Human leuko-
cyte 5-lipoxygenase: an enzyme possessing dual enzymatic activities
and a multicomponent regulatory system. Adv. Prostaglandin Throm-
boxane Leukot. Res. 17A, 1–11.
[43] Schramm, D. D., Wang, J. F., Holt, R. R., Ensunsa, J. L., Gonsalves, J. L.,
Lazarus, S. A., Schmitz, H. H., German, J. B., and Keen, C. L. (2001)
Chocolate procyanidins decrease the leukotriene-prostacyclin ratio in
humans and human aortic endothelial cells. Am. J. Clin. Nutr. 73,
36–40.
[44] Sies, H., Schewe, T., Heiss, C., and Kelm, M. (2005) Cocoa polyphenols
and inflammatory mediators. Am. J. Clin. Nutr. 81, 304S–312S.
[45] Seeram, N. P., Zhang, Y., and Nair, M. G. (2003) Inhibition of prolifera-
tion of human cancer cells and cyclooxygenase enzymes by anthocyani-
dins and catechins. Nutr. Cancer 46, 101–106.
[46] Santangelo, C., Vari, R., Scazzocchio, B., Di Benedetto, R., Filesi, C.,
and Masella, R. (2007) Polyphenols, intracellular signalling and inflam-
mation. Ann. Ist. Super. Sanita 43, 394–405.
[47] Mack, C. L. (2007) Serum cytokines as biomarkers of disease and clues
to pathogenesis. Hepatology 46, 6–8.
[48] Mao, T. K., Powell, J., Van De Water, J., Keen, C. L., Schmitz, H. H.,
Hammerstone, J. F., and Gershwin, M. E. (2000) The effect of cocoa pro-
cyanidins on the transcription and secretion of interleukin 1 beta in pe-
ripheral blood mononuclear cells. Life Sci. 66, 1377–1386.
[49] Mao, T. K., Van De Water, J., Keen, C. L., Schmitz, H. H., and Gershwin, M. E.
(2002) Effect of cocoa flavanols and their related oligomers on the secretion
of interleukin-5 in peripheral blood mononuclear cells. J. Med. Food 5,
17–22.
[50] Al-Hanbali, M., Ali, D., Bustami, M., Abdel-Malek, S., Al-Hanbali, R.,
Alhussainy, T., Qadan, F., and Matalka, K. Z. (2009) Epicatechin sup-
presses IL-6, IL-8 and enhances IL-10 production with NF-kappaB nu-
clear translocation in whole blood stimulated system. Neuroendocrinol.
Lett. 30, 131–138.
[51] Terra, X., Montagut, G., Bustos, M., Llopiz, N., Ardevol, A., Blade, C.,
Fernandez-Larrea, J., Pujadas, G., Salvado, J., Arola, L., and Blay, M.
(2009) Grape-seed procyanidins prevent low-grade inflammation by
modulating cytokine expression in rats fed a high-fat diet. J. Nutr. Bio-
chem. 20, 210–218.
[52] Terra, X., Palozza, P., Fernandez-Larrea, J., Ardevol, A., Blade, C., Puja-
das, G., Salvado, J., Arola, L., and Blay, M. T. (2011) Procyanidin dimer
B1 and trimer C1 impair inflammatory response signalling in human
monocytes. Free Radic. Res. 45, 611–619.
[53] Miyake, M., Ide, K., Sasaki, K., Matsukura, Y., Shijima, K., and Fujiwara,
D. (2008) Oral administration of highly oligomeric procyanidins of
Jatoba reduces the severity of collagen-induced arthritis. Biosci. Bio-
technol. Biochem. 72, 1781–1788.
[54] Yoon, J. H. and Baek, S. J. (2005) Molecular targets of dietary polyphe-
nols with anti-inflammatory properties. Yonsei Med. J. 46, 585–596.
[55] Ghosh, S., May, M. J., and Kopp, E. B. (1998) NF-kappa B and rel pro-
teins: evolutionarily conserved mediators of immune responses. Annu.
Rev. Immunol. 16, 225–260.
[56] Hayden, M. S., West, A. P., and Ghosh, S. (2006) NF-kappa B and the
immune response. Oncogene 25, 6758–6780.
[57] Li, Q. T. and Verma, I. M. (2002) NF-kappa B regulation in the immune
system. Nat. Rev. Immunol. 2, 725–734.
[58] Hayden, M. S. and Ghosh, S. (2004) Signaling to NF-kappa B. Genes
Dev. 18, 2195–2224.
[59] Oeckinghaus, A. and Ghosh, S. (2009) The NF-kappa B family of tran-
scription factors and its regulation. Cold Spring Harb. Perspect. Biol. 1:
a000034.
[60] Gilmore, T. D. (1999) The Rel/NF-kappa B signal transduction pathway:
introduction. Oncogene 18, 6842–6844.
[61] Pahl, H. L. (1999) Activators and target genes of Rel/NF-kappa B tran-
scription factors. Oncogene 18, 6853–6866.
[62] Mackenzie, G. G., Carrasquedo, F., Delfino, J. M., Keen, C. L., Fraga, C.
G., and Oteiza, P. I. (2004) Epicatechin, catechin, and dimeric
264 BioFactors
procyanidins inhibit PMA-induced NF-kappaB activation at multiple
steps in Jurkat T cells. FASEB J. 18, 167–169.
[63] Chacon, M. R., Ceperuelo-Mallafre, V., Maymo-Masip, E., Mateo-Sanz, J.
M., Arola, L., Guitierrez, C., Fernandez-Real, J. M., Ardevol, A., Simon,
I., and Vendrell, J. (2009) Grape-seed procyanidins modulate inflamma-
tion on human differentiated adipocytes in vitro. Cytokine 47, 137–142.
[64] Mackenzie, G. G., Delfino, J. M., Keen, C. L., Fraga, C. G., and Oteiza, P.
I. (2009) Dimeric procyanidins are inhibitors of NF-kappaB-DNA binding.
Biochem. Pharmacol. 78, 1252–1262.
[65] Terra, X., Pallares, V., Ardevol, A., Blade, C., Fernandez-Larrea, J., Puja-
das, G., Salvado, J., Arola, L., and Blay, M. (2011) Modulatory effect of
grape-seed procyanidins on local and systemic inflammation in diet-
induced obesity rats. J. Nutr. Biochem. 22, 380–387.
[66] Pallares, V., Calay, D., Cedo, L., Castell-Auvi, A., Raes, M., Pinent, M.,
Ardevol, A., Arola, L., and Blay, M. (2012) Additive, antagonistic, and
synergistic effects of procyanidins and polyunsaturated fatty acids over
inflammation in RAW 264.7 macrophages activated by lipopolysaccha-
ride. Nutrition 28, 447–457.
[67] Pallares, V., Calay, D., Cedo, L., Castell-Auvi, A., Raes, M., Pinent, M.,
Ardevol, A., Arola, L., and Blay, M. (2012) Enhanced anti-inflammatory
effect of resveratrol and EPA in treated endotoxin-activated RAW 264.7
macrophages. Br. J. Nutr. 1–12. Available on CJO 2012 doi:10.1017/
S0007114511007057.
Procyanidins and inflammation 265

HYPOTHESIS AND OBJECTIVES 
 45 
 
 
2. Hypothesis and 
Objectives 
The metabolism and immune systems are among the most fundamental requirements for 
survival, and the resulting interface from its multilevel interactions, immunometabolism, is a 
central mechanism for the promotion and maintenance of homeostasis. Therefore, the 
improper regulation of immunometabolism underlies the onset and progression of several 
diseases, such as the obesity, as well as offers a substantial therapeutic target to maintain 
and improve health. 
The importance of the nutritional profile in the maintenance of homeostasis and thus in 
health is well established and there are many diseases that result from chronic metabolic 
imbalances related to diet, including obesity, type 2 diabetes, inflammatory diseases and 
cancer. However, nutrition can also be considered as a source of bioactive compounds. 
From a molecular perspective, nutrition can be defined as a set of dietary signals sensed by 
immune and metabolic cells and capable of modulating its functionality through the 
regulation of gene expression, protein synthesis, and metabolite production. Therefore, the 
nutritional profile might play a crucial role for the proper regulation of immunometabolism 
and thus health. Based on these concepts is nutritional immunotherapy, which is intended to 
promote homeostasis through optimising the functionality of the body’s own immune system. 
Taking this into account, we hypothesised that the nutritional profile and, more 
specifically, food-derived molecular signals, could modulate immunometabolism. 
Because immunometabolism involves complex genetic, molecular, cellular and 
environmental interactions, we have analysed the nutritional regulation of 
immunometabolism based on the integration of different disciplines, including nutrition, 
metabolism, physiology, immunology, transcriptomics and bioinformatics. Different 
objectives have been proposed to assess this hypothesis: 
1. To determine the ability of food compounds to modulate the activation of the 
inflammatory response against a pathogen in innate immune effector cells 
(Chapter 2). 
To achieve this objective, LPS-stimulated human macrophages were challenged with 
different bioactive food compounds, including the procyanidins B1, B2 and C1, as well as 
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the n-3 fatty acid DHA alone or in combination with individual procyanidins. The 
immunomodulatory effects were determined by the modulation of eicosanoid production 
and COX activity, the activation of the NF-κB signalling pathway and the secretion of pro-
inflammatory mediators. 
2. To determine whether innate immune cells can sense food-derived molecular 
signals. 
After assessment of the role of food compounds in the modulation of innate immunity, the 
sensing capacity of different nutritional profiles by the NLRP3 inflammasome, the 
signalling pathway that integrates metabolism and inflammation, was evaluated. This 
main objective was separated into two parts, depending upon the nature of the dietary 
signals: 
2.1. To evaluate whether B2 procyanidin might modulate the activation of the 
inflammasome (Chapter 3). 
To determine if bioactive food compounds could interfere in the bacterial activation of 
the NLRP3 inflammasome, LPS-induced macrophages were treated with procyanidin 
B2, one of the most immunologically active molecules within the procyanidins. The 
capacity of B2 to modulate LPS-mediated inflammasome activation was measured 
based on the modulation of activation of the NF-κB signalling pathway (the priming 
step), the assembly of NLRP3 (the activation step) and the secretion of IL-1β (the 
main goal of inflammasome activation). 
2.2. To analyse the effect of the dietary fatty acid composition on 
inflammasome activation (Chapter 4). 
The nutritional profile sensing capacity of the inflammasome was assessed through 
the immunomodulatory effects of four dietary fatty acids differentiated by chemical 
structure: palmitate and stearic acid (saturated fatty acids), docosahexaenoic acid (n-
3 PUFA) and arachidonic acid (n-6 PUFA). The inflammasome sensing capacity was 
assessed through the supplementation of the different fatty acids as priming signals 
for ATP-activated macrophages, in the ability of fatty acids to interfere with LPS-
induced inflammasome activation and in the role of dietary fatty acids in the activation 
of inflammasome. 
3. To analyse the effect of chronic overfeeding of highly palatable and energy-
dense foods in the regulation of immunometabolism in rats (Chapter 5). 
To assess the role of diet-induced obesity in immunometabolic function, rats were fed the 
cafeteria diet, which is a robust model of human metabolic syndrome. The capacity of the 
immune system to recognise and respond to changes in metabolic function was 
determined based on the adipose tissue-triggered inflammatory response as well as 
through the functionality of the thymus and the spleen.  
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4. To evaluate whether homeostasis could be improved by targeting 
immunometabolism through supplementing the diet with bioactive food 
compounds (Chapter 6). 
To determine the role of the nutritional profile in the promotion and maintenance of 
homeostasis and therefore health, rats with an impaired immunometabolism, as a 
consequence of diet-induced obesity, were challenged with bioactive food compounds, 
including a procyanidin extract, oil rich in DHA or the combination of both, to improve 
homeostasis by targeting immunometabolism through the diet. 
5. To determine if genetic and environmental factors can interfere with the link 
between metabolic and immunological abnormalities in the context of diet-
induced obesity (Chapter 7). 
The influence of genetic background on the phenotypic response to diet-induced obesity 
was analysed in two inbred rat strains subjected to a metabolic challenge based on 
dietary energy content. The role of genotype was evaluated by comparing phenotypic 
and genetic adaptation, as well as by comparing the obesity-induced modulation of the 
monocyte transcriptome in both genetic backgrounds. 
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Omega-3 docosahexaenoic acid and procyanidins inhibit cyclo-oxygenase
activity and attenuate NF-κB activation through a p105/p50 regulatory
mechanism in macrophage inflammation
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Monserrat PINENT* and Mayte BLAY*1
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The inflammatory response has been implicated in the patho-
genesis of many chronic diseases. Along these lines, the
modulation of inflammation by consuming bioactive food
compounds, such as ω−3 fatty acids or procyanidins, is a
powerful tool to promote good health. In the present study,
the administration of DHA (docosahexaenoic acid) and B1, B2
and C1 procyanidins, alone or in combination, prevented the
inflammatory response induced by the LPS (lipopolysaccharide)
endotoxin in human macrophages and brought them to the
homoeostatic state. DHA and B1 were strong and selective
negative regulators of cyclo-oxygenase 1 activity, with IC50 values
of 13.5 µM and 8.0 µM respectively. Additionally, B2 and C1
were selective inhibitors of pro-inflammatory cyclo-oxygenase 2
activity, with IC50 values of 9.7 µM and 3.3 µM respectively.
Moreover, DHA and procyanidins prevented the activation of
the NF-κB (nuclear factor κB) cascade at both early and late
stages with shared mechanisms. These included inhibiting IκBα
(inhibitor of NF-κB α) phosphorylation, inducing the cytoplasmic
retention of pro-inflammatory NF-κB proteins through p105 (NF-
κB1) overexpression, favouring the nuclear translocation of the
p50–p50 transcriptional repressor homodimer instead of the p50–
p65 pro-inflammatory heterodimer, inhibiting binding of NF-κB
DNA to κB sites and, finally, decreasing the release of NF-
κB-regulated cytokines and prostaglandins. In conclusion, DHA
and procyanidins are strong and selective inhibitors of cyclo-
oxygenase activity and NF-κB activation through a p105/p50-
dependent regulatory mechanism.
Key words: cyclo-oxygenase, docosahexaenoic acid (DHA),
nuclear factor κB (NF-κB), omega-3 fatty acid, procyanidin,
prostaglandin.
INTRODUCTION
The inflammatory response is a body defence mechanism that is
triggered by an external aggression, such as trauma or infection
by external pathogens, and it represents a complex network
of cellular and molecular interactions that is responsible for
facilitating tissue repair and for returning the cell to physiological
homoeostasis [1,2]. The cellular response is composed of local
and systemic activation processes and is mediated by transcription
factors, such as NF-κB (nuclear factor κB), that modulate the
synthesis and secretion of cytokines such as IL (interleukin)-6 or
prostanoids formed by the metabolism of arachidonic acid by the
COX (cyclo-oxygenase) pathway [3].
Macrophages can be considered as the main co-ordinators of
the innate immune response, as they are the first to recognize
exogenous pathogens. Through a series of receptors based on
pattern recognition, including TLR (Toll-like receptor) types and
complement receptors, macrophages are able to identify the
most common pathogens that trigger the inflammatory response
[1,4].
IL-6 is one of the most important pro-inflammatory cytokines
secreted by macrophages in response to an inflammatory stimulus.
IL-6 is involved in the modulation of a broad range of cellular and
physiological responses [5]. COX, or PGHS (prostaglandin H
synthase), is responsible for the metabolic conversion ofω−6 AA
(arachidonic acid), the most abundant fatty acid present in the cell
membrane, into PGE2 (prostaglandin E2) and TX (thromboxane)
[5–7]. Additionally, prostanoids can also be synthesized from
ω−3 fatty acids, such as DHA (docosahexaenoic acid). The ω−6
andω−3 fatty acids lead to two different sets of eicosanoids, the E2
and E3 series respectively [8]. These eicosanoids act as chemical
messengers for the immune system, and their principal function
involves regulating the inflammatory response. Three isoforms
of COX (EC number 1.14.99.1) responsible for the biosynthesis
of eicosanoids have been described, which include COX1 (or
prostaglandin endoperoxide synthase 1), COX2 (or prostaglandin
endoperoxide synthase 2) and COX3 (or prostaglandin endoper-
oxide synthase 3) [7,9]. COX1 is constitutively expressed in most
cells and is therefore regarded as a housekeeping molecule and
is involved in the mediation of different physiological responses
(e.g. the protection of the gastric epithelium or platelet aggrega-
tion). COX2 remains undetectable in the majority of mammalian
tissues under basal conditions, although its expression is inducible
by several inflammatory stimuli [e.g. LPS (lipopolysaccharide) or
inflammatory cytokines], leading to an increase in PGE2 synthesis.
Additionally, the activation of COX2 is implicated in numerous
inflammation-associated diseases and instances of tumorigenesis
[6,9]. Therefore COX1 and COX2 are of particular interest
because they are the major targets of NSAIDs (non-steroidal
anti-inflammatory drugs). COX3 has been described as a splice
Abbreviations used: AA, archidonic acid; COX, cyclo-oxygenase; DHA, docosahexaenoic acid; ERK, extracellular-signal-regulated kinase; HRP,
horseradish peroxidase; IκB, inhibitor of nuclear factor κB; IKK, IκB kinase; IL, interleukin; LPS, lipopolysaccharide; MAPK, mitogen-activated protein
kinase; NF-κB, nuclear factor κB; NSAID, non-steroidal anti-inflammatory drug; PBMC, peripheral blood mononuclear cell; PGE2, prostaglandin E2; PUFA,
polyunsaturated fatty acid; TLR, Toll-like receptor.
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variant of COX1; however, its biological role is still poorly studied
[10].
The transcription factor NF-κB regulates the transcription
of numerous genes that control the immune response [11,12].
Although NF-κB plays an essential role in normal physiology
and in the inflammatory immune response, the constitutive
activation of NF-κB is associated with different diseases [11–14].
There are two NF-κB signalling pathways: the classical, or
canonical, pathway and the alternative route. The main difference
between these two activation pathways includes the specific
IKK [IκB (inhibitor of NF-κB) kinase] family members that
are involved [13]. In mammals, the NF-κB family consists
of five proteins, including p65 (RelA), RelB, c-Rel, p105/p50
(NF-κB1) and p100/p52 (NF-κB2), that associate with each
other to form transcriptionally distinct homo- and hetero-dimeric
complexes [15], although the p65–p50 heterodimer represents
the most abundant of the Rel dimers. NF-κB family proteins
are characterized by the presence of the RHD (Rel homology
domain), a 300 amino acid N-terminal segment responsible for
DNA binding, dimerization, nuclear translocation, interaction
with IκB family proteins and transcriptional regulation [12–14].
In resting cells, the NF-κB heterodimer is retained in the
cytoplasm and is bound to its inhibitory protein, IκB, a member
of the IκB family of proteins. In response to an inflammatory
stimulus, such as LPS from the bacterial cell wall, the classical
pathway of NF-κB activation leads to the activation of IKKβ, a
member of the IKK complex, and triggers the phosphorylation
of IκBα protein (pIκBα). pIκBα is recognized by the ubiquitin
ligase machinery, causing its polyubiquitination and subsequent
proteasomal degradation. After pIκBα degradation, the NF-κB
heterodimer is able to translocate to the nucleus, where, bound
to the κB motif found in the promoter or enhancer regions, it
induces the expression of numerous pro-inflammatory genes
[12]. The alternative activation pathway of NF-κB is not activated
by LPS, and it is independent of IKKβ and IKKγ [11–13,16].
Procyanidins are phenolic compounds that are present in a
variety of vegetables, fruits and cereals, but are mainly found
in cocoa, grapes and apples. Procyanidins are polymers that are
composed of flavan-3-ol units, such as catechin and epicatechin.
Procyanidins can be defined as bioactive food compounds,
owing to their influence on physiological status and cellular
homoeostasis, as well as their beneficial effects on health, such as
inhibition of the release of pro-inflammatory mediators [17–20].
The mechanisms involved in the modulation of the inflammatory
response by procyanidins are not yet well understood and are
currently a subject of intense study.
PUFAs (polyunsaturated fatty acids) are important constituents
of cells that are mainly involved in preserving the fluidity of
the cell membrane, regulating cellular signals or modulating gene
expression [21].ω− 3 fatty acids that are present as bioactive food
compounds can replace the ω− 6 fatty acids located in the cell
membranes of macrophages, triggering a competition between
ω− 3 and ω− 6 fatty acids during prostanoid formation [22].
In general, the eicosanoids from the 3 series that are derived
from ω− 3 fatty acids have less inflammatory activity than the 2
series that are derived from ω− 6 fatty acids. In some cases,
the eicosanoids derived from the ω− 3 fatty acids do not
have the biological activities of their counterparts [23]. DHA
is present in certain aquatic organisms, such as fish (fish oil) or
marine algae. Studies have indicated that the supplementation of
diets with ω− 3 fatty acids, such as DHA, produces beneficial
effects on symptoms in diseases characterized by chronic
inflammation, such as atherosclerosis, rheumatoid arthritis or
obesity [24,25]. The mechanisms by which ω− 3 fatty acids,
specifically DHA, exert anti-inflammatory effects remain unclear.
The present study is focused on the regulation of the
inflammatory response by DHA and the procyanidins B1, B2
and C1, alone or in combination, in LPS-stimulated human
macrophages. This modulation of the inflammatory response was
based upon the secretion of inflammatory mediators, such as IL-6
and PGE2, as well as modulation of the activity of the COX
pathway. Additionally, the modulation effects on the expression
of NF-κB family proteins and their implications in the NF-κB
signalling pathway were investigated.
MATERIAL AND METHODS
Reagents
Procyanidin dimers B1 [epicatechin-(4β→8)-catechin] and B2
[epicatechin-(4β→8)-epicatechin] were obtained from ExtraSyn-
these. Procyanidin trimer C1 [epicatechin-(4β→8)-epicatechin-
(4β→8)-epicatechin] was obtained from TransGmbH. cis-4-,
7,10,13,16,19-DHA was obtained from Sigma–Aldrich. RPMI
1640 culture medium was purchased from Gibco. Cell culture
reagents were provided by BioWhittaker, except for the
differentiating agent PMA, which was purchased from InvivoGen,
and LPS (Escherichia coli 0111:B4), which was purchased
from Sigma–Aldrich. The anti-p65, anti-p50/p105, anti-pIκBα
and FITC-conjugated goat anti-rabbit IgG were acquired from
Santa Cruz Biotechnology, and the anti-COX2 polyclonal
antibody was purchased from Bioworld. The HRP (horseradish
peroxidase)-conjugated monoclonal anti-rabbit IgG antibody
was obtained from GE Healthcare, and the advanced ECL
(enhanced chemiluminescence) Western blotting detection kit
was provided by GE Healthcare. The NSAIDs nimesulide, sc-
560 and indomethacin were purchased from Cayman Chemicals.
Bradford reagent and Histopaque®-1077 were obtained from
Sigma–Aldrich.
Cell lines and cell culture
Human THP-1 monocytes were purchased from the European
Collection of Animal Cell Cultures (ECACC number 88081201).
Cells were cultured in RPMI 1640 medium supplemented
with 2 mM L-glutamine, 100 µg/ml streptomycin, 100 units/ml
penicillin, 25 mM Hepes and 10% FBS (fetal bovine serum) at
37 ◦C in a humidified incubator with 5%CO2. The differentiation
of THP-1 monocytes into macrophages was induced by growing
the cells in fresh medium containing 0.5 µg/ml PMA for 24 h.
After differentiation, the medium containing PMA was removed
and adherent THP-1 macrophages were incubated in RPMI
medium for 24 h. Later, macrophages were treated with 25 µM
DHA, 17.3 µM B1, 17.3 µM B2 or 11.5 µM C1, or a combination
of DHA with one of the procyanidins in serum-free RPMI 1640-
supplemented medium. For all experiments, control cells treated
with ethanol alone (vehicle of the DHA and procyanidins) were
included (final concentration in the medium was!0.1%). Finally,
all of the macrophages, except for the unstimulated control, were
stimulated with 1 µg/ml LPS. The experimental design is shown
in Figure 1. Cell viability was assessed as better than 97% under
all experimental conditions using Trypan Blue staining (results
not shown).
Isolation of primary human monocyte-derived macrophages
Five healthy donors were recruited from the University Hospital
Joan XXIII. The study was approved by the Institutional Review
Board. All participants gave written informed consent for
participation in medical research. Human PBMCs (peripheral
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Figure 1 Schematic diagram of the experimental design
Macrophages used in the present study were obtained from two origins: THP-1 monocytes and primary human macrophages. (A) THP-1 monocytes were differentiated into macrophages in the
presence of 0.5µg/ml PMA for 24 h. After differentiation, the macrophages were stabilized with PMA-free medium for 24 h prior to DHA and/or procyanidin pre-treatment. (B) PBMCs were isolated
from healthy blood donors using a density gradient. Monocytes were purified and activated by adherence to plastic after 2 h. THP-1 macrophages and primary human macrophages were pre-treated
with 25µM DHA, 17.3µM B1, 17.3µM B2 or 11.5µM C1, or a combination of DHA and one of the procyanidins for 48 h. Additionally, control cells treated with just the vehicle (ethanol) were
used. Finally, pre-treated macrophages were stimulated with 1µg/ml LPS, except for the control group (without LPS stimulation), for 15 min to 24 h, depending on the subsequent analysis.
blood mononuclear cells) were isolated from healthy blood
donors by density gradient centrifugation using Histopaque®
-1077, according to the manufacturer’s protocol (Sigma–
Aldrich). Histopaque®-1077 is a solution of polysucrose (5.7
g/dl) and sodium diatrizoate (9 g/dl), adjusted to a density of
1.077+− 0.001 g/ml. Monocytes were purified by adherence to
plastic in serum-free RPMI 1640-supplemented medium inducing
monocyte activation. Briefly, 2× 106 cells/ml were seeded into
12-well plates and, after 2 h, non-adherent cells were removed by
several washes with warm PBS. Freshly isolated primary activated
monocytes were treated with DHA and/or procyanidins and were
stimulated with LPS following the same protocol as previously
described for THP-1 macrophages, which is shown in Figure 1.
IL-6 secretion
The effect of DHA/procyanidin pre-treatments on IL-6
concentration was measured with an ELISA kit following the
manufacturer’s protocol (BioLegend). The secretion of IL-6 was
normalized according to the protein content measured using a
Bradford assay.
PGE2 secretion
The effect of the DHA/procyanidin pre-treatments on PGE2 in
LPS-stimulated macrophage supernatants was determined by a
specific competitive immunoassay (EIA) following the manu-
facturer’s protocol (Cayman Chemicals). The secretion of PGE2
in culture supernatants was normalized according to the protein
concentration, which was determined using a Bradford assay.
COX1 and COX2 cell-free assay
The kinetic effects of the treatments (DHA, B1, B2 and C1) on
the activity of COX1 and COX2 enzymes were determined using
a cell-free inhibition assay, on the basis of the fact that the rate-
limiting step in prostaglandin synthesis is catalysed by COXs.
Then, the modulation of the synthesis of PGE2 from AA by DHA,
B1, B2 and C1 was determined. Briefly, the cell-free assay was
performed using purified COX1 from ram seminal vesicles and
COX2 from sheep placental cotyledons (Cayman Chemicals).
The COX isoforms were incubated with various concentrations
of AA (0.15–25 µM) for 20 min (pH 8.0), at 37 ◦C in the
presence of 18 mM adrenaline (epinephrine), 5 µM haematin
and concentrations of DHA, B1, B2, and C1 that ranged from
0.01 to 500 µM, as well as commercial inhibitors (indomethacin,
nimesulide and sc-560). The reactions were stopped by the
addition of 10 µl of 10% formic acid. The PGE2 concentration
was determined using a specific competitive immunoassay (EIA,
Cayman Chemicals) [26]. IC50 values were expressed as the
concentration of compound required to inhibit 50% of the
PGE2 biosynthesis. The kinetic constants were analysed from
double-reciprocal plots of velocity against AA concentration
using GraphPad Prism (version 5.0). Kinetic parameters were
obtained by fitting the points to the Michaelis–Menten kinetic
equation:
V = Vmax · [S]
Km + [S]
where V is the initial rate, Vmax represents the maximum enzyme
rate at saturating substrate concentrations, [S] is the substrate
concentration and Km is the substrate concentration at which the
reaction rate is half that of Vmax. The turnover number, or catalytic
constant (kcat), was calculated from the following equation:
kcat = Vmax[E]t
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where [E]t represents the total active enzyme concentration.
Additionally, the dissociation constant for inhibitor binding (K i)
was obtained from the following equation:
K i = [inhibitor]Km,obs
Km
− 1
where Km,obs represents the Km value specific for each inhibitor,
and Km is the value obtained under control conditions.
Nuclear and cytoplasm extract preparation
Pre-treated LPS-stimulated THP-1 cytoplasmic and nuclear
proteins were extracted using methods that have been described
previously [25,27]. Briefly, 2× 106 cells were washed twice with
ice-cold PBS. Cells were lysed in ice-cold buffer A [10 mM Hepes
(pH 7.9), 1.5 mM MgCl2, 10 mM KCl, 0.5 mM PMSF, 0.5 mM
DTT (dithiothreitol), 0.1% Nonidet P40 and 10 µg/ml protease
and phosphatase inhibitors]. Subsequently, cells were centrifuged,
and the supernatant, i.e. the cytoplasmic fraction, was removed
and stored at − 80 ◦C. The nuclear pellet was washed once
with PBS and resuspended in ice-cold buffer B [20 mM Hepes
(pH 7.9), 1.5 mM MgCl2, 420 mM NaCl, 0.2 mM EDTA, 25%
glycerol, 0.5 mM PMSF and 10 µg/ml protease and phosphatases
inhibitors]. The nuclear extract was obtained by centrifugation,
and the supernatant, i.e. the nuclear fraction, was removed and
stored at − 80 ◦C. The protein concentrations in the cytoplasmic
and nuclear fractions were quantified with a Bradford assay using
BSA as the standard.
Western blot analysis
Cytoplasmic and nuclear proteins were electrophoresed by
SDS/PAGE, and separated proteins were transferred on to a PVDF
membrane. The blots were blocked and incubated overnight at
4 ◦C with the appropriate primary antibody. After washing, the
blots were incubated with HRP-conjugated secondary antibody,
developed with a chemiluminescent reagent (GE Healthcare) and
exposed using the Alpha Innotech FluorChem FC2 Imager. A
semi-quantitative analysis of the proteins was performed using
ImageJ software.
Immunofluorescence staining of NF-κB p65 and confocal
microscopy
THP-1-derived macrophages were cultured on sterile commercial
poly-L-lysine-treated coverslips (BD BioCoat, BD Biosciences)
prior to pre-treatment with DHA and/or procyanidins for 48 h.
Then, THP-1 macrophages were activated with LPS for 1 h. Cells
were washed, fixed in 4% paraformaldehyde and permeabilized
with 0.5% Triton X-100. After incubation with blocking buffer,
the cells were incubated with NF-κB p65 primary antibody
overnight at 4 ◦C and were then incubated with FITC-conjugated
goat anti-mouse IgG. The coverslips were washed, and the
samples were then counterstained with ethidium bromide and
were mounted in Sigma–Aldrich 10979 mounting medium with
polyvinyl alcohol and anti-fading reagent. Confocal images were
acquired with a laser confocal-scanning microscope (Nikon
Eclipse TE2000-E) using EZ-C1 3.40 software.
NF-κB-binding assay
The effect of pre-treatment with DHA and/or procyanidins on
NF-κB p65 binding to target DNA was determined with the
Figure 2 Modulation of IL-6 secretion in LPS-stimulated human
macrophages
THP-1 and primary human macrophages were pre-treated with 25µM DHA, 17.3µM B1,
17.3µM B2 or 11.5µM C1, or a combination of DHA and one of the procyanidins for 48 h.
Then the macrophages were stimulated with 1µg/ml LPS for 24 h (except for the control group,
without LPS stimulation). (A) Inhibition of IL-6 release in THP-1 macrophages. (B) Inhibition
of IL-6 secretion in primary human macrophages. Results are presented as means +− S.E.M.
for three independent experiments for THP-1 macrophages and five donors for primary human
macrophages. Letters indicate significant differences among the IL-6 secretions. Bars that share
the same letters are not significantly different from one another, but bars with different letters are
significantly different (one-way ANOVA, Tukey test, P < 0.05).
TransAM NF-κB Chemi Assay (Active Motif), according to
the manufacturer’s protocol.
Statistical analysis
Results are expressed as the means+− S.E.M. Effects of the
pre-treatments were assessed using ANOVA. We used a Tukey
test to make pairwise comparisons. Differences were considered
significant when the P values were <0.05. All calculations were
performed using SPSS 17.0 software.
RESULTS
DHA, B1, B2 and C1 inhibit cytokine production in human
macrophages
The secretion of IL-6 was regulated by the pre-treatment of
macrophages with DHA, B1, B2 or C1, or the combination
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Figure 3 Effect of pre-treatment with 25 µM DHA, 17.3 µM B1, 17.3 µM B2 or 11.5 µM C1, or a combination of DHA and one of the procyanidins for 48 h on
the secretion of PGE2 and COX2 protein expression in LPS-stimulated human macrophages
(A) Effect of pre-treatments on PGE2 secretion in THP-1 macrophages. (B) Modulation effects of DHA and/or procyanidin pre-treatments on PGE2 release in human primary macrophages.
(C) Representative blots of COX2 expression in THP-1 macrophages. (D) Relative levels of COX2 expression in THP-1 macrophages quantified by densitometry; data are expressed relative to the
amount of COX2 expression in vehicle LPS-stimulated control cells. Results are represented as the means +− S.E.M. for three independent experiments for THP-1 macrophages and five donors for
primary human macrophages. Letters indicate significant differences (one-way ANOVA, Tukey’s test, P < 0.05) between pre-treatments in each determination.
of DHA with a procyanidin for 48 h. In both THP-1 macrophages
(Figure 2A) and primary human macrophages (Figure 2B),
the release of IL-6 was inhibited by the pre-treatments
when compared with the LPS-stimulated control. In THP-1
macrophages, pre-treatment with the B1 dimer, C1 trimer or any
combination of DHA and procyanidins was more efficient in
inhibiting the release of IL-6. Additionally, the secretion of IL-6
in primary human macrophages was significantly inhibited by B1,
B2 and C1, and any combination of DHA with procyanidin dimers.
Differential modulation of PGE2 secretion and COX2 protein
expression in human macrophages by DHA, B1, B2 or C1
The effect of the pre-treatments on the modulation of PGE2
secretion differed depending on the macrophage cell source. As
shown in Figure 3(A), the pre-treatment of THP-1 macrophages
with DHA and/or procyanidins did not lead to a significant
decrease in PGE2 secretion. Additionally, the post-transcriptional
COX2 expression (Figure 3B) was not modulated by DHA or
procyanidins. Nevertheless, in primary human macrophages, the
secretion of PGE2 was significantly inhibited with all of the pre-
treatments relative to the LPS-stimulated control group. In these
cases, the pre-treatments with B2 and combinations of DHA with
B2 and C1 were the most efficient in decreasing the secretion of
PGE2 levels to near the basal state, which corresponded to the
LPS-unstimulated control group.
DHA and procyanidins are modulators of COX activity
To carefully study the modulation of COX activity during
prostaglandin biosynthesis by DHA and procyanidins, a cell-
free assay was performed. The concentration of inhibitor that
reduced prostaglandin production by half (IC50) was used to
evaluate the effects of DHA and procyanidins in COX1 and
COX2 activity analyses. Three commercial NSAIDs, sc-560
(selective COX1 inhibitor), nimesulide (selective COX2 inhibitor)
and indomethacin (non-selective COX inhibitor) were used as
controls (Table 1). DHA and procyanidins discriminated between
the two COX isoforms. DHA and the B1 dimer were strong
selective COX1 inhibitors (IC50 value of 13.5 µM and 8.0 µM
respectively), whereas the B2 dimer and C1 trimer were strong
selective COX2 inhibitors (IC50 value of 9.7 µM and 3.3 µM
respectively). In an effort to characterize the mechanism of
inhibition of COX1 and COX2 by DHA and procyanidins,
the effects of the AA concentration on the rate of enzyme
inactivation were studied by using a fixed concentration of
inhibitor (15 µM for DHA, and 10 µM for B1, B2 and C1).
Kinetic parameters were determined by constructing Michaelis–
Menten curves (Figure 4) and Lineweaver–Burk transformations
(shown as insets in Figure 4A for COX1 and Figure 4B for COX2
respectively). The kinetic parameters for the inhibition of COX1
by DHA and B1 as well as the inhibition of COX2 by B2 and
C1 are reported in Tables 2 and 3 respectively. The modulation
of COX1 by DHA was a result of a decrease in the maximal
reaction rate (Vmax) and an increase in the Michaelis–Menten
constant (Km); therefore DHA acted as a mixed inhibitor of COX1
activity with a dissociation constant (K i) of 0.73+− 0.17 µM
for the interaction of DHA with COX1. B1 down-regulated the
biosynthesis of PGE2; additionally, it exhibited an increase in Km,
yet Vmax was not affected. This indicated that B1 competed with
AA in the biosynthesis of PGE2 by COX1 with a K i value of
6.87+− 0.66 µM. This competitive inhibition behaviour, indicated
by an increase in Km and an unaffected Vmax, were also observed
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Table 1 Selective inhibition of COX enzymes
IC50 values were determined as the concentration of the compound required to inhibit 50% of
the PGE2 production.
IC50 (µM)
Additive COX1 COX2
DHA 13.5 >50
B1 8.0 >500
B2 >500 9.7
C1 >500 3.3
Indomethacin 0.63 0.99
Nimesulide 19.0 4.9
sc-560 0.13 4.4
for the B2 and C1 regulation of PGE2 biosynthesis by COX2.
The dissociation constants for the interactions of B2 and C1 with
COX2 were 7.75+− 0.68 µM and 11.69+− 1.25 µM respectively.
The catalytic efficiencies (kcat/Km) of COX1 and COX2 were
also significantly decreased by DHA and B1, and by B2 and C1
respectively.
DHA and/or B1, B2 and C1 procyanidins are down-regulators of
NF-κB activation
The transcription factor NF-κB plays a major role in the
induction of transcription of numerous pro-inflammatory genes.
Thus the phosphorylation of IκBα is an essential step for
the nuclear translocation of the NF-κB p65–p50 heterodimer.
Figure 5(A) shows the effect of DHA and/or procyanidins
on the phosphorylation of IκBα. The pre-treatment of THP-1
macrophages with DHA or any combination of DHA and
procyanidins slightly decreased the phosphorylation of IκBα. The
expression and intracellular localization of several members of
the NF-κB family are also essential steps during the activation
of the NF-κB pathway. Therefore the effects of DHA and/or
procyanidins on the cytoplasmic and nuclear p105, p50 and p65
expression were studied (Figure 5). The cytoplasmic localization
of p105 was induced by the B2 dimer and the combination of
DHA/B2 pre-treatments on THP-1 macrophages. However, B1,
B2 and DHA/B1 pre-treatments inhibited the translocation of
p50 to the nucleus through the induction of cytoplasmic p105
expression and inhibition of p50 translocation. Furthermore, all
of the DHA and/or procyanidin pre-treatments inhibited the
nuclear translocation of p65 in THP-1 macrophages through
p65 cytoplasmic retention. Moreover, confocal microscopy was
used to visualize the effects of the pre-treatments on nuclear
and cytoplasmic p65 expression after 1 h of LPS activation.
Figure 6 confirms the dramatic inhibition of nuclear translocation,
shown in Figure 5, and demonstrates the retention of p65
in the cytoplasm rather than in the nuclei in all of the
pre-treatments.
DHA, B1, B2 and C1 decrease the NF-κB p65 DNA-binding activity
The functional effects of DHA and/or procyanidins on NF-κB–
DNA binding was assessed based on the inhibition of NF-κB
p65 binding to the κB consensus sequence, which is located in
the promoter and enhancer regions of several pro-inflammatory
genes. Figure 7 shows the inhibitory effects of all pre-
treatments (DHA and/or procyanidins) on NF-κB–DNA binding
activity.
Figure 4 Determination of Michaelis–Menten and Lineweaver–Burk
(insets) curves for the COX conversion of AA into PGE2
The kinetic parameters corresponding to the selective inhibition of COX activity were determined
by fitting the initial reaction rates to the standard Michaelis–Menten equation using a cell-free
assay. (A) Representative plots for COX1 in control (!), DHA (") and B1 (#) conditions.
(B) Representative plots for COX2 in control ($), B2 (%) and C1 (× ) conditions. The kinetic
study was determined using the mean of three determinations using eight concentrations of AA
that ranged from 0.15 to 25µM.
DISCUSSION
Bacterial LPS stimulates immune cells, such as monocytes and
macrophages, to trigger the inflammatory response. This response
is characterized by the release of an array of pro-inflammatory
mediators, such as IL-6 or PGE2, as well as the
activation of TLR-4, which results in a signal transduction
that activates the NF-κB pathway and, subsequently, the
transcription of numerous pro-inflammatory genes. Therefore
the modulation of the inflammatory response by the dietary intake
of bioactive food compounds is a powerful tool for promoting a
healthy and homoeostatic condition and for preventing disease
development. The molecular mechanisms underlying the anti-
inflammatory activities of bioactive food compounds, such
as procyanidins and PUFAs, are poorly understood and have
been under intense study. Furthermore, their combined effects
are even less understood. The present study investigated
the anti-inflammatory effects of the ω− 3 fatty acid DHA, the
procyanidins B1, B2 and C1, and the combination of DHA with any
of the procyanidins in human macrophages. To determine whether
the modulation of the inflammatory response was conserved
between the THP-1 cell line and primary human macrophages, we
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Table 2 Kinetic parameters for selective COX1 inhibition by the DHA and B1 dimers
Initial reaction rates were determined using a cell-free assay for various concentrations of AA (0.15–25µM). Data were fitted to the standard Michaelis–Menten kinetic equation and Lineweaver–Burk
transformation. The results are represented as means+− S.E.M. for three independent experiments, and the significance of the differences between the inhibitors for each kinetic parameter compared
with the control condition was analysed by ANOVA (*P < 0.05).
Sample Vmax (µM/min) Km (µM) k cat (s− 1) k cat/Km (s− 1 ·µM− 1) K i (µM)
Control (2.14+− 0.016)× 10− 3 (33+− 3.5)× 10− 3 (0.151+− 1.0)× 10− 3 4.63+− 0.47 –
DHA (1.34+− 0.05)× 10− 3* (762+− 11)× 10− 3* (0.094+− 4.1)× 10− 3 0.13+− 0.03* 0.73+− 0.17
B1 (1.95+− 0.026)× 10− 3 (19+− 9.4)× 10− 3* (0.137+− 2.5)× 10− 3 1.32+− 0.10* 6.87+− 0.66
Figure 5 Inhibition of NF-κB pathway activation by DHA and/or procyanidins in THP-1 macrophages
Western blot assays of pIκBα (A and C), p105 (B and D), p50 (E and G) and p65 (F and H) protein components of the NF-κB pathway in cytoplasmic (black columns) and nuclear (white columns
except for pIκBα) fractions of THP-1 macrophages. Cells were pre-treated with 25µM DHA, 17.3µM B1, 17.3µM B2 or 11.5µM C1, or a combination of DHA and one of the procyanidins for 48 h
following stimulation with 1µg/ml LPS for a duration that ranged from 15 min to 1 h (except for the control group). (A) Representative blot for IκBα phosphorylation. (B, E and F) Representative
blots for cytoplasmic and nuclear expression of p105, p50 and p65 respectively. (C, D, G and H) Relative protein levels of pIκBα, p105, p50 and p65 respectively, quantified by densitometry. Results
are expressed relative to the amount of NF-κB family protein expression in the vehicle LPS-stimulated control cells. Results represent the means +− S.E.M. for four to five independent experiments.
Letters indicate significant differences between the NF-κB protein expression by pre-treatment in the same intracellular localization (i.e. the cytoplasm or nucleus). Means that share the same letters
indicate that pre-treatment was not significantly different from each other in the same intracellular localization (one-way ANOVA, Tukey test, P < 0.05). *Significant differences between intracellular
localization (i.e. the cytoplasm and nucleus) in each pre-treatment (Student’s t test, P < 0.05).
determined the IL-6 and PGE2 levels for both human macrophage
models.
The concentrations of DHA and procyanidins applied to
the macrophage pre-treatments mimicked levels that would be
typical from a Mediterranean diet [28–31]. It has previously
been determined in a pharmacokinetic study that subjects who
consumed fish once or twice a month had detectable plasma
DHA levels of approximately 182 µM [32,33]. This concentration
is higher than the 25 µM DHA tested in the present study.
However, pharmacokinetic results from the administration of
plant extracts rich in polyphenols, such as cocoa or grape seed
extracts, concluded that plasma concentrations of unmodified
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Figure 6 Inhibition of NF-κB p65 nuclear translocation by DHA and/or
procyanidins (B1, B2 and C1) in THP-1 macrophages
Indirect immunofluorescence and confocal microscopy analysis was used to visualize the
subcellular localization of NF-κB p65. THP-1 macrophages were pre-treated with 25µM DHA,
17.3µM B1, 17.3µM B2 or 11.5µMC1, or a combination of DHA and one of the procyanidins
for 48 h following stimulation with 1µg/ml LPS for 1 h (except for the control group). NF-κB
p65 is represented by the green staining, nuclear DNA is revealed by ethidium bromide staining,
and the combined images are presented. The results are representative of three independent
experiments.
Figure 7 Inhibition of NF-κB p65 DNA-binding activity by DHA and/or B1,
B2, and C1 pre-treatments in THP-1 macrophages
A consensus site (5′-GGGACTTTCC-3′) binding assay was used to evaluate the effect of 25µM
DHA, 17.3µM B1, 17.3µM B2 or 11.5µM C1, or a combination of DHA and one of the
procyanidins for 48 h following stimulation with 1µg/ml LPS for 1 h (except for the control
group) on NF-κB p65 DNA-binding activity. Results are represented as the means+− S.E.M.
for three independent experiments. Letters indicate significant differences among the NF-κB
p65 DNA-binding activities, which are expressed as a percentage of the LPS-stimulated control
group. Bars that share the same letters are not significantly different from one another, but bars
with different letters are significantly different (one-way ANOVA, Tukey’s test, P < 0.05).
compounds depended on the polyphenol source. In this respect,
the range of physiological concentrations of dimers and trimers
detected was 2–10 µM in the plasma of mice models [28,29,34],
although the range of dimer and trimer concentrations in human
plasma can be greater. In the present study, the concentrations
used were 17.3 µM for the B1 and B2 dimers, and 11.5 µM for
the C1 trimer, although we observed the same anti-inflammatory
behaviour using half the concentration for each procyanidin
(results not shown).
IL-6 is a potent pro-inflammatory cytokine involved in the
modulation of a broad range of cellular and physiological
responses, including the activation of JAK (Janus kinase)/STAT
(signal transducer and activator of transcription) and MAPK
(mitogen-activated protein kinase) family members [35–39].
Therefore an increase in IL-6 secretion is a hallmark of the
activation of an inflammatory response. The pre-treatment of
THP-1 macrophages and primary human macrophages with DHA
with or without procyanidins B1, B2 and C1 translated into a
significant fall in IL-6 secretion.
COX1 and COX2 enzymes catalyse the first committed steps
during the synthesis of prostaglandins from AA. Actually, both
isoforms are of particular interest because they are catalogued as
the pharmacological targets of NSAIDs [7].
Although the secretion of PGE2 and LPS-inducible
COX2 protein expression was not down-regulated in THP-1
macrophages by pre-treatments of DHA, procyanidins B1, B2
or C1, or combinations of DHA with each of the procyanidins,
all of the pre-treatments significantly inhibited PGE2 secretion
in primary human macrophages. The discrepancy between the
modulation of PGE2 secretion in THP-1 macrophages and
primary human macrophages could be explained by the THP-1
differentiation process. To induce the differentiation of THP-1
monocytes into functional macrophages, mimicking the in vivo
process, it is necessary to treat THP-1 monocytes with a
differentiating agent, such as PMA [40,41]. The differentiation of
cells with PMA involves the up-regulation of COX1 expression
and the enhanced capacity to produce PGE2 [42,43]. Thus the
PGE2 levels released in THP-1 macrophages are not only due to
LPS induction; the PGE2 levels could also be concealed due
to the induction of COX1 by PMA.
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Table 3 Kinetic parameters for selective COX2 inhibition by the B2 dimer and C1 trimer
Initial reaction rates were determined as described in Table 2. Data were fitted to the standard Michaelis–Menten kinetic equation. Results are represented as the means+− S.E.M. for three independent
experiments, and the significance of the differences between inhibitors for each kinetic parameter compared with the control condition was analysed by ANOVA (*P < 0.05).
Sample Vmax (µM/min) Km (µM) k cat (s− 1) k cat/Km (s− 1 ·µM− 1) K i (µM)
Control (0.198+− 0.077)× 10− 3 4.22+− 0.48 (4.11+− 0.16)× 10− 3 (0.972+− 0.012)× 10− 3 –
B2 (0.252+− 0.001)× 10− 3 9.71+− 1.00* (5.25+− 0.22)× 10− 3 (0.54+− 0.00155)× 10− 3* 7.75+− 0.68
C1 (0.177+− 0.015)× 10− 3 6.78+− 1.01* (3.69+− 0.21)× 10− 3 (0.467+− 0.0423)× 10− 3* 11.69+− 1.25
Figure 8 NF-κB activation and proposed mechanism for its inhibition by DHA and procyanidins
(Left-hand panel) An inflammatory stimulus [such as TNFα (tumour necrosis factor α) or LPS] induces the activation of the IKK complex, which phosphorylates IκBα and pIκBα is degraded
by the proteasome. Then, NF-κB is able to translocate to the nucleus and activate the transcription of the pro-inflammatory genes. (Right-hand panel) DHA and procyanidins B1, B2 and C1 are
down-regulators of NF-κB at early and late stages with shared mechanisms through the inhibition of IκBα phosphorylation, the cytoplasmic retention of pro-inflammatory NF-κB proteins through
p105 (NF-κB1) overexpression, the induction of nuclear translocation of the p50–p50 transcriptional repressor homodimer instead of the p65–p50 pro-inflammatory heterodimer, the inhibition of
NF-κB DNA binding to κB sites and the secretion of NF-κB-regulated cytokines. NEMO, NF-κB essential modulator.
We set up a cell-free assay to elucidate the kinetic relationship
between DHA and procyanidins with both constitutive and LPS-
induced COX isoforms. Through the determination of the IC50
values (Table 1), we demonstrated the discriminatory capacity
of DHA and procyanidins compared with the COX isoforms.
The DHA and B1 dimers were strong and selective inhibitors of
COX1 activity, and the B2 dimer and C1 trimers were selective
inhibitors of COX2 activity. Some authors have determined that,
although COX1 and COX2 share 60% primary sequence identity,
there are differences between their active sites. These subtle
differences could play key roles in the different affinities of
COX1 and COX2 towards DHA and the procyanidins, including
the procyanidin dimer isoforms B1 and B2. On the basis of our
kinetic cell-free assay, we confirmed that DHA and procyanidins
altered the substrate specificity of COX1 and COX2 to AA, as
reflected by the modulation of the kinetic parameters. This change
in the AA specificity was the result of the modulation of the
maximal reaction rate (Vmax) and the Michaelis–Menten constant
(Km). DHA exhibited mixed inhibitory behaviour towards COX1
through the down-regulation of Vmax and the up-regulation of Km;
therefore DHA binds to a different location than the active site
where AA binds. For the B1 inhibition, a decrease in Km and no
change in Vmax demonstrated that B1 competes with AA in binding
to the active site in COX1. This competitive behaviour, a decrease
in Km and no change in Vmax, was also observed in the inhibition
of COX2 activity by B2 and C1. The decrease in apparent Km
values from DHA and B1 treatments for COX1 as well as from
B2 and C1 treatments for COX2 was the reason for the decrease
in the catalytic efficiency (kcat/Km) of PGE2 biosynthesis. The
selective inhibition of COX catalysis of PGE2 synthesis by DHA
and procyanidins in primary human macrophages was strongly
supported by the kinetic parameters that were obtained from the
cell-free assay. LPS is well described as a potent stimulus for
PGE2 secretion, which is predominantly performed by COX2
[44]. As shown in Figure 3(A), the inhibition of PGE2 was
greater for B2 (a selective COX2 inhibitor) pre-treatment than
c© The Authors Journal compilation c© 2012 Biochemical Society
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DHA or B1 (selective COX1 inhibitors), and the combination of
DHA (selective inhibitor of COX1) with B2 and C1 (competitive
inhibitors of COX2) inhibited the secretion of PGE2 to nearly
basal levels.
The transcription factor NF-κB is one of the most important
inducible transcription factors in the regulation of the expression
of most genes involved in the control of the inflammatory
response, cellular proliferation and cell adhesion [12,13]. As
an activator and modulator of many inflammatory processes,
such as pro-inflammatory cytokines and prostaglandin secretion,
the modulation of the NF-κB signalling pathway by DHA and
procyanidins in THP-1 macrophages was evaluated. The present
study demonstrated the capacity of DHA, alone or in combination
with procyanidins, to down-regulate IKKβ activity, which was
expressed as a decrease in the phosphorylation of pIκBα, a key
modulator of NF-κB activation (Figure 5A).
However, p105, or NF-κB1, is an NF-κB family member
that is associated with a dual function in the NF-κB signalling
system. LPS-induced NF-κB activation leads to the proteolytic
degradation of p105 to p50; therefore p105 can be considered as a
p50 precursor. Furthermore, p105 possesses ankyrin repeats in its
structure, as do IκB family members. These allow for association
with other members of the NF-κB family proteins in the cytoplasm
and subsequently cause the inhibition of nuclear translocation and
DNA binding of the NF-κB complex [45,46]. The p105 is bound
and retained in the cytoplasm by all NF-κB proteins, in contrast
with IκBα, which only binds to NF-κB dimers that contain a p65
subunit [16]. The degradation of p105 also liberates the p105-
associated MAPK, which is responsible for the activation of the
ERK (extracellular-signal-regulated kinase)/MAPK cascade [47].
Thus the effects of the presence of p105 in the cytoplasm can be
related to the decreased activation of the NF-κB transcription
factor [46,47] and the pro-inflammatory ERK/MAPK cascade.
Our findings showed that pre-treatments with the B2 dimer, C1
trimer and any of the combinations of DHA with B1, B2 or C1 led
to an increase in the p105 cytoplasmic retention in LPS-induced
THP-1 macrophages (Figure 5).
The classical and most abundant NF-κB heterodimer is
composed of p50 and p65 subunits and is characterized as a potent
activator of the expression of several pro-inflammatory genes.
Moreover, p50 is able to form homodimers itself, and the p50–p50
homodimers can be found in the nucleus bound to DNA. Although
p65 possesses a transactivation domain, p50 does not; therefore
the presence of the p50–p50 homodimer in the nucleus represses
the transcriptional activity of NF-κB [14,48,49]. Thus the nuclear
p50 subunit could modulate the NF-κB signalling pathway,
participating with the pro-inflammatory heterodimer p65–p50 or
the repressor homodimer p50–p50. Therefore the B2 dimer is the
most powerful compound during the induction of p50 cytoplasmic
expression and, together with B1 and DHA/B1, is an inhibitor of
p50 nuclear translocation. However, the pre-treatment of LPS-
stimulated THP-1 macrophages with any of the compounds
studied (DHA and/or procyanidins) down-regulated the nuclear
translocation of p65, and it favoured the cytoplasmic retention of
and dramatically inhibited the nuclear translocation of p65. The
stronger capacity of DHA and procyanidins to inhibit the nuclear
translocation of p65 was corroborated by p65 immunostaining and
confocal microscopy visualization (Figure 6). A greater nuclear
expression of p50 than that of p65 was observed in p50 and
p65 blots, as shown in Figure 5, for all of the pre-treatments.
In keeping with the conventional NF-κB complex structure, the
NF-κB heterodimer is formed by one subunit of each dimer,
p50 and p65 [13,14]. The fact that the pre-treatment induced
a greater nuclear expression of the p50 subunit than p65, and
the fact that the inhibition of p65 nuclear translocation was
more dramatic than that of p50, led us to consider that the
fraction of p50 detected in the nucleus was forming p50–p50
homodimers. Therefore our bioactive molecules, procyanidins
and, more significantly, DHA, not only inhibited the translocation
of the p50–p65 pro-inflammatory heterodimer, but also induced
the translocation of the p50–p50 transcriptional repressor
homodimers.
In addition, we demonstrated that the pre-treatment of THP-1
macrophages with DHA and/or procyanidins down-regulated the
binding activity of NF-κB p65 to the corresponding κB consensus
sequence located in the promoter and enhancer regions of several
pro-inflammatory genes (Figure 7).
In conclusion, most LPS-stimulated inflammatory responses
lead to the activation of the transcription factor NF-κB signalling
pathway, the secretion of cytokines and the formation of
prostaglandins (Figure 8). Therefore the selective inhibition of
COX activity in cell-free assays, the inhibition of IL-6 and PGE2
secretion, and the down-regulation of the NF-κB activation signal
pathway in human macrophages by food bioactive elements, such
as DHA and procyanidins B1, B2 and C1, lead to great interest
in their use as potential anti-inflammatory compounds. Along
these lines, the conserved and, in certain cases such as in PGE2
secretion, the improvement in the anti-inflammatory response due
to DHA, B1, B2 and C1 pre-treatments in the THP-1 cell line and
primary human macrophages is relevant proof of the capacity of
bioactive food compounds to promote good health through the
modulation of inflammation with diet.
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ABSTRACT 
Macrophage stimulation with bacterial lipopolysaccharide (LPS) triggers inflammasome 
activation, resulting in proinflammatory interleukin (IL)-1β cytokine maturation and secretion. 
IL-1β underlies the pathologies of many diseases, including obesity-related disorders, such 
as type 2 diabetes or chronic inflammation. Thus, the modulation of the inflammatory 
response through bioactive food compounds present in the diet, such as procyanidins, is a 
powerful tool to promote homeostasis. 
In this study, we provide the first evidence that procyanidin B2 inhibits inflammasome 
activation and IL-1β secretion during LPS-induced acute inflammation in human 
macrophages. The procyanidin B2-mediated inhibition of inflammasome activation includes 
the inactivation of the nuclear factor (NF)-κB signal pathway, the first stage required for the 
transcription of inflammasome precursors, through the inhibition of the nuclear translocation 
and DNA binding of the NF-κB-p65 subunit, resulting in the transcriptional repression of 
target genes, such as the cyclooxygenase 2 (COX2), the inducible nitric oxide synthase 
(iNOS) and the production of IL-6 and nitric oxide (NO). Furthermore, procyanidin B2 also 
decreases the cytoplasmic pools of NLRP3 and pro-IL-1β, limiting components of 
inflammasome activation and impeding NLRP3 inflammasome assembly and the activation 
of caspase-1, and finally the secretion of active IL-1β. 
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INTRODUCTION 
Inflammation is a fundamental, acute response of the innate immune system to noxious 
stimuli [1]. The improper regulation of the inflammatory response underlies the pathogenesis 
of many chronic diseases including metabolic syndrome and its related pathologies, 
Alzheimer’s disease and cancer [2]. 
Innate immune system effector cells, such as macrophages, trigger the inflammatory 
response through the identification of dangerous signals, such as the highly conserved 
pathogen-associated molecular patterns (PAMPs), and by sensing host-derived danger 
associated molecular patterns (DAMPs), which are involved in the disturbance of 
homeostasis [3,4]. This early sensing of dangerous signals involves pattern recognition 
receptors (PRRs) on the cell surface, such as membrane-bound Toll-like receptor (TLRs), 
and in the cytoplasm, such as NOD-like receptors (NLRs) [5]. 
Toll-like receptors function as PRRs in mammals and play an essential role in PAMP 
recognition; however, they also recognise endogenous DAMPs [6]. Therefore, the innate 
immune system senses gram-negative bacteria via Toll-like receptor 4 (TLR4) by identifying 
lipopolysaccharide (LPS), which is an integral component of the microbial outer membrane 
that triggers the inflammatory response. Then, LPS-induced TLR4 activation and signal 
transduction results in the activation and nuclear translocation of nuclear factor (NF)-κB. NF-
κB plays a central role in immunity through its ability to modulate the transcription of multiple 
inflammatory and immune genes. Thus, once activated, it binds to recognition elements in 
the promoter regions of genes encoding inflammatory cytokines such as the interleukin (IL)-
6, adhesion molecules, chemokines, growth factors and inducible enzymes such as 
cyclooxygenase 2 (COX2) and inducible nitric oxide synthase (iNOS) [7,8].  
Otherwise, the inflammasome is a cytosol-localised protein complex of the host innate 
immune system that consists of NOD-like receptor protein 3 (NLRP3), apoptosis-associated 
speck-like protein (ASC) and caspase-1, which is involved in the processing and secretion of 
interleukin (IL)-1β, a prominent inflammatory cytokine that is directly implicated in the 
pathogenesis of many disorders or indirectly implicated through the generation of other 
inflammatory mediators via IL-1 receptor signalling. NLRP3 inflammasome is unique 
because it can be activated in response to microorganism stimuli such as PAMPs and in 
response to endogenous danger signals, or DAMPs, e.g., during metabolic dysregulation.  
The secretion of IL-1β is a result of a two-step process. First, a cytosolic pool of the 
immature form of the cytokine (pro-IL-1β) and NLRP3 inflammasome, which is mediated by 
the recognition of pro-inflammatory stimuli through toll-like receptors (TLRs), is produced 
and leads to the activation and nuclear translocation of NF-κB. Second, another stimulus or 
signal induces NLRP3 inflammasome assembly, promoting the proteolytically processed of 
pro-IL-1β to its active form (IL-1β) by caspase-1. IL-1β activation and secretion is then 
regulated at the transcriptional and post-transcriptional levels, and this mechanism is 
considered preventive against the unnecessary and harmfully production of IL-1β. Thus, IL-
Procyanidin B2 inhibits inflammasome activation 
 69 
1β is only secreted in conditions where pattern recognition-mediated activation of TLRs 
regulates the cytosolic pool of pro-IL-1β, whereas the inflammasome, through sensing 
cytosolic danger signals, modulates the proteolytic processing and subsequent secretion of 
the mature form of IL-1β. 
The procyanidin B2 is a phenolic compound composed by two molecules of the flavan-3-ol (-
)-epicatechin and is mainly found in cocoa, apples or grapes and in beverages such as wine. 
Procyanidin B2 is considered as a bioactive food component because of its implication in 
health promotion as well as in the restoration and maintenance of homeostasis [9]. One of 
these beneficial effects are its anti-inflammatory properties [10–13]. 
It has been described that the molecular basis underlying the inflammatory activity of LPS 
are based on TLR4 ligand-mediated activation of innate and adaptive immunity [14], but also 
in non-dependent TLR4 signal transduction [15]. Moreover, LPS induces IL-1β secretion, 
either by NLRP3 inflammasome induction [16,17] or by activating the caspase-11-governed 
inflammasome [18]. Furthermore and taking into account the role of procyanidin B2 as an 
anti-inflammatory molecule as well as a promoter of the homeostasis, the objective of this 
study was to elucidate whether procyanidin B2 modulates both the NF-κB signal transduction 
pathway and inflammasome-mediated IL-1β secretion in LPS-stimulated macrophages.  
MATERIALS AND METHODS 
Chemicals 
The procyanidin B2 dimer (epicatechin-(4β→8)-epicatechin) was acquired from 
ExtraSynthese (Lyon, France). RPMI 1640 culture medium was purchased from Gibco 
(Barcelona, Spain). Cell culture reagents were provided by BioWhittaker (Verviers, Belgium). 
The differentiating agent PMA (phorbol 12-myristate 13-acetate) was purchased from 
InvivoGen (San Diego, USA), and LPS (Escherichia coli 0111:B4) was purchased from 
Sigma-Aldrich (Steinheim, Germany). 
Cell culture and stimulation 
THP-1 human monocytes were obtained from the European Collection of Animal Cell 
Cultures (ECACC no. 88081201) and cultured in RPMI 1640 medium supplemented with 2 
mM L-glutamine, 100 μg/ml streptomycin, 100 U/ml penicillin, 25 mM HEPES and 10% foetal 
bovine serum at 37°C in a humidified incubator with 5% CO2. THP-1 monocytes were 
differentiated to macrophages using fresh medium containing 0.5 μg/ml PMA for 24 h. After 
differentiation, the medium containing PMA was removed, and adherent THP-1 
macrophages were incubated in RPMI medium for 24 h.  
To determine the role of procyanidin B2 in the modulation of LPS-induced inflammasome 
activation, THP-1 macrophages were primed with 1 μg/ml of LPS with or without the 
supplementation of 10 μM of procyanidin B2 for the indicated times. When the experimental 
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design required, 5 mM of ATP stimuli was added to assess NRLP3-mediated inflammasome 
activation. 
Cytosolic protein extraction and Western blotting 
THP-1 macrophages were primed with 1 μg/ml of LPS, with or without 10 μM of procyanidin 
B2 supplementation, for 2 h before stimulation with 5 mM of ATP for 4 h. Cytosolic cell 
fractions were isolated, and protein expression was determined by western blotting 
according to a previously described protocol[12]. Briefly, protein was separated in a 10% 
SDS-PAGE gel, transferred to PVDF membrane and blocked prior to detection with anti-
COX2 (Bioworld), anti-iNOS (SantaCruz), anti-p65 (Santa Cruz, USA), anti-NLRP3 or anti-IL-
1β (Abcam). Semi-quantitative protein quantifications were performed using the ImageJ 
software (National Institutes of Health, Maryland, USA). 
Nitric oxide (NO) production in primary monocyte-derived macrophages 
Rat peripheral blood mononuclear cells (PBMCs) were isolated from healthy Wistar adult 
rats (Charles River Laboratories, Barcelona, Spain) by density-gradient centrifugation using 
HISTOPAQUE-1083 (Sigma-Aldrich, Steinheim, Germany). Once isolated, the monocytes 
were purified by adherence to plastic in serum-free RPMI 1640-supplemented medium. 
Briefly, 2×106 cells/ml were seeded into 12-well plates, and, after 2 h, non-adherent cells 
were removed by several washes with warm PBS. Freshly isolated monocytes were 
stimulated with 1 μg/ml of LPS and with or without 10 μM of B2 procyanidin for 19 h. The 
nitrite concentration in the culture medium was determined as a measure of nitric oxide (NO) 
production according to the Griess reaction. Standard procedure was performed using the 
Griess reagent comprised of 1% (w/v) sulphanilamide, 12.5 mM naphthylenediamide and 6.5 
M HCl. The secretion of nitrite was normalised to the protein content, which was determined 
following the Bradford method. 
Caspase-1 activation assay 
Caspase-1 activation was assessed at a range of ATP concentrations (0-10 mM) for 1 h in 
macrophages primed with 1 μg/ml of LPS. Furthermore, the procyanidin B2 effects on LPS-
mediated inflammasome activation was determined by treating THP-1 macrophages for 30 
min with LPS (1 μg/ml) with or without adding 10 μM of dimeric procyanidin previous to its 
stimulation for 1 h with 5 mM of ATP. Caspase-1 activation was assessed by adding FAM-
YVAD-fmk, a cell-permeable fluorescent probe able to bind covalently to the active form of 
caspase-1, to the cell culture. The percentage of activated caspase-1 was determined by 
fluorescence following the manufacturer’s instructions (Immunochemistry Technologies). 
Images were acquired using a Nikon Eclipse TE2000-E microscope. 
IL-1β and IL-6 secretion 
Secretion of the mature form of the IL-1β in THP-1 supernatants and the IL-6 cytokine 
released by primary murine macrophages were analysed in culture media samples using the 
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corresponding enzyme-linked immunosorbent assays (ELISA) following the manufacturer’s 
instructions (BioLegend). 
Electrophoretic mobility shift assay (EMSA) analysis of NF-κB transcriptional 
activation 
Nuclear protein extracts of THP-1 macrophages were analysed to determine NF-κB 
transcriptional activation as previously described [19]. Biotin-labelled NF-κB 
oligonucleotides: forward 5’-AGTTGAGGGGACTTTCCCAGGC-3’ and the complementary 
strand 5’-GCCTGGGAAAGTCCCCTCAACT-3’, were used for the EMSA. The reaction 
mixture was loaded onto a 4% native polyacrylamide gel in 0.5% Tris-borate-EDTA and 
transferred onto nylon membranes (Bio-Rad, Hercules, CA, USA). After UV-crosslinking, the 
interaction between the biotin-labelled NF-κB oligonucleotides and NF-κB-p65 subunit was 
detected using the non-radioactive LightShift Chemiluminescent EMSA kit (Thermo 
Scientific, Rockforf, IL, USA). 
Statistical analysis  
Results are expressed as the mean ± S.E.M. The modulatory effects induced by LPS or 
procyanidin B2 were evaluated using ANOVA. Tukey’s test was used as a post-hoc test to 
make pair-wise comparisons. Significant differences were considered when the p values 
were < 0.05. Statistical analyses were performed using the SPSS 20.0 software. 
RESULTS 
Procyanidin B2 inhibits the NF-κB transcriptional activation 
To examine the effects of procyanidin B2 in LPS-induced TLR4 signal transduction, the 
activation of the NF-κB pathway was evaluated (Figure 1). We reported that procyanidin B2 
inhibited not only the nuclear translocation of the NF-κB-p65 subunit (Figure 1 A and 1D) but 
also inhibits binding to the NF-κB DNA consensus sequence (Figure 1 B). Furthermore, this 
procyanidin B2-mediated inactivation of the NF-κB pathway was also supported by the 
diminution in the protein expression of NF-κB target genes, including COX2 (Figure 1 A and 
1C) and iNOS (Figure 1 A and 1D).  
Moreover, as expected, procyanidin B2 also decreased the secreted concentration of IL-6, 
whose gene expression is induced by LPS and regulated through NF-κB (Figure 1G), and 
the iNOS-mediated generation of nitric oxide (NO) (Figure 1F) in LPS-stimulated rat primary 
macrophages.  
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Figure 1. B2 procyanidin inhibits LPS-induced NF-κB transcriptional activation. Dimeric procyanidin 
suppresses the LPS-induced activation of NF-κB by decreasing the transcriptional activation and the protein 
expression of target genes. THP-1 macrophages were stimulated by incubating them with 1 μg/ml LPS with 
or without 10 μM of B2 dimer or with only vehicle (n.c.) for 2 h and then activating the inflammasome using 5 
mM of ATP for 4 h. (A) Representative western blot analysis of COX2, nuclear p65, iNOS and actin protein 
expression, (B) EMSA analysis of NF-κB transcriptional activation. (C, D and C) semi-quantification of the 
B2–modulated COX2, nuclear p65 and iNOS protein expression. (F and G) Secretion of nitric oxide and IL-6, 
respectively, in LPS-stimulated rat primary macrophages. The results represent the mean ± S.E.M. Bars 
sharing the same letters are not significantly different; otherwise, bars with different letters are significantly 
different (one-way ANOVA, Tukey’s test, P < 0.05). 
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Procyanidin B2 decreases the inflammasome-priming signal  
The effects of procyanidin B2 as a modulator of the LPS-induced inflammasome priming 
signal was assessed after determining the cytoplasmic pools of NLRP3 and pro-IL-1β, the 
downstream effectors of this signal and required precursors for inflammasome activation. 
Thus, the protein expression of both, NLRP3 and pro-IL-1β, was significantly decreased by 
the procyanidin B2 in the cytoplasm of LPS-primed macrophages  (Figure 2A-C). 
 
Figure 2. NLRP3 and IL-1β protein expression are inhibited by B2 dimeric procyanidin. THP-1 
macrophages were stimulated by incubating with 1 μg/ml LPS with or without 10 μM of B2 dimer for 2 h, and, 
then, the inflammasome was activated with 5 mM of ATP for 4 h. The condition referred to as n.c. refers to 
THP-1 treated only with vehicle for 6 h. (A) Representative western blot analysis of NLRP3 and IL-1β protein 
expression after LPS-primed and ATP-induced inflammasome activation. Protein semi-quantifications are 
shown for NLRP3 (B), pro-IL-1β (C) and IL-1β (D). The results represent the mean ± S.E.M. Bars with 
different letters indicate significant differences (one-way ANOVA, Tukey’s test, P < 0.05). 
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Figure 3. Inhibition of caspase-1 activation on LPS-primed macrophages by B2 procyanidin. (A) THP-
1 macrophages were primed with 1 μg/ml of LPS for 30 min, and caspase-1 was activated with different 
concentrations, from 0 to 10 mM, of ATP for 1 h. (B) Effects of co-incubation of 1 μg/ml LPS with or without 
10 μM of B2 for 30 min after caspase-1 was activated in THP-1 macrophages that were activated with 5 mM 
ATP. The condition referred to as n.c. refers to THP-1 cells treated only with vehicle for 1.5 h. The results 
represent the mean ± S.E.M. Bars with different letters are significantly different (one-way ANOVA, Tukey’s 
test, P < 0.05). 
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Procyanidin B2 inhibits inflammasome activation and IL-1β production 
To explore the role of procyanidin B2 in NLRP3 inflammasome activation, its effects on 
caspase-1 activation and the production and extracellular release of the mature form of IL-1β 
were determined. 
First, we reported the increase of active caspase-1 in LPS-stimulated THP-1 macrophages 
by ATP in a dose-dependent manner (Figure 3A). Thus, the supplementation of LPS-primed 
macrophages with procyanidin B2 significantly inhibited ATP-mediated inflammasome 
activation, as reflected by a significant decrease in the amount of activated caspase-1 
detected (Figure 3B and 3C).  
 
Figure 4. IL-1β secretion is inhibited by B2 procyanidin in LPS-primed human macrophages. (A) 
Modulation of IL-1β secretion by 10 μM of B2 in 1μg/ml LPS-primed macrophages for 2 h previous to 5 mM of 
ATP-mediated activation for 4 h. (B) Release of IL-1β in 1 μg/ml LPS-primed macrophages for 6 h with or 
without 10 μM B2 without any other exogenous inflammasome-activating stimuli. The results are represented 
as the mean ± S.E.M. Different letters indicate significant differences (one-way ANOVA, Tukey’s test, P < 
0.05). 
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Moreover, we demonstrated the inhibition of inflammasome activation by the procyanidin B2, 
after determining the cleavage and extracellular release of the mature form of IL-1β, as the 
primary function of inflammasome activation. Procyanidin B2 significantly inhibited caspase-
1-mediated IL-1β production, reflected as decreased amounts of intracellular mature IL-1β 
(Figure 2D) and a minor extracellular concentration of IL-1β secreted from LPS-primed and 
ATP-activated macrophages (Figure 4A). Moreover, procyanidin B2 also significantly 
inhibited the secretion of IL-1β when THP-1 macrophages were only primed with LPS 
without the stimulation of any other NLRP3 inflammasome-activating stimuli (Figure 4B). 
DISCUSSION 
Acute inflammation, an early defence mechanism orchestrated through the innate immune 
system, is triggered via sensing dangerous signals, e.g., PAMPs and DAMPs, by pattern 
recognition receptors, such as TLRs and NLRs [20]. Inflammation, and the improper 
regulation of this mechanism underlies a wide range of physiological and pathological 
processes [2]. Moreover, the endotoxin LPS, is a pathogen-associated molecule of Gram-
negative bacteria that, after recognition by PPRs, triggers a massive inflammatory response.  
Procyanidins, featured bioactive components with beneficial properties, have been proposed 
as a powerful tool to promote the healthy state and homeostasis through the diet. The 
procyanidin B2 is one of the forms found in plasma after procyanidin-rich food consumption 
[21], and this compound has been highlighted as one of the most immunologically active 
molecules within the procyanidins. Therefore, understanding how bioactive molecules 
contribute to a healthy lifestyle through an anti-inflammatory profile is an important objective 
of research. 
Unlike other cytokines, two sequential stages regulate the production of IL-1β. Firstly, IL-1β 
is synthesised as an immature form, pro-IL-1β, and as a NF-κB target gene, the transcription 
of this cytokine is mediated through NF-κB pathway activation. Secondly, IL-1β maturation 
and secretion depends on caspase-1-mediated proteolytic cleavage. Pro-caspase-1, the 
inactive form of caspase-1, is activated through a multiprotein complex, the NLRP3 
inflammasome, whose assembly depends on the amount of cytoplasmic NLRP3, an NF-κB 
target gene. 
Given the pivotal role of inflammasome in the maintenance of homeostasis and the 
previously described anti-inflammatory effects of procyanidin B2, particularly those involving 
the regulation of the NF-κB pathway, the modulation of inflammasome activation might be a 
potential mechanism underlying the anti-inflammatory effects promoted by the intake of 
procyanidin B2. Thereby, in this study we have elucidated that procyanidin B2 represses the 
NF-κB signal transduction pathway and inflammasome-mediated IL-1β secretion in LPS-
stimulated macrophages.  
Considering the sequential regulation of inflammasome activation, the NF-κB signal 
transduction pathway is considered an early event essential for inflammasome activation 
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and subsequent IL-1β secretion. Thus, the role of procyanidin B2 in the down-regulation of 
NF-κB pathway activation and signal transduction was confirmed through the inhibition of the 
nuclear translocation of NF-κB-p65 subunit and binding to the consensus DNA sequence, 
both hallmarks of the LPS-induced NF-κB transcription complex activation. Furthermore, this 
inhibition in the NF-κB pathway was also reflected by a decrease in the transcription of the 
NF-κB target genes, determined as the protein expression of COX2 and iNOS, two key 
enzymes for the regulation of inflammation, and the secretion of the IL-6, a pro-inflammatory 
biomarker. The B2-promoted anti-inflammatory effects might reflect the COX2-mediated 
down-regulation of the eicosanoids pathway, as previously observed for the procyanidin B2-
mediated inhibition of prostaglandin E2 secretion [12]. Moreover, the procyanidin B2 
significantly inhibited not only the LPS-induced iNOS protein expression but also the 
secretion of NO, an important intracellular and intercellular signalling molecule that underlies 
the regulation of diverse physiological and pathophysiological mechanisms, supporting the 
B2-mediated NO pathway-repressing effects previously observed for endotoxin-stimulated 
murine macrophages [11]. 
We also determined the B2-mediated modulation of inflammasome activation by determining 
the protein expression of NLRP3 and proIL-1β, two limiting components for the NLRP3 
assembly, caspase-1 activation and IL-1β maturation and secretion, the transcription of 
which are also regulated through the NF-κB pathway. We reported for the first time, that 
procyanidin B2 significantly down-regulates the expression of NLRP3 and pro-IL-1β in LPS-
primed and ATP-activated human macrophages. Notably, procyanidin B2 also inhibited the 
activation of caspase-1, determined using a fluorochrome that exclusively binds to the 
intracellular active form of caspase-1. 
Moreover, the modulation of IL-1β secretion, the main goal of inflammasome activation, in 
LPS-primed macrophages through B2 procyanidin was analysed in two different conditions. 
Thus, procyanidin B2 inhibited the LPS-induced release of IL-1β independently of 
inflammasome-triggered signals. Thus, we determined that procyanidin B2 inhibited IL-1β 
secretion during LPS-primed and ATP-mediated NLRP3 inflammasome activation, and 
procyanidin B2 also inhibited IL-1β secretion in LPS-primed and non-ATP inflammasome-
activated macrophages. Thus, these results showed that although LPS-priming in the 
absence of any additional inflammasome-activating stimuli is sufficient for the promotion of 
IL-1β synthesis, supporting a role for LPS in boosting inflammasome activation 
independently of the NLRP3 inflammasome sensor induction as previously described [16], 
the activation of LPS-primed macrophages with ATP, an NLRP3 agonist, as the second 
signal, leads to the maturation and secretion of higher amounts of IL-1β.  
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Figure 5. The proposed mechanism for the inhibition of inflammasome-mediated IL-1β secretion in 
LPS-stimulated macrophages by B2 dimeric procyanidin. B2 dimeric procyanidin inhibits the LPS-induced 
acute inflammatory response in macrophages through the inhibition of inflammasome activation at different 
levels, including the inhibition of NF-κB transcriptional activation, and the decrease of target genes protein 
expression, including the decrease of cytoplasmic pools of NLRP3 and pro-IL-1β, as well as the inhibition of 
caspase-1 activation and the production and release of IL-1β. 
Therefore, the macrophage-mediated immune response to LPS is not focused exclusively on 
the cellular transcriptional response via TLR4-mediated NF-kB activation, but rather extends 
to the direct or indirect activation of a wide array of proinflammatory mechanisms, including 
autophagy, phagocytosis and oxidative bursts, to remove the triggering stimuli and promote 
the resolution of inflammation and the restoration of homeostasis [17,22]. Some authors also 
consider the redox-perturbing properties primarily exerted through reactive oxygen species 
(ROS) production, resulting from the LPS-induced oxidative burst response as a common 
feature of NLRP3 inflammasome activators [23,24]. In contrast, procyanidins and other plant 
polyphenols have been categorised as in vivo antioxidants. Furthermore, intact dimeric 
procyanidins can be transported inside cells and interact directly with signalling proteins and 
modulate its activity [25]. Thus, the inhibitory effects of B2 procyanidins on IL-1β secretion 
might be associated with intrinsic antioxidant activity, and the potential repression of LPS-
induced ROS production would be an added value for the strong anti-inflammatory effects of 
B2 procyanidin described in this study.  
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In summary, procyanidin B2 is a strong inhibitor of NF-κB signal pathway activation via the 
modulation of NF-κB transcriptional activation at different levels, including its nuclear 
translocation, DNA binding and transcriptional regulation of NF-κB-target genes. Moreover, 
we showed that procyanidin B2 is also an inhibitor of inflammasome activation. Procyanidin 
B2 decreases the cytoplasmic pool of NLRP3 and pro-IL-1β, inhibiting inflammasome 
assembly, the subsequent activation of caspase-1 and the maturation of IL-1β; thereby 
decreasing the levels of extracellular IL-1β secreted in LPS-stimulated human macrophages. 
Thus, these data provide new insights into the mechanisms underlying the anti-inflammatory 
effects described for procyanidin B2, highlighting a new research direction concerning 
procyanidins as promising bioactive food compounds in terms of the prevention or resolution 
of disorders or diseases associated with the inappropriate activation of the inflammasome 
and IL-1β secretion. 
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ABSTRACT 
The Nod-like receptor protein 3 (NLRP3) inflammasome is considered a pivotal host platform 
responsible for sensing of exogenous and endogenous danger signals, including those 
generated as a result of metabolic dysregulation and for the subsequent, IL-1β-mediated 
orchestration of inflammatory and innate immunity responses. In this way, although the 
molecular link between diet-induced obesity and inflammasome activation is still unclear, 
free fatty acids have been proposed as one triggering event.  
We report that dietary fatty acid composition is sensed by the NLRP3 inflammasome in 
human macrophages. For this purpose, we have analysed three roles of fatty acid 
supplementation: as a priming signal for ATP-activated macrophages, in determining where 
the administration of dietary fatty acids interferes with LPS-mediated inflammasome 
activation and by inducing inflammasome activation per se. In this manner, saturated (SFAs) 
or polyunsaturated (PUFAs) fatty acids exerted different modulatory effects on 
inflammasome activation, whereas SFAs stimulated the secretion of the IL-1β cytokine, and 
PUFAs were mainly inhibitors. 
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INTRODUCTION 
The incidence of obesity worldwide has increased dramatically in recent years. Obesity is 
associated with a cluster of several chronic metabolic and inflammatory alterations known as 
metabolic syndrome, that includes impaired insulin sensitivity, type 2 diabetes, dyslipidaemia 
and atherosclerosis [1,2]. 
Immunity and metabolism are considered fundamental systems for survival. In fact, cell 
homeostasis is linked to the integration and continuous crosstalk between the immune 
system and metabolism [3]. In this way, an immune response is influenced by the nutritional 
status. Obesity is associated with chronic post-absorptive and postprandial lipid overload 
that results in hyperlipidaemia and lipid accumulation in adipose or non-adipose metabolic 
tissues. Hypertrophy and hyperplasia of adipose tissue as well as ectopic fat accumulation 
underlie the activation of the inflammatory response and promote the recruitment of immune 
cells, which are exposed to environments with high concentrations of fatty acids [4–6]. 
Tissues and blood fatty acids are mainly derived from the diet and have been used as 
dietary intake biomarkers [7]. Moreover, elevated levels of fatty acids are usually one of the 
hallmarks of obesity-related pathologies [8]. Fatty acids present in the diet can be divided 
into two major classes depending on their chemical structure: saturated (SFAs) or 
unsaturated fatty acids (UFAs). Palmitate (16:0) and stearate (18:0) are the most important 
saturated fatty acids in the blood, representing 90% of the total SFAs [7]. Moreover, UFAs 
can be divided into monounsaturated and polyunsaturated fatty acids (MUFAs and PUFAs, 
respectively), and PUFAs are further divided into two categories, namely, omega-6 and 
omega-3, based on the location of the first double bond from the methyl end of the fatty acid 
molecule. Arachidonic acid (C20:4 n-6) and docosahexaenoic acid (DHA, C22:6 n-3) are 
both considered essential fatty acids because the omega-6/omega-3 ratio is directly related 
to the pathogenesis of many diseases, including those related to the dysregulation of 
inflammatory or immune response [9]. 
On the other hand, innate immunity provides a first line of host defence that is responsible 
for recognising external pathogenic microorganisms by targeting highly conserved molecular 
patterns (also known as pathogen-associated molecular patterns, PAMPs) and for sensing 
host-derived danger signals (also known as danger associated molecular patterns, DAMPs). 
The recognition of PAMPs and DAMPs is primarily mediated through the expression of an 
array of germline-encoded, pattern-recognition receptors (PRRs), such as Toll-like receptors 
(TLRs) and Nod-like receptors (NLRs) [10,11]. Sensing of PAMPs and DAMPs by PRRs on 
innate immune cells, such as macrophages, results in the activation of different intracellular 
signalling pathways that lead to the activation of the inflammatory response [12,13].  
TLRs, a family of transmembrane proteins, play a major role in immune signal recognition 
and transduction that promotes inflammation and innate immune response activation and 
triggers the adaptive immune response [10]. Then, signal transduction from TLR4 induces 
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the activation of nuclear factor κB (NF-κB), which is a key transcription factor involved in 
regulation of the immune and inflammatory responses. In this way, cyclooxygenase 2 (PGH2 
or COX2), a NF-κB regulated gene, catalyses the rate-limiting step of prostaglandin and 
thromboxane biosynthesis, and its protein overexpression is considered a hallmark of 
inflammation. 
NLRs form central molecular platforms that are mostly expressed in the cytosol and organise 
signalling complexes such as inflammasomes [14]. Structurally, inflammasomes are large, 
multiprotein complexes consisting of Nod-like receptor protein 3 (NLRP3), apoptosis-
associated speck-like protein (ASC) and caspase-1 that recognise a diverse set of unrelated 
stimuli including PAMPs, DAMPs and even completely inorganic molecules such as silica, 
asbestos or alum. Activation of NLRP3, which is the best-characterised NLR family member, 
promotes inflammasome assembly, which triggers an inflammatory cascade that leads to 
mediation of the ASC protein adaptor, the recruitment and autocatalytic activation of 
caspase-1 and inducing the subsequent proteolytic activation of the proinflammatory 
cytokines interleukin 1β (IL-1β) and IL-18[14]. IL-1β is a key proinflammatory mediator that 
underlies the pathogenesis of metabolic disorders, including the obesity-associated 
inflammatory response and mediation of the development of insulin resistance [15]. 
Therefore, inflammasome activation must be tightly regulated at the transcriptional and post-
transcriptional levels to avoid potentially harmful inflammation [16].  
Therefore, the activation of the inflammasome and IL-1β secretion requires two signals. A 
first signal is responsible for priming the cell to induce the transcription of the immature form 
of IL-1β, pro-IL-1β and NLRP3, which are limiting factors required for inflammasome 
activation, via the TLR4-mediated NF-κB activation pathway. The second signal, the 
activation signal, promotes conformational changes that induce NRLP3 inflammasome 
assembly and drives caspase-1 activation and, therefore, IL-1β maturation and secretion 
[16]. 
Otherwise, the NRLP3 inflammasome might be activated by host-derived DAMP signals, 
which are abundant in metabolic stress. Therefore, inflammasome activation through diet-
associated sensing signals can be considered a strong link between inflammation and 
metabolic disturbances [13,14,17]. Indeed, it has been described that obesity-induced 
inflammasome activation in key metabolic tissues promote chronic inflammation and 
contribute to the development of type 1 and type 2 diabetes [18]. 
Consequently, obesity is caused by an energy imbalance and total fat intake; and different 
compositions of dietary fat (in terms of individual fatty acids) may cause different effects on 
the onset of metabolic complications. In the present study, we analysed the inflammasome-
mediated inflammatory effects of dietary fatty acids that were dependent upon its structure-
based chemical properties. For this reason, the two most important SFAs in blood, palmitate 
and stearate, and two PUFAs, DHA and arachidonic acid, were tested as physiological 
inducers of NLRP3 inflammasome activation. The aim of this study was to determine 
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whether the fatty acid composition of the diet differentially affected NLRP3 inflammasome 
priming and the activation of macrophages in a fatty acid-rich environment. 
MATERIAL AND METHODS 
Chemicals 
The dietary fatty acids sodium palmitate and cis-4-,7,10,13,16,19-docosahexaenoic acid 
were obtained from Sigma-Aldrich (Steinheim, Germany), arachidonic acid was provided by 
Cayman Chemical (Michigan, USA), and stearic acid was purchased in Panreac (Barcelona, 
Spain). The culture medium RPMI 1640 was purchased from Gibco (Barcelona, Spain). Cell 
culture reagents were provided by BioWhittaker (Verviers, Belgium), except for the 
differentiating agent PMA (phorbol 12-myristate 13-acetate), which was purchased from 
InvivoGen (San Diego, USA), and LPS (Escherichia coli 0111:B4) and adenosine 5’-
triphosphate (ATP), which were obtained from Sigma-Aldrich (Steinheim, Germany). 
Cell culture and stimulation 
Human THP-1 monocytes that were purchased from the European Collection of Animal Cell 
Cultures (ECACC no. 88081201) were cultured in RPMI 1640 medium supplemented with 2 
mM L-glutamine, 100 μg/ml streptomycin, 100 U/ml penicillin, 25 mM HEPES and 10% foetal 
bovine serum at 37°C in a humidified incubator with 5% CO2. They were differentiated into 
macrophages by cultivation in fresh medium containing 0.5 μg/ml PMA for 24 h. After 
differentiation, the medium containing PMA was removed, and adherent THP-1 
macrophages were incubated in supplemented medium for 24 h. 
To explore the role of individual fatty acids on the modulation of inflammasome priming and 
activation, three different roles were tested (Figure 1). First, the priming capacity of each 
individual fatty was determined, and, for this purpose, THP-1 macrophages were primed with 
250 μM of BSA-conjugated fatty acids for the indicated times, and the NLRP3 inflammasome 
was activated using 5 mM of ATP. Second, the interfering of dietary fatty acids with LPS-
induced inflammasome priming and its subsequent activation were analysed. Therefore, 
THP-1 cells were primed with 1 μg/ml of LPS for the indicated times before supplementation 
with 250 μM of each BSA-conjugated fatty acid. Third, the capacity of each fatty acid to 
activate the inflammasome per se was determined in terms of IL-1β secretion. In this case, 
THP-1 macrophages were supplemented with 250 μM of BSA-conjugated fatty acids without 
any other priming or activating external stimuli. Dietary fatty acids were conjugated to fatty 
acid-free BSA, which was obtained from Sigma-Aldrich (Steinheim, Germany) at a 4:1 molar 
ratio. 
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Figure 1. Experimental design. Two steps are required for the processing and release of the mature form 
of IL-1β. Primarily, a pro-inflammatory stimulus (signal 1) is triggered via the TLR4 membrane receptor, the 
activation NF-κB and the transcription of immature pro-IL-1β and NLRP3, which are two crucial proteins for 
NLRP3 inflammasome activation. In a second step, an activation signal promotes NLRP3 assembly, which 
induces the ASC-mediated recruitment and autocatalytic activation of caspase-1 into a large cytosolic protein 
named the inflammasome. Activated caspase-1 processes the immature form of IL-1β into its biologically 
active cytokine. Therefore, three different conditions have been used to evaluate the roles of individual 
dietary fatty acids as modulators of inflammasome priming and activation. In the first condition, the effects of 
dietary fatty acids as priming stimuli were determined; therefore, macrophages were primed with fatty acids 
before ATP-mediated inflammasome activation. In the second condition, the capacity of dietary fatty acids to 
interfere with LPS-induced inflammasome activation was analysed. For this purpose, LPS-primed 
macrophages were supplemented with the studied fatty acids. In the third condition, the capacity of each 
dietary fatty acid to induce inflammasome activation per se was studied. 
Protein extraction and Western blotting 
After 2 h of priming and 4 h of activation with the indicated compounds (either fatty acids, 
LPS or ATP), cytosolic fractions were extracted, and protein expression was determined by 
western blotting following a previously described procedure [19]. Briefly, protein was 
separated in a 10% SDS-PAGE gel, transferred to PVDF membrane and blocked prior to 
detection with anti-COX2 (Bioworld, Barcelona, Spain), anti-NLRP3 or anti-IL-1β (Abcam, 
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Cambridge, UK). Semi-quantification of protein levels was performed using the ImageJ 
software (National Institutes of Health, Maryland, USA). 
Caspase-1 activation assay 
THP-1 macrophages were primed for 30 min with either 250 μM of the corresponding fatty 
acids or LPS (1 μg/ml), followed by activation for 1 h with the corresponding stimuli 
according to Figure 1 (5 mM of ATP or 250 μM of fatty acids) before the addition of FAM-
YVAD-fmk, which is a fluorescent, cell-permeable probe that covalently binds only to the 
active form of caspase-1. Active caspase-1 was determined by fluorescence according to 
the manufacturer’s instructions (Immunochemistry Technologies). The fluorescent intensity 
was determined at λex=490 and λem=520 using the FLx800 Multi-Detection Microplate 
Reader (Biotek, Winooski, USA). 
IL-1β secretion 
Mature IL-1β was analysed in culture media using an enzyme-linked immunosorbent assay 
(ELISA), according to the manufacturer’s protocol (BioLegend). Levels of secreted IL-1β 
were normalised according to the protein content and measured using the Bradford assay. 
Statistical analysis  
Results are expressed as the mean ± S.E.M. The effects of fatty acids were assessed using 
ANOVA. Tukey’s test was used to make pair-wise comparisons. Differences were 
considered significant when the p values were <0.05. Calculations were performed using the 
SPSS 20.0 software. 
RESULTS 
Fatty acids modulate the activation of NF-κB 
To determine whether the fatty acid composition of a diet might have a crucial role in 
macrophage inflammasome activation, modulation of NF-κB signalling pathway was first 
analysed.  
Given the potential role of NF-κB in relaying proinflammatory signals, COX2 protein 
expression was determined to test whether fatty acid structure (saturated or 
polyunsaturated) could be involved in activation upstream of the NF-κB signalling pathway. 
The effects of dietary fatty acids on NF-κB and subsequent COX2 protein expression were 
determined for two different conditions (Figure 2 and 3, respectively). First, we determined 
the role of dietary fatty acids as a priming signal, and, for this purpose, macrophages were 
primed for 2 h with each of the studied fatty acids before their activation with ATP for 4 h. In 
this first condition (Figure 2A and B), only the use of palmitate as a priming signal potentially 
increased COX2 protein expression in THP-1 macrophages. On the other hand, the use of 
stearic acid or unsaturated fatty acids as priming signals for inflammasome activation did not 
produce any significant effect regarding COX2 protein expression. 
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Figure 2. Modulation of NF-κB activation in dietary fatty acid-primed macrophages. Saturated 
palmitate and stearic acids as well as unsaturated n-6 arachidonic acids and n-3 DHA are modulators of 
regulated NF-κB protein expression. (A) Representative western blot analysis and semi-quantification of 
COX2 (B), NLRP3 (C) and IL-1β (D) proteins expression after priming macrophages with the indicated fatty 
acids for 2 h and 4 h of ATP-inflammasome activation. The results represent the mean ± S.E.M. Bars sharing 
the same letters are not significantly different; otherwise, bars with different letters are significantly different 
(P < 0.05).  
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Figure 3. Effects of fatty acids on NF-κB activation in LPS-primed macrophages. Saturated palmitate 
and stearic acids as well as unsaturated n-6 arachidonic acids and n-3 DHA can modulate the expression of 
NF-κB-regulated proteins. (A) Representative western blot analysis of COX2, NLRP3 and IL-1β protein 
expression after priming for 2 h with 1 μg/ml of LPS prior to its supplementation with the indicated fatty acids 
for 4 h. Protein semi-quantifications are shown for COX2 (B), NLRP3 (C) and IL-1β (D). The results are 
represented by the mean ± S.E.M. Bars with different letters are significantly different (P < 0.05). 
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Second, the effects of dietary fatty acids on COX2 protein expression induced by LPS-
primed macrophages were determined. THP-1 macrophages were primed for 2 h with 
LPS prior to supplementation with the corresponding fatty acid for 4 h (Figure 3A). In this 
situation, COX2 protein expression that was induced after priming macrophages with LPS 
was decreased by supplementation with n-6 arachidonic acid (Figure 3B). 
Saturated and unsaturated fatty acids modulate NLRP3 inflammasome priming 
Among the NF-κB up-regulated proinflammatory mediators, the increase in NLRP3 and 
IL-1β transcription, which is known as the priming step, is a critical checkpoint that is 
required for inflammasome activation. In this way, to study the capacities of dietary fatty 
acids in modulating the NLRP3 and IL-1β cytosolic pools, their protein expressions were 
determined.  
In this way, while supplementation of macrophages with 250 μM of each saturated fatty 
acid (palmitate and stearic acid) before ATP activation were not effective in increasing 
the cytosolic pool of NLRP3, the n-3 DHA unsaturated fatty acids significantly decreased 
NLRP3 protein expression in macrophages (Figure 2A and C). On the other hand, in 
conditions where fatty acids were used as priming signals, a significant increase in the 
cytosolic expression of the immature or mature forms IL-1β were observed (Figure 2A 
and D). 
When macrophages were primed with LPS before fatty acid supplementation, the 
cytosolic pool of NLRP3 proteins was increased after supplementation with stearic acid, 
and it was decreased by n-6 arachidonic acid and, more importantly, by n-3 DHA (Figure 
3A and C). 
Moreover, the expression of immature IL-1β that was induced by priming macrophages 
with LPS was significantly blocked by dietary fatty acids. In this way, while stearic acid 
induced an increase in the cytoplasmic expression of pro-IL-1β, palmitate and n-6 and n-
3 unsaturated fatty acids significantly decreased its expression. It should be noted that 
the dramatic inhibition of pro-IL-1β protein expression that was promoted by DHA 
supplementation lowered the protein amount to levels similar to those of the untreated 
control (Figure 3A and D). 
Fatty acids are modulators of caspase-1 activation 
To analyse the role of dietary fatty acid on inflammasome activation, the percentage of 
activated caspase-1, an essential step in controlling IL-1β maturation after NLRP3 
assembly, was determined. 
For the first condition that was analysed, fatty acids were used as a priming stimulus for 
caspase-1 (Figure 4A). Fluorometric determinations identified n-6 arachidonic acid as a 
direct caspase-1 activator. 
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Although the supplementation of macrophages with palmitate, n-6 and n-3 fatty acids 
slightly increased the amount of active caspase-1 when macrophages were primed with 
LPS, only stearic acid induced a significant increase in caspase-1 activation, which 
enhanced the activating effects that were induced by LPS (Figure 4B).  
 
Figure 4. Dietary fatty acids are modulators of caspase-1 activation. (A) THP-1 macrophages were 
primed with 250 μM of the indicated fatty acids for 30 min, and caspase-1 was activated with 5mM of 
ATP for 1 hour. (B) After 30 min of 1 μg/ml LPS priming, 250 μM of the indicated dietary acids were 
administered for 1 hour. The results are represented by the mean ± S.E.M. Bars with different letters are 
significantly different (P < 0.05). 
IL-1β secretion is induced by fatty acid administration 
To determine whether dietary fatty acids modulated inflammasome activation, the 
secretion of IL-1β was assessed (Figure 5). The activity of fatty acids on inflammasome 
activation and the resulting IL-1β secretion was evaluated using the three different 
conditions, as detailed in Figure 1. 
First, fatty acids were used as priming signals before inflammasome activation with ATP 
(Figure 5A). Priming macrophages with either of the saturated fatty acids, palmitate or 
stearic, or with n-6 arachidonic acid significantly enhanced the secretion of IL-1β. 
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However, DHA was ineffective as a priming stimulus and in the subsequent induction of 
IL-1β secretion. 
Secondly, in LPS stimulated macrophages prior to supplementation with dietary fatty 
acids (second condition described in Figure 1), LPS-induced IL-1β secretion was slightly 
blocked by treating cells with palmitate and n-3 DHA and was significantly decreased by 
n-6 arachidonic acid (Figure 5B). 
 Finally, the effect of dietary fatty acids in directly activating IL-1β secretion without any 
other activating or stimulating signal was measured (Figure 5C). In this third condition, 
only macrophages stimulated by the saturated fatty acid palmitate were sufficient to 
induce a significant increase in IL-1β secretion. 
. 
 
 
 
 
 
 
 
 
 
 
Figure 5. Modulation of IL-1β secretion 
by dietary fatty acids. (A) Modulation of 
IL-1β secretion in fatty acid-primed 
macrophages for 2 h previous to ATP-
mediated activation. (B) Release of IL-1β in 
macrophages primed with LPS (1 μg/ml) for 
2 h and supplemented for 4 h with the 
indicated fatty acids. (C) IL-1β production 
induced by administration of the indicated 
fatty acids for 6 h. The results are 
represented by the mean ± S.E.M. Bars 
with different letters are significantly 
different (P < 0.05). 
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DISCUSSION 
Obesity is associated with a continuous increase in post-absorptive and postprandial 
fatty acid concentrations, which underlies the development of obesity-related metabolic 
complications. In this way, in chronic high-fat intake conditions, tissues and plasma-free 
fatty acid levels are commonly elevated [7,8]. 
Dietary fat has a dual role in human physiology. Besides its functions as a source of 
energy or cell membrane structural components, dietary fatty acids can also act as 
signalling molecules at different levels[20], including nuclear receptor ligands [21,22], or 
as modulators of the immune system activation. In this sense, the capacity of dietary fatty 
acids to interact with TLR4 has been previously described [23]. For this reason, in 
addition to the total dietary fat intake during the onset and progression of metabolic 
disturbances, the different composition of fat, in terms of the degree of fatty acid 
saturation, plays a key role [6,24]. In fasting conditions, the levels of free fatty acids in 
human blood are approximately of 700 μM; however, this concentration can be widely 
modified after the intake of a fatty meal [25]. Therefore, blood-circulating cells, such as 
monocytes or tissue-infiltrated macrophages, would be constantly exposed to relatively 
high concentrations of free fatty acids [26]. 
Moreover, dietary fatty acid composition can be sensed by the innate immune response, 
thus, in a diet-induced obesity context, the hyperlipidaemia-promoted excess of fat 
accumulation in metabolic tissues triggers the recruitment and activation of immune cells. 
In this way, inflammasomes are intracellular, innate immune sensors[16]. Subsequently, 
danger signals resulting from metabolic disturbance can be sensed by NLRP3, a NOD-
like cytosolic pattern recognition receptor that is expressed mostly in cells involved in the 
innate immune response, resulting in caspase-1-mediated IL-1β maturation and 
secretion. This metabolic-triggered inflammasome activation has been linked to the 
development and progression of many metabolic disorders, including, among others, 
atherosclerosis and type 2 diabetes [6,7,27]. 
In this manner, based on the assumption that dietary fatty acids might influence the 
immune system as well the function of various cellular components, the aim of this study 
was to determine whether the chemical properties that are linked to the degree of fatty 
acid saturation might differentially affect inflammasome activation and IL-1β secretion. 
For this purpose, the capacity of four different fatty acids that are present in diets, two 
SFAs (palmitate and stearic acid) and two PUFAs (n-6 arachidonic acid and n-3 DHA) as 
modulators of NLRP3 inflammasome activation was determined by supplementing 
human macrophages with physiological concentrations of fatty acids under the three 
different conditions (Figure 1). First, the role of fatty acids as a priming signal before 
ATP-induced NLRP3 inflammasome activation was studied. Second, the capacity of fatty 
acids to interfere with IL-1β secretion in LPS-primed macrophages was determined. 
Third, the inflammasome-activating properties of dietary fatty acids per se, that is, without 
the administration of any other priming or activating exogenous signal were analysed. 
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In this way, in the first proposed condition, the effects of dietary fatty acids acting as 
priming signals in inflammasome activation were evaluated. We demonstrated that both 
SFAs that were analysed, palmitate and stearic acid, as well as the n-6 PUFA acted as 
priming signals of inflammasome activation, but n-3 DHA had no effect. In this manner, 
the supplementation of macrophages with SFAs or n-6 PUFA before ATP-mediated 
inflammasome activation significantly increased IL-1β secretion, while n-3 DHA 
supplementation showed no stimulating effect on IL-1β secretion. Regarding, the 
inflammasome activation checkpoints that are regulated by these fatty acids, palmitate 
was the only fatty acid that was able to enhance COX2 protein expression in 
macrophages, supporting the role of palmitate as a TLR4 agonist and as an activator of 
NF-κB. Then, the modulation of the cytosolic pool of NLRP3 was only significantly 
modulated by DHA, which induced a decrease in its protein expression. Otherwise, 
caspase-1 activation levels were only significantly enhanced when n-6 arachidonic was 
used as a priming stimulus. 
On the other hand, although it has been controversial for years, it has currently been 
described that acute priming of LPS is solely required to boost the inflammasome and 
activate caspase-1 and the resulting secretion of mature IL-1β [28–30]. Thus, by using 
the second experimental condition, the capacities of dietary fatty acids to interfere with 
LPS-induced inflammasome activation were determined. Of the dietary fatty acids that 
were tested, the supplementation of LPS-primed macrophages with stearic acid 
potentiated the proinflammatory effects induced by LPS, which enhanced the cytosolic 
pool of the two limiting components of inflammasome activation, NLRP3 and pro-IL-1β, 
and caspase-1 activation. 
Surprisingly, arachidonic acid interfered inversely with LPS-induced NF-κB activation. We 
showed that supplementation of LPS-primed macrophages with arachidonic acid 
decreased COX2, NLRP3 and pro-IL-1β protein abundance in the cytoplasm of LPS-
primed macrophages and decreased IL-1β secretion. These results indicate that 
supplementation of macrophages with n-6 arachidonic acid might modulate the efficiency 
of LPS to induce NF-κB activation. Although, arachidonic acid is a precursor of the 
cyclooxygenase-mediated synthesis of eicosanoids, it is also stored in the cell 
membrane. It has been described that the modification of cell membrane fatty acid 
composition influences membrane fluidity, which, in turn, would modify membrane 
receptor function as well as signal transduction mechanisms[31]. Thus, an arachidonic 
acid-rich diet could modify the cell membrane composition, which could affect its fluidity 
and, then, signal transduction, as was observed for LPS-primed macrophages. 
Interestingly, n-3 DHA inhibited LPS-mediated inflammasome activation. This inhibition 
was primary mediated by the significant repression of NLRP3 and pro-IL-1β protein 
expression, which, in turn, translated to a slight decrease in the secretion of mature IL-
1β, confirming that DHA modulation of inflammasome activation is mainly through the 
inhibition of LPS-induced NF-κB activation. 
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Finally, in the third condition, the abilities of dietary fatty acids to modulate per se the 
priming and activation of the inflammasome and IL-1β were analysed. We demonstrated 
that only palmitate was able, per se without any additional stimulus (either priming or 
activating), to significantly induce the secretion of IL-1β. These results are in accordance 
with the description of palmitate as a ligand for TLR4, which promotes the activation of 
NF-κB and the transcription of its proinflammatory target genes [23]. Moreover, it has 
been described previously that the stimulation of macrophages with palmitate can induce 
the production of reactive oxygen species (ROS) [32]. Therefore, palmitate may induce 
the activation of the inflammasome and the secretion of IL-1β in macrophages by directly 
acting as a priming signal through its TLR4-agonist activity and by sensing NLRP3, which 
mediates the production of ROS, similar to that described previously for LPS [33]. 
In summary, we can conclude that dietary fatty acid composition can be sensed by 
NLRP3 inflammasome activation and that the chemical structure of these fatty acids, 
regarding the degree of saturation, is critical for its regulating effects. Whereas saturated 
fatty acids, such as palmitate and stearic acid, show mainly a proinflammatory profile by 
promoting inflammasome activation and IL-1β secretion, polyunsaturated fatty acids are 
inhibitors of inflammasome activation by mainly interfering with LPS-TLR4 signal 
transduction, NF-κB and the inflammasome activation step. With these results, we have 
provided new insights regarding the molecular-sensing mechanisms involved in signal 
transduction by high levels of fatty acids to trigger intracellular inflammatory signalling, 
which is a mechanism that underlies the development of diet-induced chronic 
inflammation and metabolic disturbances. In this manner, the diet and, more accurately, 
the modification of fatty acid composition can be a powerful tool for regulating the 
inflammatory and innate immunity responses as well as for the promotion of 
homeostasis. 
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ABSTRACT 
Objective: To determine whether diet-induced obesity affects inflammatory and immune 
responses and characterise the effect of chronic overfeeding on the regulation of lymphoid 
organs functionality.  
Design and Methods: A Cafeteria diet or a standard diet was administered to Wistar rats 
for 10 weeks. We studied the obesity-driven local inflammatory response in adipose tissue 
and the responsiveness of the thymus and the spleen to diet by gene expression analysis, 
as well as we determined the circulating levels of systemic inflammation biomarkers. 
Results: Our results support a pivotal role for adipose tissue as the central site for 
overfeeding-triggered low-grade chronic inflammation, resulting in the up-regulation of 
proinflammatory genes (F4/80, IL-6 and TNF-α) as well as the down-regulation of the anti-
inflammatory (IL-10). However, the functionality of lymphoid organs in response to obesity-
derived noxious stimuli was weakened as a consequence of diet-induced obesity, reflected 
by the down-regulated expression of the F4/80, IL-6 and IL-10 gene expression in the 
thymus and the repression of F4/80, IL-6, Crp and IL-10 gene expression in the spleen. 
Conclusion: Diet-induced obesity compromises the complex crosstalk between the 
metabolism and the immune system. Diet-induced obesity induces low-grade inflammation, 
mainly triggered by the adipose tissue, and impairs the immune system affecting thymus and 
spleen function and gene expression. 
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INTRODUCTION 
Obesity, resulting from an imbalance between energy intake and expenditure, has been 
associated with several metabolic alterations, including insulin resistance, impaired glucose 
tolerance, type 2 diabetes mellitus, dyslipidaemia, atherosclerosis, hypertension and the 
expression of pro-inflammatory biomarkers, a cluster of pathologies widely known as 
Metabolic Syndrome [1–3]. 
Indeed, there is complex and continuous crosstalk between metabolic and immune systems 
because both systems are considered among the most fundamental requirements for 
survival, and the regulation of metabolism and the immune response are integrated, 
whereby the proper functioning of each is dependent on the other [4]. Thus, the organs and 
tissues involved in the regulation of the metabolism, aside from providing the necessary 
nutrients to trigger and sustain the immune response, contain resident populations of 
immune cells, suggesting that the immune system is poised to respond to nutrient-derived 
signals. Furthermore, obesity-associated metabolic dysfunction might result in the 
malfunctioning of the immune system; thus, regulation of the immune system is 
indispensable for the maintenance of metabolic homeostasis [5]. 
Under chronic overfeeding conditions, there is a continuous imbalance between energy 
intake and expenditure, resulting in an excessive accumulation of triglycerides in the 
adipocytes, endangering the functionality of these cells and triggering a local low-grade 
inflammatory response [6]. Consequently, excessive levels of proinflammatory cytokines, 
such as tumour necrosis factor-α (TNF-α) or interleukin 6 (IL-6), are continuously produced 
in adipose tissue, promoting the recruitment of immune cells and the activation of a low-
grade inflammatory response. Although several chemotactic factors have been implicated in 
the recruitment of monocytes to adipose tissue, monocyte chemotactic protein-1 (MCP-1) 
might play a dominant role [7,8]. Thus, obesity-induced inflammation in adipose tissue 
underlies the systemic activation of the inflammatory response, leading to the widespread 
activation of the innate immune system and systemic metabolic dysfunction, an event 
associated with the development of several obesity-related disorders. The systemic effects 
of inflammation comprise among others, a global reaction known as the acute-phase 
response, characterised by pronounced changes in the concentration of circulating acute-
phase proteins, such as the C-reactive protein (CRP), complement component C3 (C3) and 
orosomucoid [9,10]. Moreover, adipose tissue is also considered as a key endocrine organ, 
mediating the release of multiple bioactive substances known as adipose-derived secreted 
factors or adipokines, which also play pivotal roles in the proper integration of metabolic and 
immune systems. The adipokines leptin and adiponectin are both involved in the control of 
energy expenditure, lipid and carbohydrate metabolism and the regulation of the immune 
response.  
Thus, inflammation is a coordinated physiological response of the innate immune system to 
harmful stimuli, whether physical, chemical or biological, to restore the system to the 
homeostasis. However, in an obesity context, a continuous surplus of energy intake 
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promotes the chronic low-grade activation of the innate immune system, impairing not only 
the resolution of inflammation but also inducing the activation of the adaptive immunity, 
reflecting the nature of the triggering stimulus.  
The immune system, comprising a complex network of organs, tissues and cells that 
integrates the innate and adaptive immunity, might play a pivotal role in the development of 
metabolic diseases [4]. Moreover, whereas immune cells and secreted mediators are 
involved in obesity-induced adipose tissue inflammation, suggesting a prominent role for the 
cellular components of both the innate and the adaptive arms of the immune system in 
obesity-induced immune activation, little is known about the role and regulation of the 
lymphoid organs in the development of obesity and obesity-related disorders. Thus, both the 
thymus, the primary lymphoid organ involved in bone marrow-derived T cell maturation, and 
the spleen, a secondary lymphoid organ considered as the immunologic filter of the blood, 
play pivotal roles in host immune function [11]. 
The activation and deregulation of the immune system in response to diet-induced chronic 
lipid overload leads to the impairment of both metabolic and immune homeostasis. However, 
the mechanisms underlying the continuous activation of inflammation and the 
responsiveness of lymphoid organs to obesity remain unclear. The aim of this study was to 
examine the diet-induced activation of immune system and to determine the role of the 
thymus and spleen, as key central and peripheral lymphoid organs, in the obesity-induced 
improper deregulation of the immune system. 
MATERIALS AND METHODS 
Animals and experimental design 
Male Wistar rats weighing 150 g were obtained from Charles River Laboratories (Barcelona, 
Spain). The animals were housed individually in a 12 h light-dark cycle. After adaptation, the 
animals were randomly distributed into two groups (n=7), fed for 10 weeks with either 
standard (STD) chow or a cafeteria (CAF) diet. A CAF diet comprised bacon, cookies, 
muffins, pate, cheese, carrots, milk and sugar added to the standard chow, generating a 
hypercaloric diet comprising 11.5% protein, 34.5% carbohydrates and 37.8% fat. The 
animals were fasted for 3 h and sacrificed through abdominal aortic exsanguination. 
Subsequently, blood samples were collected from the abdominal aorta, and heparinised 
plasma was obtained through centrifugation. Adipose fat depots (mesenteric, perirenal and 
epididymal), were excised, weighed, immediately frozen in liquid nitrogen and stored at -
80ºC until further analysis. The thymus and spleen were rapidly removed and weighed, and 
either thymocytes or splenocytes were immediately isolated. All procedures were approved 
through the Animal Ethics Committee of Rovira i Virgili University. 
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Measurement of circulating biochemical parameters 
After sacrifice, blood samples were collected, and heparinised plasma was obtained through 
centrifugation. Circulating levels of leptin and adiponectin were determined using specific 
EIAs according to the manufacturer’s instructions (Biosource International Inc., CA, USA). 
The plasmatic concentrations of orosomucoid and complement factor C3 were determined 
using ELISA kits according to the manufacturer’s instructions (GenWay, San Diego, USA). 
The ELISA kit for MCP-1 quantification was purchased from Abcam (Cambridge, USA). 
Thymocyte and splenocyte isolation. 
Thymocyte and splenocyte cell suspensions were obtained from freshly isolated lymphoid 
tissue through mechanical disruption and fractionation using a 70-μm nylon cell strainer. The 
isolated cells were treated with ACK lysis buffer (SIGMA, Barcelona, Spain) to eliminate 
erythrocytes. Trypan blue staining was performed to determine the number of live cells. 
Gene expression analysis using real-time RT-PCR 
Total RNA from mesenteric fat depots and isolated thymocytes and splenocytes was 
obtained using TRIzol reagent according to the manufacturer’s instructions (Invitrogen, 
Barcelona, Spain) and purified using RNeasy Mini Kit spin columns (Qiagen, Valencia, CA, 
USA). cDNA was generated using the reverse transcription reagent kit (Applied Biosystems, 
Madrid, Spain). The mRNA expression of Tnf-α, IL-6, IL-10, F4/80, Crp and cyclophilin 
peptidylprolyl isomerase A (Ppia), as reference gene, was determined through RT-PCR 
amplification using SsoFast EvaGreen SuperMix (Bio-Rad). The forward and reverse 
primers used for the different genes are described in Table 1. However, the expression of 
Bax, Bcl-2 and Actb, as a reference gene, was determined through RT-PCR amplification 
using TaqMan Mix (Applied Biosystems, Madrid, Spain) and gene-specific TaqMan probes: 
Rn99999125_m1 for Bcl-2, Rn01480160_g1 for Bax and Rn00667869_m1 for Actb. The 
values for the relative gene expression were normalised to the Ppia mRNA levels according 
to the 2-ΔΔCt method.  
Analysis of DNA fragmentation 
The formation of DNA fragmentation ladders was analysed using agarose gel 
electrophoresis according to a previously described method [12]. Briefly, the extracted 
thymocytes or splenocytes were suspended in 1 ml of hypotonic lysis buffer (0.2% Triton X-
100, 1 mM EDTA and 10 mM Tris/HCl, pH 7.5) and incubated for 20 min at 4ºC. The lysed 
cells were centrifuged for 5 min at 14,000 g at 4ºC, and the supernatants were collected and 
incubated with 200 μg/ml of RNase A for 1 h at 37ºC. After digesting with 200 μg/ml of 
proteinase K for 30 min at 50ºC, the DNA was precipitated overnight at -20ºC in 50% 
isopropanol containing 0.5 M NaCl. The precipitated DNA was pelleted through 
centrifugation for 15 min at 14,000 g, air-dried and suspended in buffer containing 1 mM of 
EDTA and 10 mM Tris/HCl, pH 7.5. Equal amounts of isolated DNA (10 μg) were subjected 
to electrophoresis on a 2% agarose gel. Subsequently, the bands were stained with ethidium 
bromide and photographed. 
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Table 1. Rat-specific primer sequences. 
Gene Primer sequence 
Tnf-α Forward 5' CCTCACACTCAGATCATCTTCTC 3' 
 Reverse 5' TTGGTGGTTTGCTACGACGTG 3' 
IL-6 Forward 5' CTCTCCGCAAGAGACTTCC 3' 
 Reverse 5' GCCATTGCACAACTCTTTTCTC 3' 
IL-10 Forward 5' GCAGGACTTTAAGGGTTACTTGG 3' 
 Reverse 5' GGAGAAATCGATGACAGCGT 3' 
F4/80 Forward 5' ATGCATAATCGCTGCTGGCTGAA 3' 
 Reverse 5' GAGGGCAGAGTTGATCGTGATGATC 3' 
Crp Forward 5' GGCTTTTGGTCATGAAGACATG 3' 
 Reverse 5' TCTTGGTAGCGTAAGAGAAGA 3' 
Ucp2 Forward 5' CCTCTGGAAAGGGACCTC 3' 
 Reverse 5' GAGGTCGTCTGTCATGAGG 3' 
Ppia Forward 5' CTTCGAGCTGTTTGCAGACAA 3' 
 Reverse 5' AAGTCACCACCCTGGCACATG 3' 
Statistical analysis  
The results are expressed as the mean ± S.E.M. The effects of the CAF diet were assessed 
using Student’s t-test. Differences were considered significant when the p values were 
<0.05.  The calculations were performed using SPSS 20.0 software. 
RESULTS 
Cafeteria diet promotes adiposity-induced inflammatory responses 
To determine the modulatory effects of the CAF diet on the functionality of primary and 
secondary lymphoid organs, we assessed the diet-induced effects on the activation of 
inflammatory and immune responses. 
Thereby, feeding rats a CAF diet based on high-energy foods resulted in an increase in body 
weight, with a consequent increase in different fat depots (Table 2). Furthermore, this diet-
induced increase in adiposity enhanced macrophage recruitment in adipose tissue, reflected 
as an increase in F4/80 gene expression, a macrophage-selective marker, and the activation 
of the local inflammatory response, defined by the significant transcription of pro-
inflammatory genes, including IL-6 and Tnf-α, but not anti-inflammatory genes, such as IL-10 
(Figure 1). 
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Table 2. Cafeteria diet-induced body weight and adiposity increase. *P<0.05 vs. STD 
diet-fed rats. 
 Standard diet Cafeteria diet 
Body weight gain (%) 34.92 ± 0.67 45.40 ± 0.83* 
Tissue weight   
Mesenteric fat (g) 6.25 ± 0.64 14.00 ± 1.52* 
Epididymal fat (g) 10.02 ± 0.70 21.54 ± 2.44* 
Perirenal fat (g) 8.97 ± 0.41 20.17 ± 2.02* 
Adiposity Index (mg/g bw) 55.51 ± 1.29 105.86 ± 5.38* 
 
Figure 1. The cafeteria diet induces the modulation of inflammatory biomarkers mRNA expression in 
the adipose tissue. Gene expression was measured using RT-PCR. (A) Diet effect on F4/80 macrophage 
selective marker. (B), (C) and (D) Obesity-induced modulation of Tnf-α, IL-6 and IL-10 gene expression. Data 
represent the mean ± SEM. *P<0.05 vs. STD diet-fed rats. 
Moreover, these local diet-induced modulatory effects also affected the levels of fat-derived 
plasma biomarkers (Figure 2). Indeed, the CAF diet induced a significant increase in the 
levels of circulating leptin, and although no differences were observed in the adiponectin 
concentration, the leptin/adiponectin ratio was higher in CAF-fed rats. In addition, MCP-1, 
orosomucoid and C3 plasma levels were significantly increased after the rats were fed a 
CAF diet.  
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Figure 2. Circulating concentration of biomarkers involved in the systemic responsiveness to diet-
induced obesity. Levels of leptin (A), MCP-1 (B), adiponectin (C), orosomucoid (D), the ration between 
leptin and adiponectin (E) and complement component 3 (F) were measured in plasma of STD and CAF fed 
rats. Data represent the mean ± SEM. *P<0.05 between the rats fed with STD and CAF diets. 
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Diet-induced obesity influences the features of the thymus 
The modulatory effects of the CAF diet on the functionality of thymus, the primary lymphoid 
organ involved in the maturation of T cells, were determined based on the regulation of 
thymic weight and size and the expression of genes involved in the modulation of the 
inflammatory response (Figure 3). Although no significant diet-induced effects were 
observed in terms of the thymus weight, the visual appearance of this organ was completely 
different, suggesting that the CAF diet promoted the accumulation of ectopic fat in the 
thymus. Furthermore, the CAF diet decreased the presence of macrophages, reflected by 
the down-regulated expression of the macrophage-specific gene F4/80, whereas no 
significant diet-induced differences were observed for Tnf-α transcription, and the CAF diet 
promoted the down-regulation of both IL-6 and IL-10 gene expression. 
Moreover, DNA fragmentation in the thymus was also analysed as a marker of diet-induced 
thymic atrophy. However, the rats fed either STD or CAF diets showed similar DNA ladder 
integrity patterns. Furthermore, whereas slight but not significant CAF diet-induced effects 
on the expression of the pro-apoptotic Bax gene, the CAF diet down-regulated the 
transcription of Bcl-2, an anti-apoptotic gene. 
The spleen functionality is modulated by cafeteria diet 
The diet-induced modulation of the immune system was also assessed in terms of spleen 
regulation and functionality to determine the regulation of this secondary lymphoid organ 
responsible for integrating innate and adaptive immune responses (Figure 4). The CAF diet 
induced a significant decrease in spleen weight, although no visual differences were 
observed regarding the morphology or composition of the spleen cells. 
Moreover, the expression of the genes involved in the regulation of the immune response in 
splenocytes was significantly affected in response to the CAF diet. Indeed, the CAF diet 
induced the significant repression of macrophage marker F4/80, accompanied by a 
significant decrease in IL-6, Crp and IL-10 gene expression; however, Ucp-2 was 
significantly overexpressed in the spleens of CAF-fed rats. In addition, although apoptotic 
DNA fragmentation was clearly visualised, mediating DNA laddering, no diet-induced effect 
was observed in the modulation of DNA integrity.  
DISCUSSION 
The immune system is a complex network of tissues and organs comprising molecular, 
cellular and humoral components that sense perturbations in normal physiology and trigger 
responses to restore homeostasis. Immune system components that sense obesity-induced 
metabolic stress resulting from the continuous metabolic surplus and the integration of the 
functionality of both metabolism and the immune system contribute to the proper regulation 
of the immune response as a pivotal event associated with the progression of obesity and 
obesity-related pathologies.  
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Figure 3. Cafeteria diet modulates thymus functionality. (A) Weight of thymus from standard and 
cafeteria fed rats. (B) Macroscopic pictures of the thymus from rats fed with standard and also cafeteria diet. 
Each small square represents 1 mm. (C) Gel electrophoresis of DNA fragmentation ladders. DNA was 
isolated from the thymocytes of rats under both fed conditions. (D) mRNA gene expression of the selective 
macrophage marker F4/80. (E), (F) and (G) modulation of Tnf-α, IL-6 and IL-10 the gene transcription. (H) 
and (I) Effects of diet on the modulation of the expression of apoptotic Bax and Bcl-2 genes. Data represent 
the mean ± SEM. *P<0.05 vs. STD diet-fed rats. 
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Figure 4. Spleen functionality is impaired by diet-induced obesity. (A) Weight of the spleens obtained 
from standard and cafeteria-fed rats. (B) Macroscopic pictures of the spleens from rats fed with standard and 
cafeteria diet. Each square represents 1 mm. (C) Diet modulation of F4/80 mRNA expression. (D) 
Electrophoretic analysis of thymocytes DNA fragmentation. (E), (F) and (G) modulation of Ucp-2, CRP, IL-6 
and IL-10 gene transcription. Data represent the mean ± SEM. **P<0.05 between the rats fed with STD and 
CAF diets. 
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Thus, the purpose of this study was to determine the influence of diet-induced obesity as 
both a triggering event for innate immunity and a chronic stimulus for the adaptive immune 
response through an analysis of local inflammatory responses in adipose tissue, systemic 
inflammation, and the responsiveness of the two major primary and secondary lymphoid 
organs, the thymus and the spleen, respectively. 
The cafeteria diet, a robust model for human metabolic syndrome, was used to investigate 
the obesogenic and inflammatory implications of diet-induced obesity [13]. Using this model, 
the animals were provided free access to a STD diet and concurrently offered highly 
palatable and energy-dense food. Therefore, the hedonistic overfeeding induced through a 
CAF diet in Wistar rats was reflected by an increase in body weight resulting primarily from 
the dramatic gain of adiposity. This expansion of adipose tissue activated the inflammatory 
response as a consequence of the up-regulated transcription of IL-6 and Tnf-α, key genes 
involved in the diet-induced activation of local inflammation, and the down-regulated gene 
expression of IL-10. CAF diet-induced inhibitory modulation was also associated with the 
activation of the inflammatory response. These results suggest that adipose tissue not only 
acts as storage depot for excess calorie intake, but is also involved in the obesity-induced 
inflammatory response [14]. Furthermore, diet-induced adiposity increase was accompanied 
by macrophage infiltration into adipose tissue, reflected as an increase in circulating MCP-1 
levels and expression of the macrophage-selective F4/80 gene, consistent with previous 
results associating an increase in adipose tissue-infiltrating macrophages with an increase in 
IL-6 and TNF-α production [15,16] and highlighting a pivotal role for macrophages in the 
activation of innate immunity [17]. 
Although adipose tissue is the central location for obesity-triggered local inflammation, 
mediated through adipocytes and innate and adaptive immune cells, the dysregulation of 
metabolism and immunity also affects systemic immune response activation. Furthermore, 
the specificity of the obesity-induced immune response lies in the periodicity of the triggering 
stimulus; that is, as consequence of a chronic surplus of energy, metabolic stress is 
continuously induced, impeding not only the resolution of inflammation and the deactivation 
of innate immunity but also affecting the activation of adaptive immunity [7,18]. 
However, diet-induced obesity also modulates the circulating pattern of immune regulation 
components, including orosomucoid and C3, whose plasma concentrations were increased 
in rats after feeding with a CAF diet. Orosomucoid and C3 are acute phase response 
proteins with key roles in the regulation of innate immune system, and these proteins are 
secreted by adipose tissue and at other metabolically active sites, such as the liver, in 
response to stressful conditions, such as metabolic perturbations. High circulating levels of 
both immunomodulators have been associated with the development of obesity and obesity-
related pathologies [19,20]. 
Moreover, considering the roles of adipose tissue as an endocrine and immunologically 
active organ [1,21–23], increased adiposity lead to increased plasma leptin levels, a 
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hallmark for diet-induced leptin resistance [24], and decreased circulating adiponectin levels. 
Both of these molecules are the most abundant adipokines secreted by adipose tissue, thus 
confirming the close and inverse relationship between leptin and adiponectin plasma 
concentrations and the proportion of fat storage [22]. Therefore, in addition to being essential 
for the modulation of appetite and energy expenditure, leptin is considered as one of the 
most important mediators linking nutritional status, metabolism and adipose tissue with the 
immune response [25–27]. The pivotal roles of leptin are evidenced through the 
dysregulation of leptin signalling in response to metabolic perturbations that not only impair 
the proper regulation of metabolism but also achieve appropriate immune functionality. Thus, 
high circulating levels of leptin as a consequence of diet increase adiposity, and the 
attenuation of leptin signal transduction through different converging molecular mechanisms 
prevents adequate sensing through its cognate receptor in the hypothalamus. In addition, 
leptin receptor expression is not only limited to the central nervous system, but this protein is 
also expressed in immune cells, thereby implicating leptin in the cell-mediated immune 
response and highlighting that the attenuation of leptin signalling might also affect both 
innate and adaptive immune responses. Indeed, genetically obese mice with impaired leptin 
signalling, reflecting the inhibition of either leptin (ob/ob) or leptin receptor (db/db) 
transcription, exhibit impaired immune function, resulting in inability of the immune system to 
appropriately respond to pathogenic stimuli [28,29]. Moreover, the immunomodulatory 
effects of leptin are not exclusively associated with cell-mediated immunity regulation, but 
leptin deficiency is also genetically associated with lymphoid organ atrophy [26]. 
Thus, taken together, these results suggest that the effectiveness of the immune system, as 
a homeostatic promoter, is based on the highly sensitive recognition of harmful stimulus, and 
immuno-tolerance and weakened immune responses result from chronic immune activation 
in a diet-induced obesity context, yielding extremely deleterious consequences to the host. 
Therefore, to obtain deeper insight into obesity-associated immunocompetence, we also 
examined peripheral immune responsiveness to diet-induced obesity, including the 
regulation of thymus and spleen functionality, which are essential for the appropriate 
response of the host immune system to harmful exogenous and endogenous stimuli. 
The thymus, the primary lymphoid organ responsible for de novo T cell maturation and 
output, is a vital organ for the homeostatic maintenance of the peripheral immune system. 
Thus, although we have not observed differences regarding the weight, the appearance of 
the thymus was strongly affected by diet, suggesting that a CAF diet could promote thymus 
atrophy through the induction of ectopic lipogenesis [30,31]. 
Furthermore, the CAF diet induced the down-regulation of F4/80, the selective macrophage 
marker, which is abundantly expressed in thymic cells [32]. In the thymus, macrophages 
bind and phagocytose thymic lymphocytes, and this interaction is crucial for T cell 
maturation. However, no diet-induced changes were observed for the expression of TNF-α 
in thymocytes, although this pleiotropic cytokine has been described as an immunostimulator 
of T cells proliferation, whose expression is increased in the developing thymus [33]. 
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Notably, the expression of IL-6 and IL-10 was down-regulated in thymocytes in response to 
a CAF diet. The down-regulation of IL-6 gene expression could be associated with a 
decrease in the proliferation and de novo generation of mature T cells, leading to the 
impairment of thymus-mediated immune functions. IL-10, in turn, also regulates T cell 
maturation, and the dysregulation of IL-10 expression leads to a severe T cell 
immunodeficiency [34]. The diet-induced decrease in the expression of both cytokines, with 
opposite inflammatory functions, might reflect a decrease in the macrophage subset.  
However, some authors have hypothesised the existence of immune-metabolic interactions 
in the thymus. Indeed, the thymus is a plastic tissue that undergoes massive architectural 
changes with age, and thymocytes are replaced with adipocytes, through a process known 
as thymic involution [35]. Thus, one of the mechanisms associated with thymic atrophy-
induced immunodeprivation is the increase in apoptosis leading to increased DNA 
fragmentation. Several studies have reported that apoptosis plays a critical role in T cell 
development and apoptotic thymocytes are cleared by thymic macrophages [36]. Therefore, 
we analysed the degradation of DNA in the thymocytes obtained from rats fed either STD or 
CAF diets; however, no DNA ladders or differences regarding the type of diet were 
observed. Consistently, the gene expression of Bax and Bcl-2, apoptotic proteins, in 
thymocytes was determined. Notably, only the transcription of the anti-apoptotic gene Bcl-2 
was significantly down-regulated in response to CAF diet consumption, which might reflect 
the obesity-induced atrophy of thymus functionality [37]. Thus, the CAF diet inhibited the 
immune-stimulatory capacity of the thymus through a decrease in the thymic macrophage 
population. 
The spleen, the largest lymphoid organ in the body, plays an important role not only as blood 
filter but also in the regulation of the immune-metabolic-endocrine network [38], considering 
that obesity significantly modifies the pattern of circulating metabolic and immune 
metabolites, suggesting that the spleen is crucial for immune response regulation. 
Furthermore, there is also an important association between the liver and spleen for the 
regulation of metabolism and immunity [39], and the  splenic role might be more important in 
the response to homeostatic perturbations.   
These results showed a decrease in the weight of the spleens obtained from CAF diet-fed 
rats, likely reflecting a reduction in the number of splenocytes. Indeed, the spleen is the 
storage site for several cell types, including erythrocytes, monocytes and macrophages, and 
serves as a key resource for rapid macrophage deployment and immunity regulation. Thus, 
the CAF diet induced a decrease in splenic macrophages, reflected by the down-regulation 
of F4/80 gene expression. Moreover, uncoupling protein 2 (UCP2), a mitochondrial protein 
robustly expressed in the spleen (Lamas et al., 2004), is involved in the regulation of 
metabolism and in immune function, controlling macrophage activation through the 
modulation of mitochondrial reactive species (ROS) production, showing a direct association 
between increased Ucp2 mRNA levels in the spleens of obese rats with poor oxidative burst 
activities [40]. Therefore, we demonstrated that diet-induced obesity not only reduces the 
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number of macrophages present in the spleen, limiting its capacity to counteract 
inflammatory stimuli but also that the obesity-induced weakened immune response might 
reflect limited oxidation capacity resulting from the up-regulation of splenic Ucp2 gene 
expression. In addition, diet-induced obesity also regulates the mRNA expression of IL-6 and 
Crp, systemic biomarkers of inflammation, whose expression in splenocytes is suppressed 
as result of CAF diet, consistent with the results of previous studies [41], likely inhibiting 
proper immune reactivity against obesity-related systemic biomarkers. We also showed that 
diet-induced obesity resulted in the inability of the spleen to synthesise IL-10. Thus, 
activated B cells primarily contribute to splenic IL-10 production, playing a regulatory role in 
the suppression of harmful immune responses. It has been hypothesised that the obesity-
induced down-regulation of splenic IL-10 expression results in chronic inflammation in 
adipose tissue, the liver and hypothalamus [11,42]. 
Furthermore, whereas no differences were observed regarding diet-induced apoptotic 
effects, a clear DNA degradation pattern was observed for the splenocytes obtained from 
both the STD and CAF-fed rats, demonstrated by the corresponding oligonucleosomal 
fragments from 300 to 50 kb in length [43], corresponding to apoptotic splenocytes. This 
diet-independent apoptosis hallmark in the splenocytes of rats from both groups might reflect 
the involvement of the spleen in the maintenance of peripheral tolerance via the clearance of 
circulating apoptotic cells [39]. 
In summary, we demonstrated that the obesity-triggered low-grade inflammatory response 
occurs primarily in adipose tissue, rather than lymphoid organs, and the macrophages are 
crucial cells, orchestrating not only local inflammatory responses but also inhibiting 
appropriate responses to harmful obesity-derived stimuli in primary and secondary lymphoid 
organs. Remarkably, diet-induced prolonged metabolic overload modulates functionality in 
the thymus and the spleen, reflecting a weakened sensibility of the immune response, 
promoting immune tolerance and affecting not only the regulation of metabolic and immune 
systems but also the restoration and maintenance of the homeostatic state in the entire 
body. 
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ABSTRACT 
Objective: Nutrition can be considered as a two-side coin: although an imbalance in the 
energy content is associated with the induction of obesity and obesity-related pathologies, a 
healthy state can be induced through the intake of food containing immunologically active 
compounds, such as grape seed procyanidin extract (GSPE) or docosahexaenoic acid 
(DHA). Thus, the aim of this study was to determine the immunomodulatory properties of 
these dietary components in cafeteria diet-fed rats. 
Design: Five groups of rats were fed either a standard diet (STD) or a cafeteria diet (CAF) 
for 13 weeks and three of the CAF-diet fed groups were supplemented with either GSPE at 
25 mg per kg of body weight, DHA at 500 mg per kg of body weight or the combination of 
GSPE and DHA during the last 3 weeks of the study.  
Results: GSPE and DHA suppress diet induced-inflammation by promoting a phenotypic 
switch in the molecular and cell profile of mesenteric adipose tissue. Furthermore, the 
healthy properties of GSPE and DHA supplementation are not limited to the modulation of 
adipose tissue inflammation, but also boost immune system through the modulation of cell-
mediated immunity, involving macrophages and T lymphocytes subsets, as well as stimulate 
the functionality of thymus and spleen to counteract the obesity-induced weakened immune 
responses. Moreover, the combination of the bioactivity of GSPE and DHA potentiates the 
immunomodulatory properties observed for each compound administered individually.  
Conclusion: Diet supplementation with GSPE and DHA in obese rats induces a healthy 
state, not only promoting the resolution of adipose tissue-driven inflammation but also 
boosting the obesity-induced weakened immune response.   
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INTRODUCTION 
Obesity is a complex and multifactorial disease primarily reflecting imbalanced energy 
metabolism, associated with a high incidence of metabolic disorders, including impaired 
glucose metabolism, dyslipidaemia, atherosclerosis, hypertension and the activation of 
inflammatory responses; altogether, these pathologies are known as Metabolic Syndrome 
[1,2]. 
The immune system is a coordinated physiological response comprising both innate and the 
adaptive immunity, associated with a complex network of molecules, cells and organs to 
detect perturbations, trigger adequate immune responses and restore the homeostatic state. 
Moreover, obesity has been associated with the impairment of the immune function, 
interfering with the proper regulation of the production of immune biomarkers, altering 
leukocyte counts and affecting the functionality of lymphoid organs [3,4].  
Thus, the regulation of the metabolism and the immune system are highly integrated and 
dependent on each other, indeed this interface is a central homeostatic mechanism, the 
dysfunction of which leads to the improper functionality of both systems [5]. Therefore, 
obesity is characterised in part by lipid accumulation in adipose tissue, the major site for the 
storage of excess energy in the body, triggering the activation of a local inflammatory 
response, characterised by the infiltration of immune cells, the over production of pro-
inflammatory cytokines, including tumour necrosis factor-α (TNF-α) and interleukin 6 (IL-6) 
and the reduced production of anti-inflammatory cytokines, such as interleukin 10 (IL-10) 
[6,7]. Thus, the perpetuation of this metabolic dysfunction, leads to chronic cellular stress, 
leading to an adipose-tissue driven systemic inflammatory response, considered as a pivotal 
event for the development of metabolic diseases [5]. Therefore, systemic inflammation is 
characterised by enhanced circulating concentrations of several chemotactic factors, 
including the monocyte chemotactic protein-1 (MCP-1) [8,9], and the activation of an overall 
acute-phase response, characterised by increased levels of acute-phase proteins, such as 
the C-reactive protein (CRP), the complement component C3 (C3) and orosomucoid [10,11]. 
Moreover, adipose tissue, as an endocrine organ, plays a pivotal role in the integration 
between energy balance and immune function through the synthesis and secretion of fat-
derived neuroendocrine peptides, including leptin and adiponectin. Thus, due to a chronic 
positive energy balance, these neuroendocrine-immune interactions are heightened.  
Leptin is a 16-kDa hormone synthesised in adipocytes proportionally to the amount of 
energy stored in adipose tissue to centrally regulate energy metabolism. However, the leptin 
receptor is not only expressed in the central nervous system but also in peripheral tissue 
and cells, including those involved in the immune system, demonstrating a role for leptin as 
a modulator of the immune response [12]. Thus, leptin is a potent immunomodulator, 
promoting lymphopoiesis and myelopoiesis, and leptin deficiency is associated with an 
atrophy of the thymus that primarily affects the size and cellularity of this organ [13]. In 
addition, leptin is also necessary for the induction and maintenance of the pro-inflammatory 
immune response, suggesting a link between nutritional status and the T cell profile. 
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Moreover, the direct interactions between increased obesity-induced leukocyte populations, 
including macrophages and lymphocytes, in adipose tissue, and the incremented adipocyte 
numbers within the lymphoid microenvironment, are considered as important adaptive 
responses to changes in energy balance and the pivotal cross-talk, whose impairment 
underlies the development of obesity-related pathologies [14,15]. Thus, cell-mediated 
immunity plays a pivotal role in the orchestration of the immune response to metabolic 
disturbances. In adults, the two major T cell lineages, CD4+ helper and the CD8+ cytotoxic T 
cells, are derived from bone marrow, traffic through the blood, and are subsequently 
imported into the thymus, where thymocytes receive the corresponding signals to mature 
into T lymphocytes [16]. Naïve T cells circulate in the bloodstream, as part of the peripheral 
blood mononuclear cells (PBMCs) and are activated in the peripheral lymphoid tissues, 
where the spleen is the largest secondary lymphoid organ and is essential for the host 
immune function [17]. Furthermore, a specialised subset of CD4+ T cells, known as Tregs, 
plays a key role for the maintenance of immunological homeostasis. Tregs has 
immunosuppressive activity based on the exclusive presence of a master transcriptional 
regulator, the transcription factor forkhead box P3 (Foxp3) [18]. Thus, diet induced-obesity is 
associated with the infiltration of pro-inflammatory macrophages (M1), the infiltration of pro-
inflammatory CD4+ and CD8+ T cells into adipose tissue, and the reduction of anti-
inflammatory regulatory T cells (Tregs) [19]. 
However, the modulation of metabolic and immune systems by the diet reduces the 
impairment of homeostasis; nevertheless, the intake of foods containing biologically active 
molecules improves the health status and reduces pathologies associated to 
immunometabolic disorders. Thus, a variety of bioactive food components have been shown 
to modulate the inflammatory response, including procyanidins and docosahexaenoic acid 
(DHA). However, the implications of these foods in the regulation of the immune system as a 
result of a diet-induced obesity are not fully understood. Procyanidins are phenolic 
compounds widely distributed in cereals, vegetables and in fruits, such as grapes, berries, 
cocoa or apples, associated with beneficial effects on health, such as the promotion of anti-
inflammatory activities [20,21]. Furthermore, polyunsaturated fatty acids (PUFAs) are 
important constituents of cells, mediators in metabolic and physiological processes, and 
important bioactive lipids. DHA, a ω-3 fatty acid, is present in certain aquatic organisms, 
such as fish (fish oil) or marine microalgae with known anti-inflammatory effects [22]. 
Diet-induced obesity has been associated with an adipose tissue-driven low-grade chronic 
inflammation and impairment in the immune response to both harmful exogenous and 
endogenous stimuli. Therefore, the modulation of the obesity-mediated interference of the 
innate and adaptive immune systems through the intake of food containing biologically active 
compounds could not only enhance immunity but also counteract metabolic disorders. Thus, 
the aim of this study was to determine the potentially beneficial effects of diet 
supplementation with biologically active components, including procyanidins and DHA, alone 
or in combination, in the context of diet-induced obesity. For this purpose, the 
immunomodulatory effects of the bioactive compounds were determined either for the 
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inflammatory response, including the adipose tissue-driven local and systemic inflammation, 
for cell-mediated immunity, or the modulation of lymphoid organ functionality, involving the 
thymus and spleen. 
MATERIALS AND METHODS 
Grape Seed Proanthocyanidin Extract (GSPE) 
Grape seed procyanidin extract (GSPE) was obtained from Les Dérives Résiniques et 
Terpéniques (Dax, France). According to previous studies [23], procyanidin extract derived 
from grape seeds comprises catechin (58 𝜇mol/g), epicatechin (52 𝜇mol/g), epigallocatechin 
(5.50 𝜇mol/g), epicatechin gallate (89 𝜇mol/g), epigallocatechin gallate (1.40 𝜇mol/g), dimeric 
procyanidins (250 𝜇mol/g), trimeric procyanidins (15.68 𝜇mol/g), tetrameric procyanidins (8.8 𝜇mol/g), pentameric procyanidins (0.73 𝜇mol/g), and hexameric procyanidins (0.38 𝜇mol/g).  
Oil rich in docosahexaenoic acid (DHA-OR) 
DHA-OR, obtained from Market DHATM-S, was derived from the marine algae Schizochitrium 
sp., a rich source of fatty acids, and this oil primarily comprises DHA. 
Animals and experimental design 
Male Wistar rats weighing 150 g were obtained from Charles River Laboratories (Barcelona, 
Spain). The animals were housed individually in a 12-h light/dark cycle. After the adaptation 
period, the rats were distributed in two groups, fed for 13 weeks with either standard (STD) 
chow or a cafeteria (CAF) diet. The CAF diet comprised bacon, cookies, muffins, pate, 
cheese, carrots, milk and sugar added to the standard chow, yielding an hypercaloric diet 
comprising 11.5% protein, 34.5% carbohydrates and 37.8% fat. After 10 weeks, the CAF-fed 
rats were 20 % overweight with respect to the STD diet-fed rats, and these rats were 
randomly distributed into four groups (n=7). In three of these groups, the CAF diet was 
supplemented for the last 3 weeks with GSPE (25 mg / kg of body weight), DHA-OR (500 
mg DHA / kg of body weight) or both (25 mg / kg of body weight + 500 mg DHA/kg of body 
weight) as shown in Figure 1. At the end of 13 weeks, the animals were fasted for 3 h and 
sacrificed through abdominal aortic exsanguination. After sacrifice, the plasma was obtained 
through centrifugation of the blood samples. The adipose fat depots (mesenteric, perirenal 
and epididymal) were excised, weighed, immediately frozen in liquid nitrogen and stored at -
80ºC until further analysis. The thymus and spleen were rapidly removed, weighed, and the 
thymocytes and splenocytes were immediately isolated. All procedures were approved 
through the Animal Ethics Committee of Rovira i Virgili University. 
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Figure 1. Experimental design. Rats were fed with either standard (STD) or cafeteria (CAF) diets for 10 
weeks. Subsequently, 3 of the 4 CAF-diet fed groups were supplemented with GSPE (25 mg/kg bw), DHA-
OR (500 mg/kg bw) or the combination of both (25 mg/kg bw of GSPE and 500 mg/kg bw of DHA-OR) for 
three weeks. 
Isolation of thymocytes and splenocytes. 
Thymocyte and splenocyte cell suspensions were obtained from freshly isolated lymphoid 
tissue through mechanical disruption and fractionation through a 70-μm nylon cell strainer. 
The isolated cells were treated with ACK lysis buffer (SIGMA, Barcelona, Spain) to eliminate 
erythrocytes. Trypan blue staining was performed to determine the number of live cells. 
Peripheral blood mononuclear cells (PBMCs) isolation 
Peripheral blood mononuclear cells (PBMCs) were isolated through density-gradient 
centrifugation using HISTOPAQUE-1083 according to the manufacturer’s instructions 
(SIGMA, Madrid). 
Flow cytometric T cell subset analysis 
Freshly isolated splenocytes, thymocytes and PBMCs single cell suspensions were stained 
with a three-color reagent using the Rat T cell lymphocyte cocktail (BD Bioscience, San 
Diego, CA) according to the manufacturer’s instructions. Major subsets of T lymphocytes 
were determined based on the expression of CD3+, CD4+ and CD8+ surface markers using 
flow cytometry analysis (FACS ARIA III, BD Bioscience, San Diego, CA). 
Measurement of biochemical parameters 
Circulating leptin and adiponectin levels were quantified using specific EIAs according to the 
manufacturer’s instructions (Biosource International Inc., CA, USA). Orosomucoid and 
Complement factor C3 plasma concentrations were determined using ELISAs kits according 
to the manufacturer’s instructions (GenWay, San Diego, USA). The MCP-1 determination 
was based on the ELISA kit purchased in (Abcam, Cambridge, USA). 
GSPE + DHA-OR!
STD diet group (n=7)!
CAF diet group (n=7)!
Weeks!
0! 10! 13!
GSPE group (n=7)!
GSPE!
DHA-OR group (n=7)!
DHA-OR!
GSPE + DHA-OR group (n=7)!
CAF diet!
STD diet!
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Gene expression analysis using real-time RT-PCR 
Total RNA from the isolated thymocytes and splenocytes and the mesenteric fat depots was 
isolated using TRIzol reagent according o the manufacturer’s instructions (Invitrogen, 
Barcelona, Spain) and purified using the RNeasy Mini Kit spin columns (Qiagen, Valencia, 
CA, USA). Complementary DNA was generated using the reverse transcription reagent kit 
(Applied Biosystems, Madrid, Spain) and subsequently subjected to RT-PCR amplification 
using the SsoFast EvaGreen SuperMix (Bio-Rad). The forward and reverse primers for Tnf-α 
were 5' CCTCACACTCAGATCATCTTCTC 3' and 5' TTGGTGGTTTGCTACGACGTG 3', 
respectively. For IL-6, 5' CTCTCCGCAAGAGACTTCC 3' and 5' 
GCCATTGCACAACTCTTTTCTC 3' were used for the forward and reverse primers, 
respectively. The forward and reverse primers for IL-10 were 5' 
GCAGGACTTTAAGGGTTACTTGG 3' and 5' GGAGAAATCGATGACAGCGT 3', 
respectively. F4/80 was detected using the 5' ATGCATAATCGCTGCTGGCTGAA 3' as the 
forward primer and 5' GAGGGCAGAGTTGATCGTGATGATC 3' as the reverse primer. iNOS 
gene expression was determined using 5′ GGATCTTCCCAGGCAACCA 3′ as forward and 
5′ AATCCACAACTCGCTCCAAGATT 3′ reverse primers, respectively. For Foxp3, 5' 
AAGCCAGGCTGATCCCTCTC 3' and 5' TCCAAGTCTCGTGTGAAGGC 3', were used as 
forward and reverse primers, respectively, and the primers used for Ppia detection were 5' 
CTTCGAGCTGTTTGCAGACAA 3' as a forward primer and 5' 
AAGTCACCACCCTGGCACATG 3' as a reverse primer. Relative gene expressions were 
normalised according to the Ppia mRNA levels according to the 2-ΔΔCt method. 
Statistical analysis  
The results are expressed as the mean ± S.E.M. The effects of different diet consumption 
were assessed using ANOVA. Tukey’s test was used to make pair wise comparisons. 
Differences were considered significant when the p values were <0.05.  The calculations 
were performed using SPSS 20.0 software. 
RESULTS 
GSPE and DHA-OR, individually or together, supress diet-induced adipose tissue 
inflammatory response   
To determine the immunomodulatory effects of procyanidins and DHA supplementation in 
diet-induced obese rats, the effects of the type of diet on obesity-induced adipose tissue 
dysfunction were assessed. 
Thus, the supplementation of CAF diet with bioactive compounds had no effect regarding the 
modulation of the CAF diet-induced increase in body weight (Figure 2A). Furthermore, 
whereas GSPE or DHA alone did not modulate the CAF diet-promoted increase in 
mesenteric fat depots, the mesenteric adipose tissue was significantly overexpanded in rats 
supplemented with the combination of GSPE and DHA-OR (Figure 2B).  
Procyanidins and DHA improve immune system functionality  
 131 
 
Figure 2. The supplementation of cafeteria diet with GSPE and/or DHA-OR suppresses CAF diet-
induced adipose tissue-triggered local inflammatory response. (A) Body weight gain resulting from the 
13 weeks of experiment. (B) Weight of the mesenteric adipose tissue. (C) Diet-induced modulatory effect on 
F4/80 macrophage selective marker. (D), (E), (F) and (G) Modulation of mRNA expression for the 
inflammatory biomarkers Tnf-α, IL-6, IL-10 and iNOS. (H) Diet-induced regulation of Foxp3+ regulatory T 
lymphocytes. Gene expression was measured using RT-PCR. Data represent the mean ± SEM. Different 
letters denote significant differences between the different groups (P<0.05). 
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Nevertheless, the bioactive compounds dramatically counteracted the CAF diet-induced 
adipose tissue inflammation (Figure 2C-F). Thus, the presence of macrophages was 
significantly decreased, reflected through the down-regulation of F4/80 gene expression, a 
macrophage-selective marker, and the CAF diet-induced transcription of pro-inflammatory 
genes, including Tnf-α, IL-6 and iNOS were also inhibited. The transcription of the anti-
inflammatory IL-10 cytokine was up-regulated in response to the bioactive compounds. 
Remarkably, the modulation of Tnf-α and IL-10 gene expression was significantly greater in 
animals whose diets were supplemented with the combination of GSPE and DHA-OR. 
However, the combination of GSPE and DHA-OR also improved the immunomodulatory 
effects of both compounds alone in terms of Tregs cell recruitment to mesenteric adipose 
tissue, thereby counteracting the CAF diet-induced down-regulation of regulatory T cells, 
reflected through increased Foxp3 gene expression in adipose tissue. 
Obesity-induced systemic inflammatory response is mitigated through diet 
supplementation with GSPE and/or DHA-OR. 
To determined the immunomodulatory effects of diet supplementation with bioactive 
compounds on the systemic activation of inflammation, the circulating levels of biomarkers 
involved in the regulation of immune and metabolic homeostasis were determined (Figure 3). 
The circulating concentration of leptin was differentially modulated through the bioactives. 
Thus, whereas GSPE supplementation had no effect regarding the CAF-diet induced leptin 
overproduction, the supplementation with DHA-OR and most significantly, the combination of 
GSPE and DHA-OR increased leptin-circulating levels. Nevertheless, although DHA-OR and 
the combined bioactive compounds slightly increased adiponectin levels, only the 
supplementation of the CAF diet with GSPE produced a significant increase in the plasmatic 
adiponectin concentration. 
Moreover, the supplementation of the CAF diet with any bioactive compound induced the 
restoration of the obesity-induced systemic inflammatory biomarkers to levels similar to 
those observed in STD-fed rats. Thus, circulating levels of MCP-1, orosomucoid and 
complement C3 were reduced through the supplementation of CAF diet with GSPE, DHA 
and the combination of both bioactive compounds.   
CAF diet supplementation with GSPE and/or DHA-OR modulates thymus functionality 
The capacity to modulate the adaptive response through diet supplementation with the 
bioactive compounds in CAF-diet induced obesity was determined based on the regulation 
of thymus, the largest primary lymphoid organ responsible of T cells maturation, in terms of 
morphology, the transcription of the genes involved in immune regulation and the modulation 
of T cell populations (Figure 4). 
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Figure 3. Effects of bioactive compounds, GSPE and/or DHA-OR in the concentration of circulating 
biomarkers involved in systemic responsiveness to diet-induced obesity. Levels of leptin (A), 
adiponectin (B), MCP-1 (C), orosomucoid (D) and complement component 3 (E) were measured in the 
plasma. Data represent the mean ± SEM. Identical letters indicate no differences in the indicated parameter 
between the different group diets (P<0.05). 
Although the CAF diet had no effect in terms of thymus weight, the visual appearance of the 
thymus obtained from rats fed a cafeteria diet and independently supplemented or not with a 
bioactive compound was completely different from the thymus derived from STD-fed rats. 
Furthermore, the thymus weight was only slightly modulated after the supplementation of the 
CAF diet with GSPE and DHA-OR, and this increment of weight was significantly higher for 
the thymus from rats whose diets were supplemented with the combination of GSPE and 
DHA-OR. In addition, the number of thymocytes reflected the observed weight gain; that is, 
the more heavy the thymus, the higher the number of thymocytes obtained. 
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Figure 4. Cafeteria diet supplementation with GSPE, DHA-OR and the combined bioactive 
compounds modulates thymus functionality. (A) Macroscopic pictures of the thymus from rats fed with 
standard and also with cafeteria diet alone or supplemented with the indicated bioactives. Each small square 
represents 1 mm. (B) Weight of the thymus after the 13 weeks of the experiment. (C) Total number of 
thymocytes isolated. (D), (E), (F) and (G) mRNA gene expression of genes involved in the regulation of 
inflammation, including the cytokines IL-6 and IL-10 and the selective macrophage markers F4/80 and Tnf-α. 
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Figure 4. Cafeteria diet supplementation with GSPE, DHA-OR and the combined bioactive 
compounds modulates thymus functionality. ((H) Flow-cytometric phenotyping of thymic cells. The 
distribution and total T cell count for the major T lymphocytes subsets were determined based on the 
expression of CD3+, CD4+ and CD8+ surface markers. Data represent the mean ± SEM. Different letters 
denote significant differences between the different groups for the determination of each parameter (P<0.05). 
However, regarding the regulation of the expression of the genes involved in immune 
regulation on thymocytes, no bioactive-mediated modulatory effects were observed for IL-6 
and Tnf-α gene transcription, and the expression of IL-10 was only modulated after 
supplementation with GSPE alone or in combination with DHA-OR. Furthermore, the CAF-
diet induced a decrease in the macrophage count, and this effect was partially counteracted 
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through supplementation with DHA-OR and totally balanced in the thymus from GSPE-
supplemented rats. 
Moreover, the effect of GSPE and DHA-OR diet supplementation on the counts of 
lymphocyte subpopulations was determined. Thus, not only the T cell subsets frequency but 
also the total number of thymus-contained T cells was determined. Whereas the three 
bioactive compounds differentially modulated the frequency of CD4+, CD8+ and the ratio of 
CD4+/CD8+, the total count of these T cell subsets within the thymus were not modulated in 
response to diet supplementation with the bioactive compounds. Furthermore, both, the 
frequency and the total double positive T cells, i.e., CD4+CD8+, were significantly increased 
in the thymus of rats whose CAF diet was complemented with GSPE, DHA-OR or the 
combination of both compounds. 
Spleen functionality is modulated through supplementation of the cafeteria diet with GSPE, 
DHA-OR and the combination of both bioactive components 
The effect of enriching the CAF diet with biologically active compounds on spleen weight and 
the modulation of the expression of immune genes was determined. Furthermore, spleen 
immune function was evaluated through the analysis of the composition of lymphocyte 
population (Figure 5). 
Thus, the bioactive compounds, particularly the GSPE and DHA-OR combination, 
counteracted CAF-diet induced spleen atrophy. Unlike the thymus, no bioactive effects were 
determined regarding the number of splenocytes. 
Furthermore, regarding the immunosuppressed gene expression profile resulting from the 
CAF diet, characterised by the down-regulation of macrophages and inflammatory 
biomarkers, including, IL-6, Tnf-α and IL-10, only the supplementation of the CAF diet with 
GSPE, particularly in combination with DHA-OR, significantly counterbalanced the obesity-
induced expression profile. Thus, the GSPE and DHA-OR combination counteracted the 
CAF diet-induced down-regulation of IL-6 and Tnf-α gene expression in splenocytes, while 
only GSPE slightly modulated IL-10 gene expression. Moreover, although the CAF diet-
induced diminution of the macrophage count in splenocytes was partially neutralised through 
supplementation with the combination of GSPE and DHA-OR, only GSPE supplementation 
restored the expression of the selective macrophage marker F4/80, similar to the 
observations in the splenocytes obtained from the STD-fed rats. However, the bioactive-
mediated regulation of splenic immune function primarily reflected the decrease in the ratio 
between the relative counts of CD4+ and CD8+ T cells and the increase in CD8+ T cells. 
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Figure 5. Spleen functionality is impaired by diet-induced obesity. (A) Macroscopic pictures of the 
spleens from rats fed standard and cafeteria diets alone or supplemented with the indicated bioactives. Each 
small square represents 1 mm. (B) Weight of the spleen after 13 weeks of the experiment. (C) Total number 
of splenocytes isolated. (D), (E), (F) and (G) mRNA expression of the genes involved in the regulation of 
inflammation, including IL-6 and IL-10, and the selective macrophage marker F4/80 and Tnf-α. 
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Figure 5. Spleen functionality is impaired by diet-induced obesity.  (H) Flow-cytometric phenotyping of 
splenic cells. The distribution and total T cell number for the major T lymphocytes subsets were determined 
based on the expression of CD3+, CD4+ and CD8+ surface markers. Data represent the mean ± SEM. 
Different letters denote significant differences between the different groups for the determination of each 
parameter (P<0.05). 
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The lymphocyte counts in PBMCs are influenced through supplementation of the 
CAF diet with GSPE, DHA-OR or the combination of both bioactive components 
The effects of the supplementation of the CAF diet with biologically active molecules on the 
modulation of obesity-mediated T cell populations was determined based on the analysis of 
the major T lymphocyte counts in PBMCs. 
 
Figure 6. Supplementation of cafeteria diet with GSPE, DHA-OR and its combination modulate 
obesity-induced T lymphocyte subsets. (A) Weight (B) Flow-cytometric phenotyping of peripheral blood 
mononuclear cells. The distribution and the total T cell counts for the major T lymphocyte subsets were 
determined based on the expression of CD3+, CD4+ and CD8+ surface markers. Data represent the mean ± 
SEM. Different letters denote significant differences between the different groups for the determination of 
each parameter (P<0.05). 
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Thus, supplementation with GSPE alone and in combination with DHA-OR significantly 
increased the total number of PBMCs circulating in the bloodstream compared with the 
counts obtained in rats fed CAF diets without supplementation. Furthermore, a significant 
increase in the frequency of the CD8+ T cells and significant decrease in the ratio of the 
relative counts of CD4+ and CD8+ T lymphocytes was observed. In addition, an increase in 
the total counts of circulating CD4+ lymphocytes, particularly circulating CD8+ T cells, was 
detected.  
DISCUSSION 
Nutritional status plays a pivotal role in the regulation of overall immune function. In addition 
to metabolic changes, obesity has also been associated with chronic low-grade inflammation 
and a weakened immune response. Thus, an impairment of the reciprocal interactions 
between metabolism and the immune system underlies the pathogenesis of obesity and 
obesity-related diseases [15]. The cafeteria diet is considered a robust model for human 
metabolic syndrome, characterised by promoting obesity as a consequence of the hedonistic 
hyperphagia of highly palatable and energy-dense food [24]. 
Thus, these results suggest that after feeding with a cafeteria diet, rats become obese, and 
this pathological state is hallmarked by a dramatic increase in adiposity. Furthermore, diet-
induced obesity triggers a local inflammatory response in adipose tissue characterised by 
the increased production of pro-inflammatory, not anti-inflammatory, biomarkers [7,25]. This 
pro-inflammatory state activates resident leukocytes and also triggers the recruitment and 
infiltration of circulating leukocytes, including macrophages, circulating monocytes, and 
lymphocytes, thereby resulting in the alteration of the stromal vascular fraction of adipose 
tissue [26]. An overall inflammatory response has also been observed, although obesity 
weakens lymphoid organs-mediated immune responses [3,27]. Thus, in a diet-induced 
obesity context, homeostasis is disrupted as a consequence of metabolic and immune 
dysfunctions resulting from continuous positive energy imbalance, promoting a pathological 
state. 
Because nutrition plays a central role for pathology development in diet-induced obesity, we 
proposed the supplementation of diet with nutritional bioactive compounds, including GSPE 
and DHA-OR, as an intrinsic treatment for the amelioration of obesity-induced disturbances 
and the promotion of the healthy state. Thus, we determined the potential role of compounds 
contained in foods present constitutively in the Mediterranean diet, highlighted by 
metabolically and immunologically properties, as nutritional tools to supress the diet-induced 
inflammation and boost the immune system to restore homeostasis. 
There is growing evidence that adipose tissue is a fundamental player in immuno-metabolic 
homeostasis due to its pivotal role in the orchestration of both the nutritional status and the 
activation of the obesity-induced inflammatory response [5,15]. Accordingly, we have 
analysed the modulatory effects of foods containing biologically active compounds on the 
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regulation of the obesity-induced inflammatory response. Thus, the supplementation of the 
cafeteria diet with GSPE, DHA-OR or the combination of these compounds in cafeteria diet-
induced obese rats provoked a phenotypic switch in the immunological profile of mesenteric 
adipose tissue, promoting the resolution of the adipose tissue-triggered inflammation through 
the inhibition of pro-inflammatory biomarkers transcription, such as IL-6, Tnf-α and iNOS, 
and inducing the transcription of IL-10, an anti-inflammatory cytokine. Notably supplementing 
the CAF diet with any of the bioactive compounds, administered alone or together, restored 
the obesity-induced overexpression of circulating inflammatory biomarkers to concentrations 
similar to those determined for the STD diet-fed rats. Thus, the systemic anti-inflammatory 
effects of GSPE, DHA-OR and the combination of these compounds, includes the diminution 
in the secretion of the chemokine MCP-1, orosomucoid and C3, as markers of the acute-
phase response. 
Furthermore, the secretion of immunomodulating adipokines, including adiponectin and 
leptin, was slightly modulated. Thus, GSPE supplementation highlighted an increase in the 
concentration of adiponectin in plasma, which exerts multiple anti-inflammatory actions in 
multiple cells and tissues, including the promotion of macrophage polarisation towards an 
alternative anti-inflammatory phenotype [28]. However, supplementation with the 
combination of GSPE and DHA-OR promoted increased circulating leptin levels. Notably, the 
supplementation of CAF diet with the combination of GSPE and DHA-OR induced a 
significant increase in adiposity, resulting in increased circulating leptin levels. This increase 
in adiposity, however, was not associated with inflammation-triggered adipose tissue 
dysfunction. Indeed, the GSPE and DHA-OR combination improved some of the anti-
inflammatory effects observed after supplementation with these bioactives individually, such 
as in the inhibition of Tnf-α and the induction of IL-10 gene expression. Leptin regulation is of 
great of interest because in addition to its central role as an endocrine hormone for the 
regulation of energy metabolism, leptin also exerts pleiotropic actions on multiple organs 
[29]. Thus, we showed that the diet-induced increment of adiposity is reflected by a rise in 
circulating leptin levels, which is detected by the cognate leptin receptor located in the 
hypothalamus, mediating the central regulation of energy metabolism [30,31]. Nevertheless, 
in obesity-induced hyperleptinaemia, leptin signalling is attenuated [32], resulting in leptin 
resistance. However, leptin also plays a pivotal role in the regulation of both innate and 
adaptive immunity, affecting not only the cell-mediated immune response but also the 
functionality of lymphoid organs. In innate immunity, leptin promotes the phagocytic function 
of macrophages and increases the production of pro-inflammatory cytokines and reactive 
oxygen species (ROS). In addition, in adaptive immunity leptin associates nutritional status 
with T cell function [33,34]. Furthermore, leptin is essential for the lymphoid organ 
homeostasis [35]. Thus, considering the results observed for GSPE and DHA-OR diet 
supplementation, increased leptin levels might reflect an increase in the activation of the 
immune response; that is, in combination, GSPE and DHA-OR might act as stimulators of 
the immune response. 
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In addition, the immunomodulatory effects of GSPE and DHA supplementation are not 
limited to the modulation of the immune response at a molecular level, but these bioactive 
compounds also modulate cell-mediated immunity. Thus, the supplementation of the CAF 
diet with biologically active components induced a decrease in the number of macrophages 
recruited to adipose tissue resulting from diet-induced obesity. Notably, the combination 
between GSPE and DHA-OR also modulated the T cell lymphocyte profile in adipose tissue 
by increasing the recruitment of Treg cells. This small subset of CD4+ lymphocytes plays an 
important role in the control of inappropriate immune responses through a potent 
immunosuppressive role in inflammatory disorders [36]. Indeed, the immunomodulatory 
effects of Treg cells are based on the production of the anti-inflammatory cytokine IL-10, the 
modulation of the effector T cell response and the promotion of the anti-inflammatory M2 
macrophage phenotypic polarisation [37,38]. Thus, we can associate the significant increase 
in the Treg cell subset in the adipose tissues of CAF-fed rats, whose diets were 
supplemented with the combination of GSPE and DHA-OR, with the significant increase in 
IL-10 secretion and the anti-inflammatory phenotypic profile. Thus, the combination of these 
two biologically active compounds might improve anti-inflammatory effects through the 
promotion of Treg cell recruitment in adipose tissue [39]. 
Moreover, obesity has also been associated with the induction of immunological 
disturbances and an impairment of the immune system, both functionally and quantitatively. 
Thus, the impairment of immune function affects the responsiveness of primary and 
secondary lymphoid organs, including the thymus and spleen, to perturbations in 
homeostasis. Furthermore, obesity-induced quantitative impairment of immunity is 
evidenced as T lymphocytopenia, promoting a decrease in T lymphocytes, including both 
helper (CD4+) and cytotoxic (CD8+) T cells, in peripheral blood, spleen and thymus [40–42].  
Thus, the thymus is a primary lymphoid organ, vital for the homeostatic maintenance of 
immunity, associated with a central role in thymocyte differentiation and maturation into 
functional T lymphocytes [43]. Moreover, obesity accelerates thymic aging, characterised by 
compromising the generation of naïve T cells and the replacement of lymphoidstromal 
thymic zones with adipose tissue. Furthermore, diet-induced obesity reduces T cell 
repertoire diversity leading to immunosenescence [44,45]. Thus, considering the obesity-
induced impairment of thymus functionality, the results suggest that the CAF diet per se 
modulates thymus morphology, as reflected by the visual appearance of the thymus from 
CAF diet-fed rats, independently of supplementation with bioactive compounds, compared 
with STD diet-fed rats. This change in the morphology suggests that the CAF diet could 
promote thymus atrophy by increasing perithymic adipose tissue [44]. Furthermore, we 
assessed the immunomodulatory role of GSPE and DHA-OR, counteracting the obesity-
induced modulatory effects in terms of the morphology and functionality of the thymus. Thus, 
the supplementation of the CAF diet with the combination of GSPE and DHA-OR not only 
significantly increased the weight of the thymus but also increased the thymocyte counts. 
These results suggest that supplementation with these bioactive compounds promoted 
weight increase not only as a consequence of a CAF diet-induced ectopic fat accumulation 
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on the thymus [15], but rather might reflect increased thymocyte counts. However, GSPE 
supplementation also improved T cell maturation through the significant modulation of the 
expression of F4/80, a selective marker of macrophages, and the cytokine IL-10. Thus, 
whereas thymic macrophages are crucial in T cell maturation through the expression of the 
major histocompatibility complex molecules (MHC), whose recognition is the basis of T 
lymphocyte selection and maturation [46,47], IL-10 regulates T cell maturation; indeed, a 
decrease in IL-10 expression in the thymus is associated with T cell immunodeficiency [48]. 
Moreover, we characterised the immunostimulatory effects of GSPE, particularly in 
combination with DHA-OR, on improving thymus functionality through the induction of 
thymopoiesis as consequence of a greater pool of progenitor CD4+CD8+ T cells, 
counteracting the obesity-induced immunodeficiency state resulting from defects in T-cell 
generation in thymus [13,44]. 
The spleen is the largest secondary lymphoid organ involved in blood filtration, the regulation 
of the immune-metabolic-endocrine network, and the integration of innate and adaptive 
immune responses [49]. Thus, the proper functionality of the spleen is key for responses 
against homeostatic perturbations. Thus, bioactive food components, such as GSPE and/or 
DHA, significantly counteract the obesity-induced loss of splenic functionality. Notably, the 
GSPE and DHA-OR combination, increases spleen weight, but not splenocytes counts and 
improves the capacity of the splenocytes to appropriately respond to obesity-induced stimuli 
through the increased transcription of IL-6 and Tnf-α, as biomarkers involved in the reactivity 
against the presence of obesity-related systemic biomarkers [50]. Moreover, 
supplementation with bioactive compounds increases the number of infiltrated macrophages, 
which plays a key role in host immunity, linking innate and adaptive immune systems based 
on the recognition of harmful stimuli through the expression of a large variety of pathogen 
receptor molecules [51]. Furthermore, supplementing the CAF diet with these bioactives also 
modulated T cell subsets in the spleen, particularly inducing a slight increase in the total 
numbers of CD8+ T cell population and changing the relative proportion of helper and 
cytotoxic T lymphocytes. 
In addition, T cell counts within the PBMCs were also modulated through supplementation 
with bioactive compounds. The bioactive supplementation of the CAF diet with GSPE, alone 
or in combination with DHA-OR, resulted in increased counts of circulating PBMCs and CD4+ 
and CD8+ T cells.  Remarkably, the relative composition of the T cell subset in peripheral 
blood changed as a consequence of the increased frequency of CD8+ T lymphocytes. 
Notably, the bioactive-mediated stimulation of new T cell generation, associated with higher 
counts of CD4+CD8+ T lymphocytes in thymus, was reflected as an increase in the 
circulating pools of both CD4+ and CD8+ T lymphocytes, counteracting obesity-induced 
lymphopenia. 
Notably, the combination of GSPE and DHA-OR, considered as biologically active 
components, not only showed anti-inflammatory properties but also improved the 
immunostimulatory effects observed when these compounds were administered individually. 
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In addition, these results provide the first demonstration that the administration of both 
bioactive compounds potentiates the immunomodulatory effects of the individual 
administration of these compounds. Thus, the GSPE-DHA combination not only suppressed 
obesity-induced systemic inflammation but also inhibited obesity-triggered adipose tissue 
inflammation principally by promoting a switch in immune cells towards an anti-inflammatory 
phenotype, reflected as an increase IL-10 expression and Treg cell subpopulation. 
Furthermore, the GSPE-DHA combination also improved the functionality of lymphoid 
organs, including the thymus and the spleen, through the generation of new T lymphocytes 
and by improving the responsiveness to homeostatic perturbations. These results suggest 
that the supplementation of diet with the combination of procyanidins and DHA induces a 
healthy state through the promotion of the resolution of adipose tissue-driven inflammation 
and improvements in the ability to boost the obesity-induced weakened immune response.  
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ABSTRACT 
In the present study, we investigate the differential phenotypic response between Lewis 
(LEW) and Wistar Kyoto (WKY) inbred rats after a metabolic challenge based on the dietary 
energy density.  
Although the cafeteria (CAF) diet promoted higher weight gain, a consequence of the 
increase of energy intake, in both strains, we found that the metabolic management of this 
energy surplus was significantly affected by the genetic background. Detailed phenotypic 
profiling showed a strain-specific pattern of energy metabolism and modulation of the 
metabolites profiles in plasma, revealing that while LEW rats are a strain prone to diet-
induced obesity, WKY rats are resistant. 
Genome-wide gene expression analysis confirmed the different transcriptional response in 
the circulating monocytes of LEW and WKY rats. By comparing differentially expressed 
genes between CAF-fed LEW and WKY rats, we identified the Acss2 gene as key hub-gene 
within a network of highly co-expressed genes that were functionally enriched as nutrient 
sensors, the expression modulation of which could be underlying the phenotype. 
The phenotypic and transcriptional analyses also pointed to the leptin-signalling pathway as 
a divergent point between the strain-specific adaptations to diet. Our results revealed that 
LEW rats (genetically prone to diet-induced obesity) were resistant to the central effects of 
leptin receptor stimulation. On the other hand, in WKY rats (resistant to diet-induced obesity) 
the transduction of central and peripheral leptin signalling was not attenuated by the diet. 
These results were mirrored by the activation of STAT3 as a result of the down-regulation of 
hypothalamic Socs3 gene expression or primary Mir223 gene expression down-regulation in 
peripheral monocytes. 
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INTRODUCTION 
Obesity can result from the imbalance between the energy intake and expenditure and is 
associated with the development of an array of metabolic disorders collectively known as 
metabolic syndrome [1,2]. 
A prolonged excess of nutrient consumption results in the continuous saturation of the white 
adipose tissue’s ability to store energy as fat, triggering a cytokine-driven response 
characterised by the secretion of pro-inflammatory chemokines that underlie an obesity-
induced inflammatory response. Monocyte chemotactic protein-1 (MCP-1) is one of the most 
important adipokines due to its ability to recruit macrophages to the adipose tissue [3,4]. In 
addition, the continuous activation of the local inflammatory response underlies the chronic 
low-grade systemic inflammation that results in the widespread activation of the immune 
system [5]. Thus, white adipose tissue plays a key role in the regulation of metabolism, not 
only as the major site for energy storage but also as an endocrine organ that regulates the 
production of hormones such as leptin, indispensable for the regulation of immune and 
inflammatory responses [6–8]. Although the obesity-induced inflammatory response is 
triggered and takes place primarily in white adipose tissue, other organs are involved in 
obesity-induced inflammation. C-reactive protein (CRP) and orosomucoid are acute-phase 
proteins, which are produced mainly in the liver, and high circulating levels of CRP or 
orosomucoid are considered biomarkers of systemic inflammation and metabolic 
disturbances [9–12]. 
Leptin, a 16 kDa adipocyte-derived circulating cytokine, is produced in proportion to fat 
stores in order to regulate energy metabolism via its highly expressed cognate receptor in 
the central nervous system (CNS) [13]. In addition to its key role for the maintenance of 
energy homeostasis, leptin modulates both humoral and cell-mediated immunity, highlighting 
its pivotal role in linking nutritional status with the neuroendocrine and immune systems [14]. 
Leptin signalling is dependent on the presence of the long isoform of the leptin receptor 
(LerRb), which bears homology to members of the class I cytokine receptor (gp130) 
superfamily. Leptin stimulation activates the Janus-activated kinase (JAK)/signal transducers 
and activators of transcription (STAT) pathway, leading to the formation of a LepRb/JAK2 
complex that, after trans-phosphorylation, results in STAT3 activation and the induction of 
SOCS3 expression; SOCS3 in turn negatively regulates leptin signalling by phosphorylating 
JAK2 [15–17]. The diet-induced excessive intake of energy or fat deposition leads to the 
development of resistance to leptin through the attenuation of hypothalamic STAT3 
transcription factor activation by different molecular mechanisms, including an impaired 
transport of leptin across the blood-brain barrier or the presence of several negative 
regulators of leptin signalling, such as the protein-tyrosine phosphatase 1B (PTP1B), the 
tyrosine phosphatases SH2-containing protein tyrosine phosphatase-2 (SHP-2) or an 
enhanced expression of SOCS3, the negative feedback regulator of intracellular leptin 
signalling [18–20]. 
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The reciprocal interactions between the most important organs and tissues involved in 
metabolism and immune cells have been described as key events in the pathogenesis of 
obesity and its associated diseases [7]. Therefore, the threats to the dynamic crosstalk 
between metabolic regulation and the immune system that are promoted by obesity may 
endanger the maintenance of homeostasis [11]. Monocytes, the blood-circulating precursors 
of tissue-differentiated macrophages and dendritic cells, are powerful stress-sensing 
immune cells that play central roles in the regulation of the inflammatory and innate immune 
response through the release of inflammatory cytokines and in the activation of the adaptive 
immune response [21]. Monocytes are of particular interest because, as circulating immune 
cells, they are exposed to the systemic environment, including the metabolic factors and pro-
inflammatory cytokines produced and secreted by organs and tissues; therefore, the activity 
and expression profiles (i.e. transcriptomes) of monocytes may reflect the physiological state 
of the whole organism. 
The susceptibility to obesity has an established underlying genetic component, but 
environmental influences, such as dietary effects, may be required to induce its 
manifestation [22–27]. Furthermore, although the interactions between genes and the 
environment that are associated with the development of obesity are not fully understood, 
the fact that some inbreed strains are susceptible to diet-induced obesity, whereas other are 
resistant, suggests that the genetic background contribute to the variability in obesogenic 
phenotypes between individuals [28–31]. Although different obesity models have been used 
to understand the genetic factors that underlie the regulation of energy homeostasis, diet-
induced obesity models, such as the cafeteria diet (CAF)-induced obesity, are considered to 
be a robust model of the human metabolic syndrome and its related pathologies [32]. In a 
CAF diet, obesity is induced as consequence of hyperphagia resulting from the voluntary 
intake of highly palatable and energy-dense cafeteria-style foods present in Western-type 
diets instead of the standard chow [32]. Taking into account the distinct genetic background 
of inbred rat strains (phenotypically different) such as Lewis (LEW) and Wistar Kyoto (WKY) 
rats, and using the CAF diet-induced obesity model in these rats, both genetic and 
environmental factors can be controlled, providing a powerful tool for understanding the 
interactions between the genotype and the environment that underlie the development of 
complex traits such as metabolic syndrome. These inbred strains have been widely studied 
for their differential susceptibility to experimental glomerulonephritis through macrophage 
activation [33,34] and present a markedly distinct macrophage transcriptome, which result in 
differential macrophage activation [35,36]. 
Here, we studied the phenotypic and transcriptional responses of LEW and WKY rats, in 
response to CAF diet in order to determine the “gene-diet” interactions, focusing specifically 
on whole genome expression profiles in the circulating monocytes of these rats. We found 
that although the CAF diet promoted higher energy intake and weight gain for both strains, 
the metabolic and transcriptional management of this excess of energy was significantly 
influenced by the genetic background. 
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MATERIALS AND METHODS 
Animals and experimental design 
Male LEW (LEW/Crl) and WKY (WKY/NCrl) (Charles River, Margate, UK) rats, weighing 190 
g and 130 g, respectively, were housed individually in a 22 ºC temperature-controlled room 
with a 12-h light/dark cycle. After an adaptation period, rats from each strain were randomly 
distributed into two experimental groups (n=5) and fed with either a standard chow diet 
(STD) (Panlab, Barcelona, Spain) or a cafeteria diet (CAF) composed of bacon, biscuits, 
pate, muffins, carrots, and milk with sugar for seven weeks. The daily total energy and 
distribution of the diets are described in Table 1.   
Table 1. Total energy and diet composition. 
 Standard diet Cafeteria diet 
Energy Intake (Kcal/day) 2.9 7.5 
    Protein (% energy) 21.7 10.4 
    Carbohydrate (% energy) 66.2 38.6 
     Fat (% energy) 9.6 50.8 
 
After seven weeks of the indicated diet, the rats were fasted for 9 h and euthanised by 
exsanguination under anaesthesia. Blood was collected from abdominal aorta, and 
circulating monocytes were immediately isolated. The liver, hypothalamus, thymus, spleen 
and white adipose tissue depots (mesenteric, epididymal and perirenal) were rapidly 
removed, weighed, frozen in liquid nitrogen and stored at -80 ºC until analysis. All the 
procedures were performed with the approval of the Animal Ethics Committee of the 
Universitat Rovira i Virgili (Tarragona, Spain).   
Measurement of adiposity and body weight gain 
The effects of diet on body weight gain were determined by weekly measuring the weight 
difference between the current week and those weights measured at the beginning of the 
experiment. In this way, the effect of the different morphology of LEW and WKY rats was 
avoided. The adiposity index was computed at the end point as the sum of the weight of 
mesenteric, epididymal and perirenal fat pads and expressed as a percentage of total body 
weight. 
Food intake 
The rats were housed individually in metabolic cages for 48 h, and their food intake was 
assessed in week 5 of the experiment based on a measurement of the feeding pattern for 
each animal. The total energy intake and the contribution of each macronutrient to the total 
intake were normalised to the metabolic mass. 
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Energy metabolism 
The energy metabolism components were measured, in at least 3 rats per group, using an 
indirect open-circuit calorimeter (Panlab Harvard Apparatus, Barcelona, Spain). The oxygen 
consumption (VO2) and carbon dioxide production (VCO2) of the rats were monitored 
simultaneously every 10 min in two metabolic chambers during the first 200 min of the 
postprandial period. The respiratory quotient was calculated from gas exchange 
measurements (RQ=VCO2/VO2), and the substrate oxidation values were calculated as 
previously described [37,38].  
Measurement of biochemical parameters in plasma 
After sacrifice, blood was collected, and heparinised plasma was obtained by centrifugation 
and stored at -80 ºC until analysis. Triglycerides and glucose levels were measured by 
enzymatic colorimetric methods (QCA, Barcelona, Spain). The concentration of β-
hydroxybutyrate was determined using an ELISA kit provided by BEN (Milano, Italy), the 
non-esterified free fatty acid ELISA kit was purchased from WAKO (Neuss, Germany), the 
commercial kit for the determination of leptin was provided by EMD Millipore (Darmstadt, 
Germany), and the ELISA kits used to measure the plasma concentrations of MCP-1 
(Abcam, Cambridge, USA) and Orosomucoid were purchased from GenWay (San Diego, 
USA). 
Quantitative RT-PCR 
Total RNA from the liver, mesenteric fat depot and hypothalamus was isolated using TRIzol 
reagent according to the manufacturer’s instructions (Invitrogen, Barcelona, Spain) and 
purified with RNeasy Mini Kit spin columns (Qiagen). cDNA was generated by reverse-
transcription from total RNA using the reverse transcription reagent kit (Applied Biosystems, 
Madrid, Spain) and was subjected to RT-PCR amplification using SsoFast EvaGreen 
SuperMix (Bio-Rad). Relative gene expressions were normalised according to the cyclophilin 
peptidylprolyl isomerase A (Ppia) mRNA levels. The forward and reverse primers used for 
the different genes are described in Supplementary Table S1. The relative gene expression 
was normalised to the Ppia mRNA levels using the 2-ΔΔCt method. 
Isolation of circulating monocytes, RNA extraction and microarray preparation 
Peripheral blood mononuclear cells (PBMCs) were isolated by density-gradient 
centrifugation using HISTOPAQUE-1083 solution (SIGMA, Madrid). Monocytes were purified 
based on their adherence to plastic in serum-free RPMI-supplemented medium. Thus, after 
90 min, the non-adherent cells were removed by several washes with warm PBS, and the 
total RNA from the adherent monocytes was extracted using the TRIzol reagent according to 
the manufacturer’s instructions (Invitrogen, Barcelona, Spain) and purified using RNeasy 
microkits (Qiagen). The quality of total RNA isolated was determined using the Agilent 2100 
Bioanalyser. The RNA Integrity Number (RIN) of RNA ranged from 9.10-10. One hundred 
and fifty nanograms of total RNA was amplified, labelled and hybridised to Rat Gene 1.0 ST 
arrays (Affymetrix, Santa Clara, CA, USA) using the Ambion WT Expression kit (Life 
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Technologies) according to the manufacturer’s instructions. The Affymetrix Rat Gene 1.0 ST 
arrays contain a subset of microRNA specific probes that align to the stem loop sequences 
allowing the analysis of the precursor forms of microRNA. 
Microarray analysis of differential gene expression 
The data from microarrays were normalised using the robust multi-array average (RMA) 
method [39], implemented in the Affymetrix Bioconductor package, and the differentially 
expressed genes were determined using the linear model implemented in the limma 
Bioconductor package. The Benjamini and Hochberg method was used to adjust P-values 
for multiple testing and control of the false discovery rate. Gene Ontology (GO) terms and 
Kyoto Encyclopedia of Genes and Genomes (KEGG) pathways analysis was performed 
using the GOstats Bioconductor package [40]. 
Gene co-expression network 
A gene co-expression network was constructed from the gene expression profiles of the 
transcripts whose expression was differentially modulated (absolute fold change >1.5) when 
comparing the expression profiles of circulating monocytes from CAF diet-fed WKY and 
LEW rats. The co-expression network was inferred using a graphical Gaussian model 
(GGM) implemented in the R package GeneNet [41]. Briefly, a partial-correlation matrix was 
estimated by computing the partial correlation between the expression profiles of each gene 
pair. Bayesian posterior edge probability >0.95 (corresponding to a local false discovery rate 
<5%) was used to determine the significance of the resulting pairwise partial correlations. In 
the resulting co-expression network the nodes represent the set of genes that were 
differentially expressed and co-expressed between WKY and LEW rats, and the edges link 
the pairs of genes whose expression is not conditionally independent, defined as the 
pairwise partial correlation once the common effects of the other genes in the subset are 
removed [42]. To identify sub-clusters (modules) within the network we used the MCODE 
algorithm implemented in the clusterMaker plugin [43] of Cytoscape software [44], and the 
modules were functionally annotated with GO terms and KEGG pathways using the GOstats 
Bioconductor package [40]. The selected clusters were analysed using the cyto-Hubba 
plugin [45] to determine the hubs and bottlenecks that represent the key regulatory genes 
within the network. 
Statistical analysis 
The phenotypic data are expressed as the mean ± SEM. Strain and diet specifics effects 
(represented by a hash tag or an asterisk, respectively) were assessed using ANOVA or 
Student’s t-tests, as appropriate. Differences were considered to be significant when the p-
values were < 0.05. These calculations were performed using SPSS 17.0 software. 
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RESULTS 
The cafeteria diet promotes voluntary hyperphagia and weight gain but a differential 
profile of adiposity in LEW and WKY rats 
To investigate the role of the genetic background on the phenotypic response to a diet-
induced obesity, two inbred rat strains, LEW and WKY, were fed with a cafeteria diet (CAF) 
for 7 weeks. The rats were allowed free access to highly palatable and energy-dense foods 
in addition to standard chow; animals of both genotypes showed significantly increased body 
weight in response to the CAF diet (Figure 1A and 1B). 
This weight gain was accompanied by a significant increase in the total energy intake 
resulting from voluntary hyperphagia (Figure 1C). Regarding the distribution of energy 
obtained from food intake macronutrient, the cafeteria diet-induced enhance of energy intake 
was mainly due to a substantial increase in fat intake (Figure 1D). In addition, although the 
data were normalised to the metabolic weight, no differences were observed between the 
caloric intake of LEW and WKY (Figure 1E and 1F). When comparing the effects of the 
cafeteria diet on the contribution of each macronutrient to the total energy intake, the 
percentage of calories from fat intake shifted from the least important to the most important 
energy source, independent of the genetic background (Figure 1G and 1H). 
Although the cafeteria diet caused no significant differences in carbohydrate intake, we 
observed that WKY rats fed with either standard chow or the cafeteria diet ingested 
significantly fewer carbohydrates than LEW rats under the same metabolic conditions. 
Furthermore, when comparing the effects of CAF on body composition with respect to the 
standard diet (STD)-fed rats (Table 2), no significant strain differences were found for liver 
weight, however an increase in kidney weight was observed for CAF-fed WKY rats in 
comparison to the STD-fed rats. The CAF diet promoted an increase in thymus weight for 
both strains but did not affect spleen weight. Moreover, CAF-fed LEW and WKY rats showed 
greater adipose accumulation than the STD-fed rats. Therefore, even though the weights of 
the most relevant fad pads were increased equally for LEW rats, the WKY rats showed a 
different profile of adiposity: the CAF diet induced significant increases in adiposity only in 
the epididymal and perirenal fat pads but not the mesenteric fat pads. 
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Figure 1. Body weight and food intake pattern in response to the STD and CAF diets. (A and B) Body 
weight gain changes in STD- and CAF-fed LEW and WKY rats, respectively. (C, D, G and H) The measured 
total energy intake and the energy intake from fat, protein and carbohydrates, respectively. (E and F) The 
distribution of the macronutrient intake based on the food consumption in STD- and CAF-fed LEW and WKY 
rats, respectively. *P<0.05 between the rats fed with the STD diet and the CAF diet within each strain, 
defined as the diet effect 
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Table 2. Cafeteria diet effect on adiposity and organs weight. 
 LEW WKY 
 Lean Cafeteria Lean Cafeteria 
Metabolic organs     
     Liver weight (g) 11.09 ± 0.43 12.35 ± 0.32 7.16 ± 0.17 8.28 ± 1.55 
     Kidneys weight (g) 2.85 ± 0.05 2.97 ± 0.08 1.99 ± 0.07 2.47 ± 0.07 
     
Immune-involved organs     
     Spleen weight (g) 0.76 ± 0.06 0.63 ± 0.03 0.61 ± 0.02 0.59 ± 0.05 
     Thymus weight (g) 0.46 ± 0.02 0.58 ± 0.03 0.27 ± 0.01 0.44 ± 0.03 
     
White adipose tissue depots     
     Mesenteric fat (g) 3.93 ± 0.38 7.95 ± 0.47 * 2.27 ± 0.18 3.78 ± 0.49 
     Epididymal fat (g) 3.53 ± 0.16 11.32 ± 1.56 * 3.22 ± 0.07 6.98 ± 0.57 * 
     Perirenal fat (g) 4.98 ± 0.37 11.37 ± 1.01 * 4.29 ± 0.31 8.96 ± 0.41 * 
     Adiposity index (%) 3.05 ± 0.13 7.42 ± 0.64 * 3.40 ± 0.13 5.99 ± 0.25 * 
 
Energy metabolism response to cafeteria diet is genotype dependent in the rat 
To investigate the effects of cafeteria diet-induced overfeeding on the postprandial energy 
metabolism response, we determined the energy expenditure, metabolic rate and fuel 
oxidation in LEW and WKY rats. 
An increase in energy expenditure was observed during the earliest times of postprandial 
phase independent of the genetic background and diet; this increase was greater and more 
sustained for LEW (STD and CAF) rats (Figure 2). Although the energy expenditure of CAF-
fed LEW rats was higher than that of the corresponding STD-fed rats at some specific time 
points, no significant differences were observed for the postprandial energy expenditure, 
determined as the area under the curve (AUC) (Figure 2A). In contrast, for WKY rats, the 
CAF diet induced a shorter but greater increase in energy expenditure compared to the STD 
diet, and this expenditure remained high during most of the postprandial state. This resulted 
in a significant CAF-induced increase in the energy expenditure of WKY rats, measured as 
the AUC during the postprandial state (Figure 2B). 
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Figure 2. Postprandial metabolic responsiveness to diet. Energy expenditure, RQ and substrate 
oxidation were determined based on gaseous exchange measured by indirect calorimetry during the first 200 
min of the postprandial period in STD- and CAF-fed LEW and WKY rats. (A and B) The energy expenditure 
for LEW and WKY rats; the inset graphs correspond to the area under the curve (AUC) measured during the 
200 min recorded. (C and D) The respiratory quotients of LEW and WKY rats, respectively, calculated using 
the quotient VCO2/VO2. (E and F) Carbohydrate oxidation in response to the diet challenge (STD or CAF 
diets) for LEW and WKY rats. (G and H) Fat oxidation during the postprandial state after the consumption of 
the STD or CAF diet in LEW and WKY rats. *P<0.05 vs. STD diet-fed rats within each strain (diet effect). 
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The metabolic rate measured as the respiratory quotient (RQ) showed similarly a difference 
in the energy metabolism pattern between LEW and WKY rats. Although STD-fed LEW rats 
maintained a RQ around of 1.0-1.1, which can be associated primarily with carbohydrate 
oxidation and endogenous fatty acid synthesis (Figure 2C) (as expected from the 
predominance of carbohydrates as the main substrate source (Figure 2E) instead of the 
oxidation of fat (Figure 2G)). However the RQ determined in STD-fed WKY rats was lower 
when comparing with STD-fed LEW rats and significantly greater for most measured times 
than in CAF-fed WKY rats (Figure 2D). The RQ of STD-fed WKY rats suggested that fat is 
the principal fuel for energy production (Figure 2H) instead of carbohydrates (Figure 2F), 
indicating that the energy metabolism pattern of STD-fed WKY rats differed with respect to 
that observed in STD-fed LEW rats. The CAF-fed LEW and CAF-fed WKY rats showed a RQ 
of approximately 0.70 (Figure 2C and D), suggesting that CAF-diet promotes fat oxidation 
rather than carbohydrate oxidation (Figure 2E and F) as the most important fuel energetic 
source (Figure 2G and H). 
The profile of diet-induced circulating metabolites is genotype-dependent in the rat  
The phenotypic response to the cafeteria diet in LEW and WKY rats was assessed by 
determining the plasma levels of several metabolites previously described as biomarkers of 
metabolic homeostasis (see Methods).  
Genotype-dependent differences were observed for the modulation of plasma levels of 
obesity-related biomarkers in the rat. Notably, although CAF induced a significant increase in 
the plasma levels of glucose, triglycerides, NEFAs, β-hydroxybutyrate and MCP-1 in LEW 
rats, no similarly strong induction was observed on the plasma levels of these biomarkers in 
WKY rats (Figure 3A-C and 3F). Furthermore, LEW rats showed higher circulating levels of 
NEFAs with both analysed diets, whereas the glucose and triglyceride levels were only 
significantly higher when comparing CAF-fed LEW and WKY rats. Moreover, the β-
hydroxybutyrate and the orosomucoid plasma levels of STD-fed WKY rats were higher than 
those of CAF-fed WKY rats and were also significantly higher than those of STD-fed LEW 
rats. 
The plasma leptin concentration was enhanced by the cafeteria diet, and although the diet-
induced hyperleptinaemia was independent of the genetic background, the leptin 
concentrations were, for the different proposed diets, significantly higher for LEW rats than 
for WKY rats (Figure 3E). 
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Figure 3. Circulating levels of the biomarkers involved in dietary responsiveness. The plasma 
concentration of glucose (A), triglycerides (B), NEFAs (C), β-Hydroxybutyrate (D), leptin (E), MCP-1 (F) and 
orosomucoid (G) were measured in STD- and CAF-fed LEW and WKY rats. The data represent the mean ± 
SEM. *P<0.05 between the rats fed with the STD diet and the CAF diet within each strain (the diet effect), 
#P<0.05 between the rats from the two strains fed with the same diet (STD or CAF; the strain effect). 
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The effect of diet on monocytes gene expression is genotype dependent in the rat  
Once we determined that LEW and WKY responded phenotypically differently to diet-
induced obesity challenges, we set out to investigate genome-wide the transcriptional 
response to diet in these strains. To explore the genes and pathways that underlie the 
metabolic-immunological crosstalk of the differential phenotypic response we carried out 
gene expression profiling of circulating monocytes from STD- and CAF-fed LEW and WKY 
rats. Microarray data were analysed in two ways. First, we compared the monocyte 
expression profiles of CAF-fed WKY and LEW rats in order to identify the genes that underlie 
the strain-dependent adaptation to diet-induced obesity. Second, we analysed the strain-
specific modulation of the transcriptome of circulating monocytes by the CAF diet.   
The expression profiles of circulating monocytes from WKY and LEW CAF-fed rats were first 
compared in order to determine the genetic basis of the strain-dependent response to 
obesity. This analysis identified 8,479 transcripts that were nominally differentially expressed 
(p<0.01) between the circulating monocytes from CAF-fed WKY and LEW rats; 75.5% of 
these transcripts were more highly expressed in WKY rats than in LEW rats (Supplementary 
Table S2). We prioritized a set of 29 transcripts that were significantly differentially 
expressed after correction for multiple testing (FDR <5%) and with fold change (FC) > 5 
when comparing the expression profiles from WKY and LEW rats (Figure 4A). This subset of 
highly differentially expressed transcripts included macrophage activation 2 like (Mpa2l), a 
target gene of nuclear factor-κB (NF-κB) [46], that was 26-fold up-regulated in WKY and 
lactate dehydrogenase A (Ldha), the gene encoding for the enzyme that catalyses the 
conversion of lactate to pyruvate during the glycolysis under anaerobic conditions in LEW 
rats (down-regulated in WKY with a fold change of -60.95). Furthermore, 6 of the 29 
transcripts with high differential expression between WKY and LEW (Klra7, Irg1, Ly49si1, 
Plk2, Rnd3, Lilrb3l) were also identified previously as differentially expressed transcripts 
comparing the untreated bone marrow-derived macrophages of WKY and LEW rats [35]. 
 
 
 
Figure 4. Gene expression profile of circulating monocytes from STD- and CAF-fed LEW and WKY rats. (A) 
Strain-specific differentially expressed genes. Transcripts with more than 5-fold differences between CAF-fed 
WKY and LEW rats are shown; the red bars correspond to the transcripts that are overexpressed in WKY 
rats, and the green bars indicate the transcripts that are overexpressed in LEW rats. The full list of the 
differentially expressed genes is included in Supplementary Table S3. (B) Effect of the CAF diet on the gene 
expression profile of circulating monocytes from WKY rats. The full list of differentially expressed genes is 
given in Supplementary Table S8. (C) The effect of the CAF diet on the gene expression profile of circulating 
monocytes from LEW rats. The full list of differentially expressed genes is given in Supplementary Table S7. 
(D and E) A summary of the over-represented Gene Ontology Categories based on a Gene Set Enrichment 
analysis of the differentially expressed genes between CAF-fed WKY and LEW rats. The complete list of 
significantly over-represented terms is given in Supplementary Table S4. 
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To gain insights into the molecular processes and pathways underlying these transcriptional 
responses, we analysed a larger set of 954 transcripts that were more than 1.5 up- or down-
regulated in CAF-fed WKY rats compared with CAF-fed LEW rats for enrichment of gene 
ontology (GO) terms. The GO terms were manually curated to remove redundant categories 
resulting from overlapping gene sets (Supplementary Table S3), and the most relevant terms 
that were significantly over-represented are shown in Figure 4D and E. The overexpressed 
genes in CAF-fed WKY rats were enriched for terms related to the activation of the 
inflammatory and immune responses resulting from the up-regulation of classical 
inflammatory mediators such as interferon gamma (Ifng, FC = 2.43), tumour necrosis factor 
(Tnf, FC = 2.11), nitric oxide synthase 2 (Nos2, FC = 1.68), interleukins (IL) including IL1a 
(FC = 2.66), IL6 (FC = 2.41), IL12a (FC = 2.34), IL18 (FC = 1.96) and IL23a (FC = 3.45) as 
well as genes involved in the regulation of eicosanoid production such as the gene encoding 
for cyclooxygenase 2 (prostaglandin-endoperoxide synthase 2 or Ptgs2, FC = 2.71) and the 
gene encoding the 5-lipoxygenase (arachidonate 5-lipoxygenase or Alox, FC = 2.70). 
Moreover, the overexpressed genes were also enriched for terms related to the positive 
regulation of the JAK-STAT cascade, specifically via the promotion of the tyrosine 
phosphorylation of STAT3. Nevertheless, the genes that were under-expressed in CAF-fed 
WKY rats compared to CAF-fed LEW rats were significantly enriched for very few gene 
ontologies, highlighting the functional gene enrichment in the immune system.  
We then investigated gene regulatory networks using the gene expression profiles assessed 
in circulating monocytes (see Methods). In order to identify individual genes and the gene 
clusters whose co-regulation underlie the strain-specific responses to diet, gene co-
expression networks were inferred based on the differentially expressed transcripts that 
showed a fold change greater than 1.5, independent of the direction of modulation between 
the circulating monocytes from CAF-fed WKY and LEW rats (Figure 5A).  
 
 
 
Figure 5. The gene co-expression network of the genes that are differentially expressed in CAF-fed 
WKY and LEW rats. (A) A simplified representation of the network and the MCODE-based clusters; detailed 
information on the genes within each cluster is shown in Supplementary Figure S1. Cluster number 2, 
significantly enriched as nutrient sensor, is highlighted, and the significantly over-represented Gene Ontology 
categories from the selected sub-cluster are shown. The edge shape is related to the direction of the partial 
correlation; the continuous lines represent partial positive correlations, and dotted lines refer to partial 
negative correlation. The node colour represents the fold change between the expression of the 
corresponding transcript in CAF-fed WKY and LEW rats; red nodes correspond to genes that are 
overexpressed in WKY rats, and green nodes correspond to genes that are overexpressed in LEW rats. The 
highlighted node within cluster 2 represents a high-scoring differentially expressed gene. (B) Functional 
enrichment analysis of the MCODE-based co-expressed gene clusters. Significantly over-represented GO 
terms and KEEG pathways within each cluster are represented.  
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The resulting network is composed of a single connected component formed by 742 protein-
coding genes linked by 8,215 edges. We then used the molecular complex detection 
(MCODE) cluster algorithm [47] to extract functional modules of densely interconnected 
genes. The biological relevance of the genes included in each of the 16 MCODE-derived 
clusters (the clustered genes are reported in Supplementary Figure S1) was tested with GO 
and the KEGG [48] analysis of the functional significance of biochemical pathways (Figure 
5B). Although not all of the modules were enriched significantly for GO terms or KEGG 
pathways, the genes in cluster 2 (representing 40 annotated protein-coding genes), were 
functionally enriched for nutrient sensors (P-value = 2.94×10-4), responders to hormone 
stimuli (P-value = 1.90×10-3), and components of the NOD-like receptor signalling pathway 
(P-value = 6.84×10-3). Topology analysis of cluster 2 identified the Acyl-CoA synthetase 
short-chain family member 2 (Acss2) as the most important hub within the cluster, that is the 
gene with the largest degree and the highest betweenness score within the cluster. The 
functional relevance of Acss2 as regulator of nutrient sensing was initially investigated by 
analysing the overlap of Quantitative Trait Loci (QTLs) within the region encoding for the 
Acss2 gene using previous QTL mapping results from the Rat Genome Database [49]. This 
analysis revealed that within the 29 overlapping QTLs, 8 are related to traits associated with 
the regulation of the metabolism, including a body weight QTL (Bw94), a glucose level QTL 
(Gluco39) and a serum leptin concentration QTL (Slep7) (Supplementary Table S4). 
Furthermore, we determined the association between the mRNA expression of Acss2 in 
peripheral monocytes and metabolism-related traits (Supplementary Table S5), and found 
significant negative correlations between the expression of Acss2 and the plasma levels of 
glucose (r = -0.71), triglycerides (r = -0.68), leptin (r = -0.61) and NEFAs (r = -0.61) and with 
the total fat (r = -0.59) and body weight (r = -0.59). Furthermore, a topological analysis inside 
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this nutrient sensing gene cluster revealed a functional sub-module consisting of 9 highly co-
expressed genes; all of these nodes were overexpressed in CAF-fed WKY rats compared to 
the LEW-fed rats and significantly enriched for inflammatory response genes and genes that 
function in response to lipid and glucocorticoid stimuli. 
We also determined the effects of diet on the monocyte gene expression profile from LEW 
and WKY rats (Figure 4C and 4B, respectively). We determined that the phenotypic 
response of LEW rats to the CAF diet resulted in moderate changes in monocyte gene 
expression, and although 228 transcripts were differentially up-regulated and 195 transcripts 
were significantly down-regulated (FDR<5%), the magnitude of gene expression modulation 
by the diet was moderate (Supplementary Table S6). Gene ontology and KEGG analysis of 
these differentially expressed transcripts did not show significant enrichment for obvious 
obesity-related pathways. In contrast, the modulation of the circulating monocyte expression 
profile by CAF diet in the WKY rats resulted in the diet-induced up-regulation of 483 
transcripts and the down-regulation of 449 transcripts (Supplementary Table S7). Amongst 
the CAF diet-induced differentially expressed genes in WKY rats we identified the down-
regulated Mir223. miR-223, the mature form of Mir223, directly targets STAT3 to regulate its 
activation [50]. Functional enrichment analyses showed that the up-regulated transcripts 
were significantly enriched for the Wnt signalling pathway among other non-obesity-related 
pathways, while the genes that were down-regulated by the CAF diet were functionally 
enriched for the peroxisome proliferator-activated receptor (PPAR) signalling pathway. 
WKY, unlike LEW rats, are not susceptible to diet-induced leptin resistance 
The results obtained regarding the phenotypic and transcriptional response to diet-induced 
obesity between LEW and WKY rats pointed to the diet-induced modulation of leptin and its 
signalling pathway as a possible divergent point between the two strains. To analyse the role 
of leptin in the differential phenotypic response to the cafeteria diet in LEW and WKY rats, 
the relationship between circulating leptin levels and metabolic-related traits was determined 
by means of correlation analysis (using non-parametric Spearman Rank Correlation 
coefficient). 
In LEW rats, positive significant correlations were observed between plasma leptin levels 
and the main morphometric parameters related to the induction of leptin secretion, such as 
energy intake, body weight and the adiposity index. Furthermore, a strong correlation was 
observed between the plasma leptin levels and triglycerides (Supplementary Table S8). 
Significant relationships between circulating leptin levels and the measured energy intake 
levels, body weight, adiposity and the expression of Lep in the mesenteric fat pad were also 
observed in WKY rats. However, non-significant correlations were observed between leptin 
levels and the plasma concentrations of triglycerides and glucose, respectively 
(Supplementary Table S8), suggesting strain-dependent relationships with secreted leptin in 
the rat. 
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Figure 6. The expression of key genes involved in the regulation of leptin signalling. Gene expression 
was measured by RT-PCR. (A) The effect of the CAF diet on leptin gene expression in mesenteric fat pads 
from LEW and WKY rats. (B) The effect of diet on the expression of leptin receptor B, Socs3 and C-reactive 
protein in the liver. (C) The effect of diet on the hypothalamic regulation of leptin receptor B and Socs3 gene 
expression in LEW and WKY rats. *P<0.05 between the rats fed with the STD diet and the CAF diet within 
each strain (diet effect). (D and E) Association between leptin and biomarkers related with the development 
and progression of obesity. The network of significant non-parametric Spearman correlations (P<0.05) 
between the circulating leptin levels and morphometric parameters, food intake-related values, circulating 
metabolites and the expression of the genes involved in leptin signalling in LEW and WKY rats, respectively. 
The node colour represents the fold change between the levels of the corresponding parameter in CAF and 
STD-fed LEW and WKY rats; red nodes correspond to parameters that are up-regulated by CAF diet. The 
edge colour represents the significant Spearman correlation relationship. 
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The effects of genotype on the central and peripheral regulation of diet-induced 
leptin signalling 
To assess whether the differential phenotypic response to diet-induced obesity in LEW and 
WKY rats was a consequence of a differential regulation of the leptin signalling pathway 
genes, the expression of key genes involved in the regulation of leptin signal transduction in 
metabolically active organs, including the mesenteric fat pad, the hypothalamus and the liver 
were measured. 
While rats of both genotypes react to cafeteria diet by inducing the expression of leptin (Lep) 
in the mesenteric fat pad (Figure 6A), we found different expression patterns of the genes 
involved in the transduction of leptin signalling in the hypothalamus (Figure 6B) and liver 
(Figure 6C). While no diet-induced effects were observed for the gene expression of leptin 
receptor B (LepRb), the modulation of Socs3 gene expression was inversely modulated by 
the cafeteria diet in LEW and WKY rats (Figure 6B). Therefore, the CAF diet promoted an 
increase in Socs3 gene expression in LEW rats and a strong inhibition of Socs3 gene 
expression in WKY rats. 
Furthermore, the diet-induced modulation of leptin receptor B gene expression in the liver 
was also opposite for LEW and WKY rats; in LEW rats, the gene expression of LepRb was 
up-regulated, and in WKY rats, it was not (Figure 6C). Nonetheless, although Socs3 gene 
expression in the liver was down-regulated by the CAF diet in both strains, this inhibition was 
only significant in LEW rats. The CAF-mediated modulation of Crp gene expression in the 
liver was also determined as a biomarker of diet-induced inflammation. The gene expression 
of Crp was only significantly up regulated by the CAF diet in LEW rats. 
Finally, when comparing the significant relationships between plasma leptin levels and the 
measured metabolic traits, different diet-specific and genotype-specific effects were 
observed (Figure 6D and 6E). Strong relationships were observed between circulating leptin 
levels and the measured levels of energy and fat intake, final body weight, weight gain, the 
expression of Lep in mesenteric fat and the expression of Socs3 in liver for both genetic 
backgrounds, suggesting that diet is the main modulator of these effects. However, the 
relatively high correlations observed between plasma leptin levels and thymus weight, 
carbohydrate intake, the expression of Socs3 in the hypothalamus and the circulating levels 
of triglycerides and MCP-1 in LEW rats and the correlation between plasma leptin and β-
hydroxybutyrate and kidney weight in WKY rats suggest strain-specific effects. 
DISCUSSION 
In the present study, we showed the differential genotypic and phenotypic response of two 
homogeneous genetic backgrounds, LEW and WKY rats, subjected to a metabolic challenge 
based on dietary energy density. We show that the CAF diet resulted in an increase in 
weight gain due to diet-induced hyperphagia and to the hedonic preference for fat intake, 
reflected primarily in the increased adiposity, independent of the strain.  
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Despite the fact that both genetic backgrounds showed hyperphagia and changes in body 
composition in response to the CAF diet challenge, the postprandial energy metabolism 
pattern and the peripheral substrate utilisation were different for both strains. The CAF diet-
induced body weight increase of LEW rats was supported not only by the increase in the 
energy intake but also by the maintenance of the energy expenditure, as well as by the 
switch to fat instead of carbohydrates as the primarily oxidation source to obtain energy. 
This pattern of energy metabolism is consistent with the typical energetic response, which 
was previously observed in outbred rats in response to a CAF diet [51,52]. On the other 
hand, the lower metabolic rate observed in STD-fed WKY rats may be attributed to an 
ineffective use of carbohydrates as the major energy substrate, resulting instead in the β-
oxidation of fatty acids as the principal fuel source. In fact, some degree of carbohydrate 
intolerance had been reported previously for lean WKY rats, although in that occasion rats 
were still not fully inbred [53,54]. Furthermore, the very high levels of circulating β-
hydroxybutyrate, one of the main ketone bodies produced by the liver, determined in the 
plasma of STD-fed WKY rats supported this non-predominant oxidative glucose utilisation 
[55,56]. Moreover, the disparity observed between the circulating levels of ketone bodies in 
STD- and CAF-fed WKY rats may be an indication that the source of the dietary 
carbohydrates plays a key role in carbohydrate metabolism, as has been previously 
described for other rat strains [57]. Therefore, although no effect of diet on the amount of 
carbohydrate intake was observed, the complexity of the major carbohydrate form found in 
each type of diet was different. Thus, while the main carbohydrate found in the STD diet was 
starch, a polysaccharide, the most abundant carbohydrate found in the CAF diet was the 
sucrose, a disaccharide.  
Plasma metabolic profiling also corroborated the disparity in the phenotypic response to CAF 
diet of both genetic backgrounds. Thus, while CAF diet challenge induced hyperglycaemia 
and hypertriglyceridaemia in LEW rats, no effect of diet was observed in WKY rats. 
Furthermore, although the expansion of the adipose tissue was observed as an increase in 
leptin circulating levels independent of the genetic background, the downstream response to 
this diet-induced hyperleptinaemia was strain-specific. Therefore, in LEW rats, the strong 
relationship between plasma leptin levels and the nutritional status-associated traits, 
including the food intake, adiposity and plasma triglycerides, may be associated with the 
metabolic phenotype resulting from central leptin resistance, a pivotal event underlying the 
development of obesity and its associated dysfunctions [58]. Nevertheless, although the 
secreted leptin levels showed close relationships with diet-induced traits involved in the 
upstream regulation of leptin signalling such as food intake and adiposity in WKY rats and 
the same pattern was observed in LEW rats, the metabolic traits that were influenced by the 
regulation of leptin signalling, such as triglycerides plasma levels, did not respond to a diet-
induced increase in adiposity in the same way as leptin; in other words, in WKY rats, the 
diet-induced hyperleptinaemia was not reflected in an impairment of lipid metabolism. This 
finding can have important implications because of the role of leptin as an integral endocrine 
regulator of energy metabolism. Therefore, our data suggest continuous functional 
interactions between the leptin axis and other metabolic pathways, including the lipid 
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metabolism pathway. Leptin is involved, among other functions, in fat storage regulation and 
in the modulation of the glucose metabolism independent of its effects on energy balance, 
mediated by its underlying mechanisms as the regulator of fatty acid β-oxidation [59,60] or 
controller of peripheral tissue insulin sensitivity [61]. 
The diet-induced modulation of the inflammatory response was also strain-specific. Whereas 
the overfeeding-induced obesity promoted inflammation in LEW rats, as reflected by the 
increase in fat-derived MCP-1 circulating levels and the overexpression of Crp in liver (both 
believed to be robust biomarkers of diet-induced inflammation), the inflammatory response 
was not induced by diet in WKY rats. A physical interaction between CRP and leptin in 
plasma has been hypothesised; this interaction has been proposed to spatially impair the 
transmission of leptin across the blood-brain-barrier and to impede the activation of central 
leptin signalling [62,63].  
The evidence about the influence of genetic components as determinants of the phenotypic 
response to diet [25,26] points to genetic components as the factors underlying the 
differential responsiveness to the dietary energy density between the LEW and WKY rats. 
The role of peripheral monocytes as professional stress-sensing cells that circulate 
throughout the body and the pivotal role of leptin in the regulation of energy metabolism and 
as an immunoregulator linking nutritional status to the immune response, suggest that 
monocytes and the regulation of their gene expression profiles are highly valuable for the 
determination of the host genetic factors influencing the plasticity of the response to diet-
induced obesity. In this study, the genes and pathways that underlie the strain-specific 
responsiveness to the dietary energy density were determined by comparing the gene 
expression profiles of circulating monocytes from STD diet- and CAF diet-fed LEW and WKY 
rats using genome-wide microarrays. The differentially expressed genes underlying the 
strain-dependent response to the CAF diet were determined by comparing the expression 
profiles of monocytes from CAF-fed WKY and LEW rats. Notably, the genes that were 
significantly overexpressed in WKY rats were over-enriched for the activation of 
inflammatory and immune response GO categories. Indeed, genes encoding classical 
inflammatory mediators, including Ifng, Tnf, Nos2, several interleukins and regulators of 
eicosanoid production were significantly overexpressed in CAF-fed WKY rats. When the 
overexpressed genes in CAF-fed LEW rats were compared with those in WKY rats, the 
strong overexpression of Ldha stands out; Ldha may be involved in the differential energy 
metabolism patterns of both strains. 
Moreover, a gene co-expression network analysis of the differentially expressed genes in 
monocytes identified a module of highly interconnected genes enriched not only for nutrient 
sensing genes but also for response to hormone stimuli and the NOD-like receptor-signalling 
pathway. Acss2 was identified as the most highly connected hub gene and given its degree 
of interconnectivity modification of the expression of Acss2 might have a large impact on the 
biological functions of the cluster [64]. Acss2 encodes a protein member of the Acyl-CoA 
synthetase short-chain family, an enzyme that catalyses the ligation of the acetate derived 
from the β-oxidation of fatty acids to CoA to produce acetyl-CoA for oxidation through the 
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citric acid cycle (TCA); in this way, Acss2 is an essential enzyme for energy expenditure 
under ketogenic conditions [65]. QTLs related to complex obesity-related traits such as body 
weight and glucose and leptin levels were found to overlap within Acss2. Acss2 gene 
expression has been proposed [66] as an accurate diagnostic biomarker of glucose 
intolerance, being negatively correlated with glucose plasma levels. Additionally, Acss2 gene 
expression in WBC has been linked with hepatic concentrations of TCA-involved 
metabolites, including citrate, malate, succinate and fumarate, whose production depends 
directly on the ACSS2 protein activity. Consistent with these results, here we found that, in 
addition to the overexpression of Acss2 in CAF-fed WKY rats, which showed significantly 
lower glucose levels that CAF-fed LEW rats, there is a significant and strong correlation 
between Acss2 gene expression in circulating monocytes and the corresponding glucose 
plasma levels. Acss2 levels also significantly correlate with plasma leptin levels and the 
body weight, traits related to the overlapping QTLs, and with the plasma levels of 
triglycerides and NEFAs. Therefore, our results confirm that a low expression of Acss2 in 
circulating monocytes is an indicator of impaired glucose metabolism. Furthermore, Acss2 is 
involved in de novo lipogenesis, and in the regulation of the triglyceride storage capacity of 
adipose tissue and also plays a key role as a nutrient sensor. Acss2 expression is regulated 
by sterol regulatory element-binding proteins (SREBPs), transcription factors, which are 
believed to be key regulators of nutritional homeostasis [67]. SREBPs, especially SREBP-1, 
which is abundantly expressed in monocytes, have also been described as a link between 
the lipid metabolism and the innate immune response through its direct regulation of core 
genes involved in the inflammasome activation [68], supporting the significant over-
representation of the NOD-like receptor signalling pathway in the co-expressed genes within 
the Acss2-regulated nutrient sensing cluster. Thus, our gene expression and regulatory 
network results suggest that Acss2, a nutrient sensing protein and a diagnostic biomarker of 
glucose resistance, is a key regulator gene for the differential responsiveness to dietary 
energy density and a pivotal genetic link for the integration of metabolic and immune 
homeostasis. 
We found that the phenotypic response of LEW rats to the CAF diet was translated to a 
moderate modification of the gene expression profile of the circulating monocytes from LEW 
rats, and any obvious obesity-related ontology or pathway was enriched. Otherwise, 
although the phenotypic response to the CAF diet in WKY rats was apparently non-existent, 
a substantial set of genes was differentially modulated by the diet. Between the CAF diet-
induced differentially expressed genes highlights the down-regulation of Mir223 expression. 
miR-223, the mature form of Mir223, is a microRNA that is highly expressed in monocytes 
and directly targets STAT3 to regulate its activation; the down-regulation of miR-223 
expression, such as was induced by the CAF diet in monocytes from WKY rats, is 
associated with the activation of STAT3 [50]. This regulatory function of miR-223 may be an 
underlying mechanism and corroborates our results regarding the non-attenuation of 
JAK/STAT signalling pathway induced by high leptin levels observed in WKY rats.  
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Taken together, all the phenotypic and transcriptomics results with respect to the differential 
response of LEW and WKY rats to a diet-induced energy surplus indicate that the regulation 
of the leptin signalling axis might underlie the strain-specific response. 
Our data confirm, in a genotype-independent manner, what has been previously 
hypothesized: an overfeeding-induced increase in adiposity promotes the adipocyte-
mediated up-regulation of leptin transcription, increasing the circulating leptin levels [17]. 
Once it is secreted, plasma leptin can be sensed by the central nervous system, and more 
specifically by the hypothalamus, where leptin recognition by its receptor (LepRb) elicits the 
JAK2-mediated activation of STAT3, a transcription factor that is essential for leptin 
functionality. Remarkably, our analysis of leptin receptor signal transduction in the 
hypothalamus revealed important differences in the regulation of downstream leptin 
signalling between LEW and WKY rats. Although no diet-specific effects were observed 
regarding the amount of LepRb expressed in the hypothalamus, the modulation of 
hypothalamic Socs3 transcription was dependent not only on the diet but also on the genetic 
background. This strain-specific regulation of Socs3 expression by the CAF diet is highly 
relevant for the functionality of leptin signalling because Socs3 acts as a negative-feedback 
regulator of leptin signal transduction by inhibiting JAK tyrosine kinase activity via its binding 
to the Src homology-2 (SH2) domain of the phosphorylated leptin receptor [19]. Thus, while 
the enhanced expression of Socs3 in the hypothalamus of CAF-fed LEW rats confirms the 
attenuation of central leptin signalling, a hallmark feature of leptin resistance [18,19,69,70], 
the down-regulation of Socs3 expression observed in CAF-fed WKY rats is associated with 
an increase in central leptin sensitivity. Therefore the hyperleptinaemia derived from the 
overfeeding-induced adipose tissue expansion in WKY rats was not translated to an 
attenuation of the leptin signalling, but the opposite. This finding can have potential health 
implications because the suppression of hypothalamic Socs3 expression has been proposed 
as a potential therapy to confer resistance to diet-induced obesity [19] and may partially 
explain the non-responsiveness to the dietary energy density observed in CAF fed WKY 
rats. 
Furthermore, the effect of diet on the peripheral regulation of leptin signalling was also 
strain-specific, and the impairment of central leptin signalling in CAF-fed LEW rats was also 
observed in the liver by the significant up-regulation of LepRb transcription and the down-
regulation of Socs3, a phenomenon that is associated with an increase in liver insulin 
sensitivity and with the promotion of the lipogenesis-induced inflammatory response and the 
obesity [71]. Nonetheless, in CAF-fed WKY rats, LepRb gene expression was down-
regulated by the diet, whereas Socs3 expression was slightly but not significantly decreased; 
this peripheral inactivation of LepRb in CAF-fed animals compared with the STD-fed ones is 
consistent with the over-repression of SOCS3 in hypothalamus and is supported by previous 
results [70]. 
Our data proposed SOCS3 and its differential regulation as an important underlying event in 
the genotype-dependent responsiveness to the dietary energy density observed between 
LEW and WKY rats. In fact, the molecular mechanisms that underlie the SOCS3-mediated 
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attenuation of leptin intracellular signalling are based on the binding of SOCS3 to 
phosphorylated Tyr985 in the leptin receptor and the direct binding of SOCS3 to JAK2, 
blocking its docking domain and preventing its phosphorylation as well as the 
phosphorylation and then the activation of STAT3 [15,19,20]. We can therefore hypothesize 
that the maintenance of STAT3 activation through its phosphorylation consequence of 
SOCS3 or miR-223 down-regulation is an essential step for the phenotypic response to diet. 
Moreover, LepRb and its intracellular tyrosine residues may also play a pivotal role in the 
regulation of STAT3 activation under chronic leptin stimulation [69]. Indeed, single-gene 
mutations in the leptin receptor, which are also known as the fa-gene, have been reported to 
be involved in the pathophysiology of obesity. The obese phenotype expressed by the 
Zucker Fatty rats (fa/fa) results from a missense mutation in the extracellular domain of the 
rat leptin receptor diminishing therefore the number of leptin receptors [72,73]. Interestingly, 
another rat model of obesity, the Wistar Kyoto fatty (WKY/NDrt-fa), is a congenic strain of 
WKY rats that resulted from backcrossing the fa-gene from the Zucker rats into the WKY/N 
background [74]. In fact, the selection of WKY rats as the recipient strain of the Zucker fa-
gene was justified due to the glucose metabolism observed in lean WKY rats characterized 
by glucose intolerance accompanied by exaggerated insulin secretion [53,54]. 
Although no strain-dependent differences were observed when comparing the biometric and 
energy intake response to the CAF diet in LEW and WKY rats, the metabolic management of 
the excess of energy were different in the two strains. Our results confirm that the 
phenotypic and genetic responses associated with obesity are more complex than a simple 
balance between energy intake and expenditure and suggest that the genetic background 
plays a prominent role. 
In summary our integrated genetic, phenotypic and monocyte gene expression analyses in 
LEW and WKY rats subjected to metabolic challenge, show that the leptin axis, and 
specifically the LepRb-mediated regulation of STAT3 activation under conditions of chronic 
ligand stimulation, plays a pivotal role in the genotype-dependent adaptation to diet-induced 
obesity.  
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4. General discussion 
The body’s homeostasis is constantly threatened with various types of pathogenic and host-
derived stimuli. A wide-ranging immune response is responsible for preserving the body 
against these homeostatic disturbances. The immune response and metabolism are 
interdependent systems, resulting in an interface that is known as immunometabolism. The 
optimal function and regulation of immunometabolism is crucial for human health.  
Through nutrition the organism is continuously challenged with foreign components and 
other immunologically relevant molecules. These nutrients and food compounds have 
biological and immunological importance in all stages of life. They are essential for the 
survival of the organism, influencing the body’s physiology from absorption through 
metabolism until excretion [110]. Therefore, our hypothesis postulated that molecular signals 
contained in food could modulate the function of immunometabolism through regulation of 
the immune system. In this sense, the nutritional immunotherapy concept refers to the 
promotion of homeostatic balance through natural food-based compounds, optimising the 
body’s own immune system to induce, enhance or suppress the immune response and 
restore the system back to homeostasis.  
To achieve this purpose, it is first necessary to have greater insight about the intricacies of 
the immune response and how it could be modulated by the nutritional profile. Taking this 
into account, the first part of this thesis is focused on the analysis of whether the immune 
system, and specifically its effector cells, the macrophages, is able to sense different dietary 
patterns through a challenge with different bioactive food compounds.  
Consequently, to understand the magnitude of immune regulation by nutrition, it is important 
to characterise the macrophages and their role as innate immune effector cells. 
Macrophages are found in all tissues throughout the body, and the primary function of 
macrophages and their precursors, blood monocytes, is to detect harmful stimuli and 
orchestrate an adequate activation and resolution of the inflammatory response to protect 
the host. This situates macrophages as vital cells for the proper functioning of the immune 
system [111]. Furthermore, macrophages are not only pivotal cells for the immune system 
but also have central functions for the regulation of homeostasis. Macrophage plasticity is 
very great and the microenvironment plays a key role in the phenotypic switch, so once 
stimuli are sensed by the macrophage, the molecular response differs greatly depending on 
the precise nature of the challenge.  
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For that reason, studying the influence of the nutritional profile on macrophage activity can 
be considered a powerful in vitro model to elucidate the potential role of dietary patterns in 
the preservation of immuno-homeostasis. Therefore, the research included in this part aimed 
to identify whether macrophages could be targeted by the diet. We analysed the two most 
important signalling pathways involved in sensing immunological disturbances and activating 
the inflammatory response, the NF-κB and the NLRP3 inflammasome pathways. We further 
sought to determine the molecular mechanisms that underlie the nutritional modulation of 
macrophage activity.  
In this way, according to the first objective proposed, human macrophages were 
challenged with bioactive food compounds, including the pure forms of dimeric and trimetric 
procyanidins (B1, B2 and C1), an n-3 PUFA (the DHA) or the combination of each individual 
procyanidin with DHA, to determine the ability of the tested compounds to modulate the 
activation of the inflammatory response. Procyanidins and DHA have been previously 
described as important immuno-active food compounds [112–115]. Afterwards, 
macrophages were stimulated with bacterial LPS, mimicking innate immune response 
activation. The capacity of the food bioactive compounds to interfere with the activation of 
macrophages was assessed through the modulation of cyclooxygenase-dependent 
eicosanoid production as well as through measurement of TLR4 signal transduction, NF-κB 
transcription factor activation and transcriptional regulation. 
In this sense, we first evaluated whether procyanidins, in pure dimeric and trimeric forms, 
and DHA could specifically modulate the synthesis of PGE2, one the most important 
pleiotropic mediators of inflammation. COX1 and COX2 are the enzymes responsible for 
catalysing the first committed steps in the production of prostaglandins from arachidonic 
acid. Using a cell-free assay, we demonstrated the different abilities of the tested 
procyanidins and DHA to interact with both COX isoforms and alter the affinity of the 
substrate, arachidonic acid. DHA is a potent and selective inhibitor of the COX1 isoform with 
an IC50 of 13.5 μM, being able to modulate the affinity between AA and COX1 by binding at 
a different site than AA, resulting in its mixed inhibitory behaviour. The B1 procyanidin is also 
a specific inhibitor of COX1 activity, with an IC50 of 8.0 μM, although in this case, B1 
competes directly with AA to bind in the active site of the enzyme. Moreover, B2 and C1 
procyanidins are strong and competitive selective inhibitors of the COX2 isoform, with an 
IC50 of 9.7 μM and 3.3 μM, respectively. In addition, this specific behaviour of the 
compounds to decrease the catalytic efficiency of prostaglandin synthesis was also 
corroborated by measuring the secreted levels of PGE2 in human primary macrophages. 
Both COX isoforms have been extensively studied because they are considered pivotal for 
the widespread actions of the inflammatory response. Therefore, COX1 and COX2 are the 
pharmacological targets of the non-steroidal anti-inflammatory drugs (NSAIDs). 
On the other hand, the cell membrane pattern recognition receptor TLR4 is fundamental for 
recognition of harmful stimuli and activation of innate immunity. TLR4, besides being 
considered the host sensor of LPS, is also considered a pivotal sensor for DAMPs 
recognition [10,116]. Therefore, we analysed the capacity of bioactive food compounds to 
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modulate one of the most fundamental pathways of innate immunity, the TLR4 signal 
transduction pathway that results in the activation of the transcription factor NF-κB. NF-κB 
has been shown to tightly regulate gene networks involved in the differentiation, proliferation 
and activation of macrophage effector pathways. Therefore, modulation of the activation of 
NF-κB involves the simultaneous regulation of the transcription of its target genes and their 
downstream pathways.  
We demonstrated that B1, B2 and C1 procyanidins, and DHA alone or in combination with 
procyanidins, prevented activation of the transcription factor NF-κB at both early and late 
stages within the NF-κB signalling pathway. The bioactive food compounds interfere with 
activation of the NF-κB transcription factor by several molecular mechanisms. On the one 
hand, bioactive food compounds can promote the cytoplasmic retention of the NF-κB 
classical heterodimer (p65:p50) and therefore inhibit its nuclear translocation by two 
mechanisms. First, they can mediate the down-regulation of IKKβ activity, which was 
determined by the inhibition of pIκBα phosphorylation, and second, they can promote the up-
regulation of p105. p105 has dual functions within the NF-κB pathway, as it is both the 
precursor of the p50 subunit and is capable of retaining in the cytoplasm all the different NF-
κB subunits. Therefore, the overexpression of p105 could be associated not only with a 
decreased proteolytic formation of p50 but also with an increased cytoplasmic retention of 
NF-κB. On the other hand, the bioactive food compounds, and more specifically DHA, 
stimulate the nuclear translocation of the NF-κB p50:p50 homodimer instead of the p65:p50 
heterodimer. The subunits that compose the NF-κB transcription factor are fundamental 
because while the p65 subunit possesses a transactivation domain, the p50 subunit does 
not [117]; therefore, the presence of the p50:p50 NF-κB homodimer could decrease the 
transcriptional activity of the NF-κB heterodimer. The repression of NF-κB nuclear 
translocation and transcription of its target pro-inflammatory genes was also supported by 
the bioactive compound-induced down-regulation of the binding activity of the p65 subunit to 
the corresponding κB consensus sequence found in the promoter and enhancer regions of 
several pro-inflammatory genes, as well as by the inhibition of secreted levels of the IL-6 
pro-inflammatory cytokine, one of the target genes for the NF-κB transcription factor. 
From the results derived from the first objective, we concluded that macrophages, 
the effector cells of the innate immune system, sense the presence of bioactive food 
compounds in the intercellular microenvironment. All the tested bioactive 
compounds, pure procyanidins, DHA and DHA-procyanidins combinations, have anti-
inflammatory properties. They exert these properties by inhibiting the production of 
prostaglandins through interfering directly and specifically with cyclooxygenases, 
the rate-limiting enzymes, as well as by the suppression of the activation and nuclear 
translocation of NF-κB in LPS-activated macrophages. Furthermore, the molecular 
mechanisms underlying the immunosuppressive functions of the bioactive 
compounds were not the same, which make us consider that the intracellular 
modulation of the inflammatory response is compound-dependent and that intrinsic 
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factors, including chemical properties or the nutritional profile, could determine the 
role of the bioactive compounds as functional modulators of the immune response. 
Once we determined that bioactive food compounds modulate the activation of the 
inflammatory response, we wanted to determine, through the second objective, the 
specificity of macrophages to sense different nutritional profiles. For this purpose we 
evaluated the activation of the NLRP3 inflammasome pathway under different conditions. In 
the first condition, we evaluated the ability of the procyanidin B2 to modulate inflammasome 
activation, and in the second condition we challenged macrophages with four different fatty 
acids to analyse the capacity of the inflammasome to sense different dietary compositions. 
The determination of how the innate immune system senses noxious stimuli is a central 
question in immunology. Whereas TLR4, a Toll-like receptor, detects the presence of 
noxious molecular patterns extracellularly, NLRP3, a NOD-like receptor, recognises 
intracellular stimuli.  
The inflammasome is the putative metabolic sensor that links the inflammatory response 
with metabolism [118]. Inflammasome activation is the result of a two-step process. In the 
first step, a priming signal induces the NF-κB-mediated transcription of the limiting 
inflammasome components, NLRP3 and the immature form of IL-1β, pro-IL-1β. During the 
second step, an activation signal promotes conformational changes that induce NLRP3 
inflammasome assembly and drives the activation of caspase-1, which mediates the 
proteolytic maturation and secretion of IL-1β, which is considered a potent pro-inflammatory 
cytokine that initiates inflammation and metabolic dysfunction. 
Given the potential shown by the procyanidin B2 as an inhibitor of NF-κB activation, along 
with the fact that NF-κB activation is the first step required for inflammasome activation, 
added to the role of TLR4 and NLRP3 as the most important sensors for the innate immune 
system to detect and activate the inflammatory response, we hypothesised that procyanidin 
B2 could also inhibit the activation of the inflammasome and thus the secretion of IL-1β. 
Accordingly, macrophages were primed with LPS with or without the presence of B2, and 
subsequently the inflammasome was specifically activated using ATP. The procyanidin B2 
was chosen because, according to our previous results, procyanidin B2 and procyanidin C1 
were the most immunologically active forms within the pure forms of procyanidins tested. 
However, the bioavailability of procyanidins is largely influenced by their degree of 
polymerisation, and due to the dimeric structure of B2 versus the trimeric of C1, procyanidin 
B2 is favoured for absorption and thus its plasma concentration is higher [119,120]. Whereas 
dimeric procyanidins can be directly absorbed in the small intestine, the absorption of the 
trimeric form is controversial and, unlike B2, there is not a clear consensus regarding its 
unmodified presence in plasma [121]. 
Procyanidin B2 inhibited the activation of the inflammasome at both early and late stages, 
which included the repression of NF-κB-mediated transcription of NLRP3 and pro-IL-1β, two 
limiting components for inflammasome assembly, as well as the activation of caspase-1 and 
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the subsequent release of the cytokine IL-1β. Therefore, we concluded that procyanidin B2 
inhibits the activation of the inflammatory response by blocking the activation of NF-κB and 
the NLRP3 inflammasome, both of which play central roles in sensing noxious stimuli and 
orchestrating inflammatory responses by rapidly inducing a variety of pro-inflammatory 
mediators. 
Within the context of the second proposed objective, we evaluated whether the 
inflammasome could differentially sense the presence of dietary fatty acids. Elevated 
concentrations of free fatty acids are one of the hallmarks of diet-induced obesity. This 
continuous lipid overload promotes a fatty acid spillover in metabolic and non-metabolic 
tissues, which is associated with the recruitment and activation of macrophages [122]. Thus, 
recruited macrophages are exposed to intercellular environments with high concentrations of 
free fatty acids [123]. In addition, the fatty acids contained in the blood and in tissues are 
mainly derived from the diet [124]. Dietary lipids or free fatty acids are more than just 
nutrients for energetic purposes; they are also signalling molecules. It is noteworthy that free 
fatty acids can affect the immune system directly through gene modulation or interference in 
the production of other inflammatory mediators such as the eicosanoids [110]. Dietary fatty 
acids can also be incorporated into cell membranes, and depending on the dietary lipid 
composition, the cellular membrane structure will be affected in terms of its fluidity, lipid raft 
formation, cell signalling and antigen presentation. The ability to be incorporated into the cell 
membrane is dependent upon each fatty acid, which in turn will determine the bioactivity of 
the fatty acid [110]. 
Therefore, taking these considerations into account, we determined the effects of four 
dietary fatty acids, two saturated fatty acids (palmitate and stearic acid), one n-3 fatty acid 
(DHA) and one n-6 (arachidonic acid), on the modulation of inflammasome activation in 
macrophages. The sensing capacity of the inflammasome was evaluated, using the dietary 
fatty acids as a priming signal in ATP-activated macrophages, by measuring the capacity of 
fatty acids to interfere with the LPS-induced inflammasome activation, and by measuring the 
ability of the dietary fatty acids to modulate the activation of the inflammasome. 
From our results we determined that the chemical properties of dietary fatty acids, in terms 
of their degree of saturation, are fundamental for their immunological activity. In this way, the 
stimulation of macrophages with both saturated fatty acids tested (palmitate and stearic 
acid) or arachidonic acid was enough to prime the macrophages and stimulate, together with 
ATP as an additional activation signal, the activation of the inflammasome and the 
subsequent secretion of IL-1β. The capacity of the dietary fatty acids to interfere with LPS-
induced priming and activation of inflammation highlights the role of stearic acid because it 
potentiates the pro-inflammatory effects of LPS. 
Surprisingly, the role of arachidonic acid in the modulation of inflammasome priming and 
activation was dependent on the intracellular environment, that is, using arachidonic acid as 
a priming signal and ATP as an activating signal, the inflammasome became primed and 
activated and the macrophages secreted increased levels of IL-1β. However, with LPS in the 
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cellular milieu, the immunomodulatory effects of arachidonic acid were the reverse, 
decreasing the activation of the NF-κB-mediated priming step and also decreasing the 
secretion of IL-1β. Therefore, the immunomodulatory action of arachidonic acid could be 
mediated by its incorporation into cell membranes, interfering in membrane receptor function 
and in LPS-TLR4 signal transduction [125]. 
DHA was not able to induce activation of the inflammasome, and when macrophages were 
stimulated with LPS, DHA inhibited the activation of the inflammasome mainly through the 
inhibition of NF-κB activation rather than directly affecting the second step of inflammasome 
activation.  
We also showed that palmitate was the only tested dietary fatty acid with a direct 
engagement of immune sensors, being able to enhance the secretion of IL-1β. However, 
although there is evidence indicating that palmitate is a TLR4 ligand able to activate NF-κB, 
it is not clear if palmitate is also able to bind to the NLRP3 inflammasome and directly 
activate the caspase-1 mediated maturation of IL-1β. Furthermore, the interaction between 
macrophages and palmitate is associated with the production of reactive oxygen species 
(ROS), one of the described DAMPs for inflammasome activation [126]. 
Taking together all the results included within the second objective, we concluded 
that bioactive food compounds promote functional changes in innate effector 
immune cells, as well as that bioactive food compounds can modulate the activation 
of inflammation and the innate immune system. In addition, our results demonstrated 
that the immunological activity of food compounds is bioactive-dependent and 
therefore, macrophages and their receptors, including TLR4 and NLRP3, may 
recognise specific bioactive food motifs. 
Once we determined the pivotal role of the nutritional profile in the modulation of innate 
immunity, through the modulation of the activation of the inflammatory response in human 
macrophages, we set out to extrapolate our objectives to an in vivo model to incorporate the 
complex and interdependent functional connections between the immune system and 
metabolism. In obesity, the immune response, nutrition and metabolism are closely 
interconnected. Accordingly, the second part of this thesis is focused on understanding the 
role of the nutritional profile in the immunometabolic balance and in the maintenance of 
homeostasis. To achieve this objective, Wistar rats were immunometabolically challenged 
using highly palatable and energy dense foods, also known as the cafeteria (CAF) diet. 
By feeding the CAF diet, which is considered a robust model of human metabolic syndrome 
[99], the body weight and the adiposity of the rats increased. Our results confirmed that in a 
diet-induced obesity context, the adipose tissue is a powerful immune organ, and the 
functions of adipocytes exceed the mere storage of surplus energy. It has been described 
[122] that when adipocytes store too much lipid, they begin to expand and rapidly proliferate, 
causing a lack of oxygen that leads to hypoxic conditions. As a consequence, fat cells die 
and release their lipid cargo. This process features a shift in the immunological profile of 
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adipose tissue, turning it from anti-inflammatory to proinflammatory, which is manifested by 
the up-regulation of IL-6 and Tnf-α pro-inflammatory gene expression and the down-
regulation of IL-10, an anti-inflammatory cytokine. As the fat cells die, macrophages travel to 
the over-expanded fat depots to remove the lipid droplets. Increased circulating levels of the 
chemotactic protein MCP-1 and expression of the F4/80 gene, a selective macrophage 
marker in adipose tissue, support this adipose-mediated recruitment of macrophages. 
However, as macrophages are not as efficient as adipocytes at storing lipids, they begin to 
spill over into other tissues, such as the liver or the pancreas [122]. The inappropriate 
accumulation of lipids amplifies the local low-grade inflammation into a systemic 
immunometabolic imbalance through the modulation of the circulating pattern of 
immunoregulatory factors. This imbalance results in increased circulating levels of acute 
phase proteins, such as complement factor C3 and orosomucoid, as well as changes in 
adipokines, such as elevated leptin and lowered adiponectin levels. 
It has been widely described that diet-induced obesity is accompanied by a low-grade 
inflammatory response in metabolic tissues, a fact considered a pivotal feature of chronic 
metabolic disorders [123,127,128]. The role of the thymus and spleen, a primary and 
secondary lymphoid organ, respectively, in the regulation of this metaflammation is 
unknown. For this reason, in our third objective we evaluated the effect of diet-induced 
obesity in the thymus and the spleen. 
The thymus is a vital organ for maintenance of the homeostasis of the peripheral immune 
system, as it is responsible for the maturation and output of de novo T cells. In the thymus, 
no differences were found in terms of weight, although the thymic appearance was 
profoundly influenced by the CAF diet, indicating that the obesity-induced lipid spillover can 
affect not only metabolic tissues but also the thymus. Moreover, the existence of 
immunometabolic interactions in the thymus has been postulated, leading to massive 
architectural changes over time that result from the replacement of thymocytes by 
adipocytes and leading to a thymic atrophy-induced immunodeprivation [129]. Diet-induced 
obesity also affected the functionality of the thymus by the alteration of the expression 
pattern of genes involved in the proliferation and de novo generation of T cells, including 
decreased IL-6 and IL-10 cytokine gene expression and the expression of the macrophage 
marker F4/80, which performs crucial functions for T cell maturation [130]. The obesity-
induced decreased generation of de novo T cells, also known as lymphopenia, has 
deleterious consequences for the host because it results in a T cell pool containing dominant 
memory T cell clones. This limits the diversity and the repertoire of T cells, which impairs the 
establishment of a functional and effective immune system [131]. 
In addition, the spleen is the largest secondary lymphoid organ in the body and plays an 
important role not only for blood filtration but also for the immune-metabolic-endocrine 
network. The spleen is where the interaction between bloodstream metabolites and immune 
cells occurs [50]. Furthermore, an interplay also exists between the spleen and the liver for 
the regulation of immunometabolism [132]. We showed that diet-induced obesity resulted in 
a decrease in splenic weight, leading to a reduction in macrophages counts, as evidenced 
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by a decrease in F4/80 gene expression. We also showed that obesity impairs the immune 
response by decreasing oxidative burst activity and the activation of macrophages by 
reducing the production of reactive oxygen species (ROS), events associated with increased 
expression levels of the Ucp2 gene and decreased IL-6 and Crp gene expression, both 
inflammatory biomarkers. Furthermore, diet-induced obesity supresses the splenic 
expression of IL-10, a marker of B cells. The down-regulation of IL-10 gene expression in the 
spleen has been related to the promotion of chronic inflammation in adipose tissue, the liver 
and the hypothalamus [133].  
From the results elucidated by this third objective, we concluded that diet-induced 
obesity disturbs immunometabolic homeostasis, affecting the immune function and 
gene expression of adipose tissue and also of lymphoid organs. In this way, whereas 
obesity induced an inflammatory response in adipose tissue, the functionality of 
lymphoid organs, in terms of their capacity to sense homeostatic disturbances and 
trigger responses to restore homeostasis, is weakened. 
In accordance with our results originating from the last objective, we hypothesised that 
nutrition can target the immunometabolic axis, impairing its functionality; nevertheless, the 
main objective of our research was not only to know the impact of an unhealthy diet on 
immune homeostasis but also to determine the potential of foods and bioactive compounds 
to be used as tools to promote the proper function of the immune system and therefore to 
improve health through nutrition. Accordingly, with our fourth objective we proposed to 
counteract the immunometabolic impairment derived from an obesity-induced homeostasis 
imbalance through the dietary intake of food extracts rich in bioactive food compounds with 
known immunomodulatory properties.  
For this purpose, using the previously described in vivo model of unbalanced 
immunometabolic homeostasis resulting from intake of the CAF diet, we assessed the 
potential of nutritional immunotherapy by supplementing the diet of unhealthy obese rats 
with the extracts of foods containing immunologically active compounds, including the grape 
seed procyanidin extract (GSPE), an oil rich in DHA (DHA-OR) and the combination of both. 
As we determined previously, diet-induced obesity triggered a local inflammatory response 
in the adipose tissue. Therefore, we first analysed the effects of the bioactive supplements 
on the immune profile of adipose tissue, to corroborate the anti-inflammatory properties 
observed in vitro for both the pure forms of procyanidins and DHA. Thus, we showed that 
supplementation of the cafeteria diet with GSPE, DHA-OR or the combination of both 
bioactive compounds supressed the obesity-triggered inflammatory response. 
Supplementation induced a phenotypic shift of the pro-inflammatory immunological profile of 
the adipose tissue, promoted the resolution of inflammation through the down-regulation of 
gene expression of inflammatory mediators such as IL-6, Tnf-α, and iNOS, and induced 
transcription of the IL-10 gene. 
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Additionally, it is noteworthy that the immunomodulatory effects of the bioactive compounds 
are not limited to the modulation of immunity at a molecular level, as cell-mediated immunity 
was also influenced. Therefore, the presence and recruitment of macrophages to the 
adipose tissue of the bioactive-supplemented rats was decreased, as is reflected by the 
down-regulation of F4/80 gene expression and also by the decrease in circulating levels of 
the chemotactic factor MCP-1. In agreement with our results, the profile of T cells within 
adipose tissue was also influenced by supplement intake, promoting the recruitment of 
Tregs, the immunosuppressive CD4+ lymphocytes, characterised by the production of IL-10 
and the promotion of the anti-inflammatory M2 macrophage phenotype [134,135]. 
Furthermore, the local anti-inflammatory properties of the bioactive compounds were also 
observed at the systemic level by the down-regulation of the circulating levels of acute 
inflammation biomarkers, such as complement C3 and orosomucoid, to levels similar to 
those determined for rats fed a standard diet. 
Moreover, we determined the potential of bioactive compound-based nutritional 
immunotherapy to counteract the obesity-induced weakened immune system by analysing 
the immunomodulatory effects of the bioactive compounds on thymus and spleen 
functionality. We also analysed their regulatory effects on T cell populations in the thymus, 
the spleen and as part of the circulating PBMCs population. Notably, the bioactive 
compounds, and more strongly the combination of GSPE and DHA, induced the generation 
of naïve T cells, determined by increased counts of both thymocytes and also CD4+CD8+ T 
cells in the thymus. Furthermore, this striking immunostimulatory effect in the thymus was 
also reflected in the quantification of increased numbers of both CD4+ and CD8+ T cells 
within the population of circulating PBMCs. The bioactive compounds, particularly GSPE, 
also neutralised obesity-induced thymic atrophy. 
The cafeteria diet supplemented with GSPE and DHA, and particularly the GSPE-DHA 
combination, increased the size of splenocytes and also the capacity of the spleen to 
counteract obesity-induced immunometabolic dysfunction, reflected by increased 
transcription of IL-6 and Tnf-α, both immune response boosters, as well as increased 
numbers of immune cells, including macrophages and CD8+ T cells, which play a key role in 
linking the innate and adaptive immune responses.  
The immunostimulatory properties of the bioactive compounds are based on their capacity to 
promote the generation of de novo T cells, as well as their role in boosting splenic function to 
counteract obesity-induced immunotolerance. They furthermore improve the capacity of the 
immune system to sense noxious stimuli and enhance the responsiveness of the immune 
system against obesity-triggered homeostatic disturbances.  
Additionally, the intake of GSPE and DHA in combination improved the immunomodulatory 
effects observed when supplementing the bioactive compounds separately. Indeed, although 
adiposity and circulating leptin levels increased, the local and systemic inflammatory 
responses were supressed and the functionality of the thymus and spleen was enhanced. In 
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this way, leptin could be playing a key role in the stimulation of the immune system. 
According to our results, the rats that were supplemented with the GSPE-DHA combination 
had higher circulating leptin levels as well as a major infiltration of Treg cells and IL-10 
secretion in the adipose tissue. In addition, this group of rats also showed significantly higher 
counts of thymocytes and naïve T cell generation in circulation. 
Targeting immunometabolism through the intake of food extracts rich in procyanidins 
and DHA, both immunologically bioactive compounds, improves health by targeting 
the immunometabolic axis and counteracting the obesity-induced homeostatic 
imbalance. We can conclude that in the context of obesity-induced unhealthy rats, 
the combination of both tested bioactive compounds, GSPE and DHA, provides 
added value to the anti-inflammatory effects observed for each bioactive compound 
individually. So, whereas DHA is mainly characterised by its anti-inflammatory 
properties and GSPE by its capacity to boost the immune response, in combination 
they improve both properties, increasing both anti-inflammatory and 
immunostimulatory effectiveness. 
Obesity is not a simple consequence of the positive energy imbalance resulting from the 
difference between energy intake and expenditure. There is strong evidence that obesity is a 
complex phenotype resulting from the interaction of both genetic and environmental factors 
[107,109,136–138]. Metabolic challenge in combination with nutrigenomics approaches, 
such as the transcriptomics, is a powerful tool to understand the phenotypic response and 
gene-diet interactions. In addition, much greater complexity is revealed when the phenotypic 
effect is compared between the different genetic backgrounds of inbred strains.  
Therefore, in our fifth objective, two rat strains were simultaneously exposed to a defined 
environmental (dietary) challenge to determine the molecular and genetic factors involved in 
the phenotypic response to obesity. For this reason, we subjected the LEW and WKY rats, 
two phenotypically different inbred rat strains, to a diet challenge based on dietary energy 
content. After 7 weeks of challenge, either with the standard (STD) or CAF diet, the 
physiological response at the organism level, energetic metabolism, modulation of the 
plasma metabolites and the dietary influence on the transcriptional profile of circulating 
monocytes were carefully analysed. 
As expected, offering the CAF diet to rats resulted, independently of genetic background, in 
a voluntary hyperphagia that led to a high increase in energy intake resulting mainly from the 
preference for fat intake. CAF diet-induced body weight gain was accompanied by greater 
increases of whole body fat mass. However, the distribution of visceral fat mass was 
different between both strains. While LEW rats exhibited a significant increase in the weight 
of mesenteric, epididymal and perirenal fat pads, WKY only had increased weight of the 
epididymal and perirenal fat pads, with varying weights of the mesenteric fat pad. According 
to previous studies, the inappropriate localisation of accumulated fat can cause health 
problems [122]. 
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The postprandial energy metabolism pattern and peripheral substrate utilisation in response 
to the increased energy intake were also strain-specific. In LEW rats, the diet-induced weight 
gain of the CAF group was supported by increased energy intake and the maintenance of 
the expended energy, as well as through the carbohydrate-to-fat switch as the primary 
oxidation fuel source, showing a pattern of energy metabolism in accordance with those 
observed previously for diet-induced obesity in rats [139,140]. However, despite the fact that 
diet-induced weight gain in WKY rats was supported by an increase of energy intake, energy 
expenditure was also higher for the rats that were fed the CAF diet. 
The influence of genetic background in the obesity phenotype was also supported through 
the determination of a strain-specific differential profile of plasma metabolites between CAF 
fed LEW and WKY rats. While the CAF diet challenge induced hyperglycaemia, 
hypertriglyceridemia and high levels of circulating free fatty acids in LEW rats, the 
concentrations of the corresponding metabolites were unaltered by the diet in WKY rats. 
Regarding the diet-induced modulation of immunometabolic mediators, the CAF diet 
promoted higher plasma leptin levels in a genotype-independent manner. However, the 
circulating levels of MCP-1, a chemoattractant that reflects the activation of the local 
inflammatory response and the obesity-induced recruitment of monocytes to adipose tissue 
[141], were only augmented in LEW rats fed the CAF diet.  
To gain insight into the complex interactions between genetic and dietary factors in obesity, 
we focused on the genotype-dependent modulation of the whole genome expression profiles 
of the circulating monocytes in LEW and WKY rats. The usefulness of PBMCs for nutrition 
and obesity studies has been previously highlighted, suggesting that these circulating cells 
are a potential source of homeostatic imbalance markers associated with obesity, as well as 
suggesting that the modulation of the gene expression of PBMCs reflects the transcriptional 
changes in many solid tissues, including liver, adipose tissue and muscle [31,32]. However, 
in these studies the PBMCs were considered a black box and the variability of the cellular 
pool was not taken into account, which, as we have demonstrated in our fourth objective, 
could be significantly affected by the nutritional profile. For this reason, we isolated only the 
monocyte fraction from the pool of PBMCs to increase robustness and eliminate the 
variability derived from the great phenotypic complexity of the immune cells.  
Circulating monocytes are considered the peripheral sensors of immunometabolic 
homeostasis, and we used different approaches to identify the genetic basis for the 
differential phenotypic response to diet-induced obesity. First, through the comparison of the 
transcriptome of monocytes between the CAF diet fed LEW and WKY rats, we determined 
that the modulation of the gene expression profile was also genotype-dependent. Notably, 
the genes overexpressed in WKY monocytes were functionally enriched into inflammatory 
and immune responses, as well as into the positive regulation of the JAK-STAT cascade 
through the promotion of the tyrosine phosphorylation of STAT3. However, the genes over-
expressed in CAF-diet-fed LEW rats were not as numerous as in WKY rats, highlighting the 
functional gene enrichment of the immune system. 
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Second, mediating the gene co-expression network based on the genes whose expressions 
were modulated genotype-specifically by the CAF diet, the power to detect gene-gene 
interactions genome-wide was enhanced. The clustering of the co-expressed genes 
revealed a sub-network of genes functionally enriched as nutrient sensors, responders to 
hormonal stimuli and components of the NOD-like receptor-signalling pathway. Remarkably, 
the Acyl-CoA synthetase short-chain family member 2 (Acss2) was identified as the hub 
within the gene sub-network. Additionally, Acss2 is considered a nutrient-sensor gene, and 
besides overlapping with the metabolism-related quantitative trait locus (QTLs), we 
corroborated that Acss2 gene expression in peripheral monocytes is inversely associated 
with the plasma levels of glucose, triglycerides, leptin and NEFAs as well as with body and 
adiposity weights, being considered as a biomarker of glucose intolerance [142]. The 
expression of Acss2 is regulated by the sterol regulatory element-binding proteins (SREBPs) 
transcription factors, which are key regulators of energy homeostasis and links between lipid 
metabolism and the innate immune response, directly mediating the regulation of the genes 
involved in inflammasome activation [143]. 
Third, by the comparison of the gene expression profiles between the monocytes of CAF diet 
fed rats of each strain with the respective genotype-STD diet control groups, we found a 
moderate diet-induced modulation of the monocyte transcriptome in LEW rats. Surprisingly, 
although the phenotypic response of WKY rats to the CAF diet challenge was apparently 
non-existent, a substantial set of genes was modulated differentially by the diet. Among all 
the differentially expressed genes due to the CAF diet, a highlight was the down-regulation 
of Mir223 gene expression, the immature form of miR-223. A decrease in miR-223 
expression resulted in the activation of STAT3 in macrophages, which is directly targeted by 
miR-223, and in JAK2-STAT3 signal transduction [144]. 
Taking into account the strain-specific phenotypic response, as well as the differential 
modulation of gene expression profiles by diet induced-obesity, the evidence suggested that 
the leptin signalling pathway might be underlying these differences. Despite the fact that the 
expression of the leptin gene in adipose tissue and the plasma leptin levels were genotype-
independently increased by the CAF diet, the subsequent metabolic events underlying the 
complexity of the obesity phenotype were strain-specific. It is noteworthy that, in accordance 
with the early events associated with obesity-induced immunometabolic homeostatic 
imbalance, chronic overfeeding results in overexpansion of adipose tissue and 
hyperleptinemia. This chronic stimulation of central leptin signalling leads to the attenuation 
of signal transduction and resistance to the immunomodulatory effects of leptin. To better 
understand the role of leptin signalling in the strain-specific phenotypic and genotypic 
response to diet-induced obesity, the expression of the pivotal genes involved in the central 
and peripheral regulation of the leptin signal transduction pathway were analysed. We found 
that, while no diet-related effects were observed regarding the modulation of the leptin 
receptor (LepRb) in the hypothalamus, the regulation of Socs3 gene expression, the 
negative feedback regulator of leptin signal transduction, was dependent not only on the 
genetic background but also on the diet. While the diet-induced up-regulation of Socs3 gene 
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expression in the hypothalamus of the LEW rats supported their central leptin resistance, the 
Socs3 down-regulation in the hypothalamus of the CAF diet-induced obese WKY rats 
confirms the non-attenuation of central leptin signalling. The suppression of hypothalamic 
Socs3 gene expression has been postulated as a potential mechanism underlying the 
resistance to diet-induced obesity [145]. 
In conclusion, the phenotypic and transcriptome characterisation of the response of 
LEW and WKY rats to a hyper-caloric diet challenge outlined the pivotal role of the 
genetic background within the complex interaction between the genetic and the 
dietary factors. Our analyses revealed that whereas LEW rats were prone to diet-
induced obesity, the WKY rats were resistant and that this disparity is closely related 
to a differential regulation of central leptin signal transduction. 
In summary, we conclude from our studies that the nutritional profile is a powerful tool to 
target the immunometabolic axis and that bioactive food compounds, such as the 
procyanidins and docosahexaenoic n-3 fatty acid, improve immune system efficiency, thus 
promoting homeostasis and a healthy state. 
The main conclusions obtained from this thesis are: 
1. NF-κB and NLRP3 inflammasome signalling pathways enable macrophages to 
sense their environment and shape immune responses. 
2. LPS-induced macrophage activation can be supressed by bioactive food 
compounds. 
• B1, B2 and C1 procyanidins and DHA inhibit the activation and nuclear translocation 
of the transcription factor NF-κB. 
• Bioactives compounds interfere with the production of prostaglandins by direct and 
specific modulation of COX activity. While B1 procyanidin and DHA are strong and 
selective inhibitors of COX1, the B2 and C1 procyanidins are selective suppressors 
of COX2 activity. 
3. NLRP3 inflammasome activation depends on dietary composition. 
4. The immunological activity of food compounds is dependent on bioactive 
compounds. 
• The pure procyanidins tested (B1, B2 and C1) and the PUFAs (DHA and arachidonic 
acid) are anti-inflammatory compounds. However, SFAs (palmitate and stearic acid) 
are pro-inflammatory dietary compounds. 
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5. Diet induced obesity significantly affects immunometabolic homeostasis. 
• Triggering adipose tissue-mediated inflammation. 
• Impairing the immune function of the thymus and spleen. 
6. Nutritional immunotherapy allows improved health through targeting 
immunometabolic function with bioactive food compounds. 
• GSPE and DHA counteract obesity-induced inflammation in adipose tissue as well 
as weakened immunity. 
• The administration of GSPE and DHA together provides added value to the 
immunomodulatory effects observed for each bioactive compound individually. 
• Supressing adipose tissue-triggered inflammatory response. 
• Boosting the immune system to resolve the obesity-induced homeostatic 
disturbance. 
7. The genetic background plays a pivotal role in the complex interaction between the 
genetic and dietary factors that result in the phenotypic expression of obesity-
associated traits. 
• While LEW rats are prone to diet-induced obesity, WKY rats are resistant. 
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Abbreviations 
APC Antigen-presenting cell 
Asc Apoptosis associated speck-like protein 
CAF Cafeteria 
COX Cyclooxygenase 
DAMP Damage-associated molecular pattern 
DC Dendritic cell 
DHA Docosahexaenoic acid 
ERK Extracellular signal-regulated protein 
kinase 
FFA Free fatty acid 
Foxp3 Forkhead-winged-helix transcription 
factor 3 
GSPE Grape seed procyanidin extract 
IFN-γ  Interferon γ 
Ig Immunoglobulin 
IKK IκB kinase 
IL Interleukin 
iNOS Inducible nitric oxide synthase 
JAK Janus kinase 
JNK c-Jun N-terminal kinase 
LPS Lipopolysaccharide 
LRR Leucine-rich repeat 
MAPK Mitogen-activated protein kinase 
MCP-1 Macrphage chemotactic protein-1 
miR MicroRNA 
NEFA Non-esterified fatty acid 
NF-κB Nuclear factor κB 
NLR Nod-like receptor 
NLRP3 Nod-like receptor protein 3 
NO Nitric oxide 
NSAID Non-steroidal anti-inflammatory drug 
PAMP Pathogen-associated molecular pattern 
PBMC Peripheral blood mononuclear cell 
PGE2 Prostaglandin E2 
PLA2 Phospholipase A2 
PPAR-γ Peroxisome-proliferator-receptor-
activated γ 
PRR Pattern recognition receptor 
PUFA Polyunsaturated fatty acid 
RHD Rel homology domain 
ROS Reactive oxygen species 
SFA Saturated fatty acid 
STAT Signal transducer and activator of 
transcription 
TIR Toll/IL-1 receptor 
TLR Toll-like receptor 
TNF-α  Tumour necrosis factor α
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Resum 
La immunoteràpia nutricional es basa en fomentar la salut mitjançant el consum de 
compostos bioactius presents de manera natural en els aliments, com les procianidines, un 
tipus de flavonoid, i/o l’àcid docosahexaenoic (DHA), un àcid gras omega-3, optimitzant la 
funcionalitat del propi sistema immune i millorant així el seu paper com a responsable de la 
preservació de l’organisme enfront desestabilitzadors de la homeòstasis. La recerca que 
aquesta tesi abasta es centra en el paper del perfil nutricional en la regulació de la interacció 
immunitat-metabolisme (immunometabolisme). 
Amb aquesta finalitat, en la primera part del treball presentat en aquesta tesi, es va 
determinar si els macròfags, les cèl·lules efectores de la immunitat innata, poden percebre 
de manera diferencial la composició de la dieta. Hem demostrat que els compostos 
bioactius dels aliments modulen, a nivell molecular, l’activació dels macròfags. A més, 
aquest efecte immunomodulador és dependent del compost, on factors intrínsecs com les 
propietats químiques o nutritives són determinants per la seva bioactivitat. 
La segona part va tenir com a objectiu determinar el paper primordial del patró nutricional en 
la regulació de la interacció entre el sistema immune i el metabolisme. Utilitzant un model 
d’obesitat induïda per la dieta es va inferir que, mentre una dieta hipercalòrica provoca un 
deteriorament de l’immunometabolisme, el consum de bioactius com les procianidines i/o el 
DHA, pot enfortir-ne la relació. 
A la tercera part, es va analitzar el paper de les interaccions gen-dieta en l’expressió 
fenotípica dels trets associats amb la obesitat. Per aquest motiu, dos races de rates 
congènites, fenotípicament diferents, van ser sotmeses a un desequilibri immunometabòlic 
com a conseqüència de la ingesta d’una dieta hipercalòrica. Es va deduir que les 
interaccions entre els factors genètics i nutricionals són fonamentals per a la susceptibilitat 
d’un genotip a l’obesitat induïda per la dieta. 
Hem establert que el perfil nutricional és una eina poderosa per orientar la funcionalitat de 
l’eix immunometabòlic. A més, arribem a la conclusió que compostos bioactius presents en 
els aliments poden millorar-ne l’eficiència d’aquest eix, promovent així un estat saludable. 
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